Processing 00000000.tx.1: Familial Danish Dementia CO-EXISTENCE OF DANISH AND ALZHEIMER AMYLOID SUBUNITS (ADan AND A) IN THE ABSENCE OF COMPACT PLAQUES* Yasushi Tomidokoro, Tammaryn Lashley, Agueda Rostagno, Thomas A. 

Phrase: "Familial Danish Dementia CO-EXISTENCE OF DANISH"

Phrase: "AND"

Phrase: "ALZHEIMER AMYLOID SUBUNITS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "(ADan"

Phrase: "AND"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "IN THE ABSENCE"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "OF COMPACT PLAQUES"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "* Yasushi Tomidokoro,"

Phrase: "Tammaryn Lashley,"

Phrase: "Agueda Rostagno,"

Phrase: "Thomas A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.2: Neubert||, Marie Bojsen-Mller**, Hans Braendgaard, Gordon Plant, Janice Holton, Blas Frangione, Tamas Rvsz, and Jorge Ghiso1 From the Departments of Pathology, Psychiatry, and Pharmacology and the ||Skirball Institute for Biomolecular Medicine, New York University School of Medicine, New York, New York 10016, the Department of Neuropathology and Brain Bank, Institute of Neurology, London WC1N3BG, United Kingdom, the Departments of **Neuropathology and Neurology, rhus University Hospital, rhus DK8000, Denmark, and The National Hospital for Neurology and Neurosurgery, London WC1N3BG, United Kingdom Received for publication, April 13, 2005 , and in revised form, August 5, 2005.  

Phrase: "Neubert||,"

Phrase: "Marie Bojsen-Mller"

Phrase: "*"

Phrase: "*,"

Phrase: "Hans Braendgaard,"

Phrase: "Gordon Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0032098:Plant [Plant]
   768 E C0006038:Botany [Occupation or Discipline]
   750 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "Janice Holton,"

Phrase: "Blas Frangione,"

Phrase: "Tamas Rvsz,"

Phrase: "and"

Phrase: "Jorge Ghiso1 From the Departments of Pathology,"

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "and"

Phrase: "Pharmacology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "and"

Phrase: "the ||Skirball Institute for Biomolecular Medicine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0021621:institute medicine [Health Care Related Organization]
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: "New York University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York 10016,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]

Phrase: "the Department of Neuropathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587493:Neuropathology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Brain Bank,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442598:Bank [Manufactured Object]
   861   C0872261:Bank [Manufactured Object]

Phrase: "Institute of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "London WC1N3BG,"

Phrase: "United Kingdom,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: "the Departments of **Neuropathology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   827   C1540677:neuropathology [Pathologic Function]
   827   C1555824:Neuropathology [Intellectual Product]

Phrase: "and"

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "rhus University Hospital,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "rhus DK8000,"

Phrase: "Denmark,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: "and"

Phrase: "The National Hospital for Neurology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   760   C1510665:Hospital [Qualitative Concept]

Phrase: "and"

Phrase: "Neurosurgery,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027926:Neurosurgery [Biomedical Occupation or Discipline]
  1000   C0524850:Neurosurgery [Therapeutic or Preventive Procedure]

Phrase: "London WC1N3BG,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "April 13,"

Phrase: "2005 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "August 5,"

Phrase: "2005."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES DISCUSSION REFERENCES  Familial Danish dementia is an early onset autosomal dominant neurodegenerative disorder linked to a genetic defect in the BRI2 gene and clinically characterized by dementia and ataxia. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Familial Danish dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "an early onset autosomal dominant neurodegenerative disorder"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   904   C0814120:early onset disorder [Disease or Syndrome]
   876   C0277793:onset disorder [Temporal Concept]
   827   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   799   C0012634:Disorder [Disease or Syndrome]

Phrase: "linked to a genetic defect"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   778   C0000768:Birth Defect [Congenital Abnormality]
   778   C1737329:Birth defect [Congenital Abnormality]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "in the BRI2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "clinically"

Phrase: "characterized by dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "ataxia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004134:Ataxia [Sign or Symptom]
   928 E C0234366:Ataxic [Sign or Symptom]
Processing 00000000.tx.4: Cerebral amyloid and preamyloid deposits of two unrelated molecules (Danish amyloid (ADan) and -amyloid (A)), the absence of compact plaques, and neurofibrillary degeneration indistinguishable from that observed in Alzheimer disease (AD) are the main neuropathological features of the disease. 

Phrase: "Cerebral amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "preamyloid deposits of two unrelated molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333562:Deposits [Functional Concept]

Phrase: "(Danish amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(ADan"

Phrase: ")"

Phrase: "and -"

Phrase: "amyloid (A)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "the absence of compact plaques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "neurofibrillary degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085400:Neurofibrillary degeneration [Acquired Abnormality]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "indistinguishable from that"

Phrase: "observed in Alzheimer disease (AD)"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1441672:Observed [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "the main neuropathological features of the disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.5: Biochemical analysis of extracted amyloid and preamyloid species indicates that as the solubility of the deposits decreases, the heterogeneity and complexity of the extracted peptides exponentially increase. 

Phrase: "Biochemical analysis of extracted amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "preamyloid species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "indicates"

Phrase: "that"

Phrase: "as"

Phrase: "the solubility of the deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037628:Solubility [Qualitative Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "the heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "and"

Phrase: "complexity of the extracted peptides exponentially"

Phrase: "increase."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.6: Nonfibrillar deposits were mainly composed of intact ADan-(1-34) and its N-terminally modified (pyroglutamate) counterpart together with A-(1-42) and A-(4-42) in 1:1 mixture. 

Phrase: "Nonfibrillar deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "were"

Phrase: "mainly"

Phrase: "composed of intact ADan-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205266:Intact [Qualitative Concept]
   770   C1554187:Intact [Idea or Concept]

Phrase: "(1-34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "its N-terminally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "(pyroglutamate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "counterpart together with A-"

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "in 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1 mixture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]
Processing 00000000.tx.7: The post-translational modification, glutamate to pyroglutamate, was not present in soluble circulating ADan. 

Phrase: "The post-translational modification,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modification [Molecular Function]
   827   C0392747:Modification [Functional Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1554963:modification [Qualitative Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "glutamate to pyroglutamate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in soluble circulating ADan."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0175630:Circulating [Functional Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
Processing 00000000.tx.8: In the amyloid fractions, ADan was heavily oligomerized and highly heterogeneous at the N and C terminus, and, when intact, its N terminus was post-translationally modified (pyroglutamate), whereas A was mainly A-(4-42). 

Phrase: "In the amyloid fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "ADan"

Phrase: "was"

Phrase: "heavily"

Phrase: "oligomerized"

Phrase: "and"

Phrase: "highly heterogeneous at the N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019409:Heterogeneous [Qualitative Concept]

Phrase: "and"

Phrase: "C terminus,"

Phrase: "and"

Phrase: ","

Phrase: "when"

Phrase: "intact,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "its N terminus"

Phrase: "was"

Phrase: "post-translationally"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "(pyroglutamate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "mainly A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")."
Processing 00000000.tx.9: In all cases, the presence of A-(X-40) was negligible, a surprising finding in view of the prevalence of A40 in vascular deposits observed in sporadic and familial AD, Down syndrome, and normal aging. 

Phrase: "In all cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the presence of A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(X-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "negligible,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332269:Negligible [Qualitative Concept]

Phrase: "a surprising finding in view of the prevalence of A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0037088:Finding [Sign or Symptom]
   739   C0243095:Finding [Finding]
   739   C2825141:Finding [Finding]

Phrase: "in vascular deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "observed in sporadic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205422:Sporadic [Temporal Concept]
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "familial AD,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "Down syndrome,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "and"

Phrase: "normal aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]
Processing 00000000.tx.10: Whether the presence of the two amyloid subunits is imperative for the disease phenotype or just reflects a conformational mimicry remains to be elucidated; 

Phrase: "Whether"

Phrase: "the presence of the two amyloid subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "imperative for the disease phenotype"

Phrase: "or"

Phrase: "just"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a conformational mimicry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0233577:Mimicry [Mental or Behavioral Dysfunction]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated"

Phrase: ";"
Processing 00000000.tx.11: nonetheless, a specific interaction between ADan oligomers and A molecules was demonstrated in vitro by ligand blot analysis using synthetic peptides. 

Phrase: "nonetheless,"

Phrase: "a specific interaction between ADan oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "A molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "was"

Phrase: "demonstrated"

Phrase: "in vitro by ligand blot analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synthetic peptides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]
Processing 00000000.tx.12: The absence of compact plaques in the presence of extensive neuro fibrillar degeneration strongly suggests that compact plaques, fundamental lesions for the diagnosis of AD, are not essential for the mechanism of dementia.  

Phrase: "The absence of compact plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of extensive neuro fibrillar degeneration strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0011164:Degeneration [Pathologic Function]
   804   C1880269:Degeneration [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that compact plaques,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "fundamental lesions for the diagnosis of AD,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0221198:lesions [Finding]
   711 E C1546698:Lesion [Intellectual Product]

Phrase: "are"

Phrase: "not essential for the mechanism of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES DISCUSSION REFERENCES  Familial Danish dementia (FDD),2 originally described by Strmgren et al. in 1970 (1) as heredopathia opthalmo-oto-encephalica, is an early onset autosomal dominant neurodegenerative disorder characterized by cataracts, deafness, progressive ataxia, and dementia (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Familial Danish dementia (FDD),"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "2 originally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "described by Strmgren et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]

Phrase: "in 1970"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "as"

Phrase: "heredopathia opthalmo-oto-encephalica,"

Phrase: "is"

Phrase: "an early onset autosomal dominant neurodegenerative disorder"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   904   C0814120:early onset disorder [Disease or Syndrome]
   876   C0277793:onset disorder [Temporal Concept]
   827   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   799   C0012634:Disorder [Disease or Syndrome]

Phrase: "characterized by cataracts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086543:CATARACTS [Anatomical Abnormality]
   790   C0521707:Cataracts [Acquired Abnormality]
   790   C1880022:Characterized [Activity]

Phrase: "deafness,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0011053:Deafness [Disease or Syndrome]
  1000   C0018772:deafness [Finding]
  1000   C0581883:Deafness [Disease or Syndrome]
   928 E C0525064:DEAF [Patient or Disabled Group]
   928 E C1547302:Deaf [Intellectual Product]

Phrase: "progressive ataxia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1859521:Ataxia, progressive [Finding]
   861   C0004134:Ataxia [Sign or Symptom]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: "and"

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: Retinal neovascularizations eventually resulting in vitreous hemorrhage and neovascular glaucoma may also be present (3). 

Phrase: "Retinal neovascularizations eventually"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C0035320:Retinal Neovascularization [Pathologic Function]
   827   C0035298:Retinal [Body Part, Organ, or Organ Component]
   793   C0027686:Neovascularization [Pathologic Function]

Phrase: "resulting in vitreous hemorrhage"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0042909:Vitreous Hemorrhage [Pathologic Function]
   833   C0332294:Resulting in [Functional Concept]
   833   C1963280:Vitreous hemorrhage [Finding]
   770   C0019080:Haemorrhage [Pathologic Function]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "neovascular glaucoma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0017609:Glaucoma, Neovascular [Disease or Syndrome]
   861   C0017601:Glaucoma [Disease or Syndrome]
   861   C0997768:Glaucoma [Eukaryote]
   861   C1962986:Glaucoma [Finding]
   789   C0027686:Neovascularity [Pathologic Function]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Cataracts occurring around 20 years of age seem to be the first manifestation of the disease. 

Phrase: "Cataracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086543:CATARACTS [Anatomical Abnormality]
  1000   C0521707:Cataracts [Acquired Abnormality]

Phrase: "occurring around 20 years of age"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C1510829:Age-Years [Temporal Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0439234:years [Temporal Concept]
   719 E C0439508:/year [Temporal Concept]
   719   C1709305:Occur [Activity]
   719   C2745955:OCCUR [Temporal Concept]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the first manifestation of the disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1280464:Manifestation of [Qualitative Concept]
           manifestation
   753   C0205319:manifestation [Functional Concept]
Processing 00000000.tx.16: Hearing loss develops 10-20 years later, and cerebellar ataxia occurs, in general, shortly after the age of 40. 

Phrase: "Hearing loss"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0011053:hearing loss [Disease or Syndrome]
  1000   C0018772:hearing loss [Finding]
  1000   C1384666:Hearing Loss [Finding]
   861   C0018767:Hearing [Physiologic Function]
   861   C1455844:hearing [Finding]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "develops"

Phrase: "10-20 years later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "cerebellar ataxia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007758:Cerebellar Ataxia [Sign or Symptom]
   861   C0004134:Ataxia [Sign or Symptom]
   861   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellar [Tissue]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "in general, shortly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205246:General [Spatial Concept]
   861   C1553889:General [Idea or Concept]

Phrase: "after the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.17: Paranoid psychosis usually appears after the age of 50, evolving to cognitive impairment and dementia in the majority of the cases. 

Phrase: "Paranoid psychosis usually"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1456784:Paranoid psychosis [Mental or Behavioral Dysfunction]
   827   C0033975:Psychosis [Mental or Behavioral Dysfunction]
   827   C0349204:Psychosis NOS [Mental or Behavioral Dysfunction]
   755 E C0459435:Psychotic [Finding]

Phrase: "appears after the age of 50,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001779:Age [Organism Attribute]
   753   C0700364:APPEAR [Qualitative Concept]

Phrase: "evolving to cognitive impairment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   770   C0332253:Evolving [Functional Concept]
   770   C0684336:Impairment [Pathologic Function]
   770   C1516691:Cognitive [Functional Concept]

Phrase: "and"

Phrase: "dementia in the majority of the cases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.18: Most patients die in their fifth or sixth decade of life. 

Phrase: "Most patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "die in their fifth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205439:Fifth [Quantitative Concept]
   715   C0011065:Expired [Organism Function]
   715   C0231800:Expired [Organ or Tissue Function]
   715   C1704631:Expire [Idea or Concept]

Phrase: "or"

Phrase: "sixth decade of life."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2981279:Decade [Quantitative Concept]
Processing 00000000.tx.19: Neuropathologically, FDD shares several features with Alzheimer disease (AD), among them widespread cerebrovascular amyloidosis, parenchymal amyloid and preamyloid lesions, and neurofibrillary degeneration (4, 5). 

Phrase: "Neuropathologically,"

Phrase: "FDD"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "several features with Alzheimer disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "(AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "among them widespread cerebrovascular amyloidosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0520574:Cerebrovascular amyloidosis [Disease or Syndrome]
   827   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "parenchymal amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "preamyloid lesions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "and"

Phrase: "neurofibrillary degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085400:Neurofibrillary degeneration [Acquired Abnormality]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.20: Vascular and perivascular amyloid, parenchymal preamyloid lesions, and scarce neuritic plaques in the hippocampus are mainly composed of ADan peptides (4). 

Phrase: "Vascular"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005847:vascular [Body Part, Organ, or Organ Component]
  1000   C1558950:VASCULAR [Finding]
  1000   C1801960:Vascular [Qualitative Concept]
   944 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   944 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C0005767:Blood [Tissue]
   900 E C0005768:blood [Body Substance]
   900 E C0229664:Blood [Body Substance]
   900 E C0392895:Bloods [Population Group]
   884 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "perivascular amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "parenchymal preamyloid lesions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0221198:lesions [Finding]
   793 E C1546698:Lesion [Intellectual Product]

Phrase: "and"

Phrase: "scarce neuritic plaques in the hippocampus"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "mainly"

Phrase: "composed of ADan peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.21: ADan deposits co-localize with dystrophic neurites surrounding the plaques and with neurofibrillary tangles immunoreactive with hyperphosphorylated tau antibodies. 

Phrase: "ADan"

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "co-localize with dystrophic neurites"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2674684:Dystrophic neurites [Finding]
   760   C0085103:Neurites [Cell Component]
   760   C0333607:Dystrophic [Functional Concept]
   760   C0392752:localize [Spatial Concept]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and with neurofibrillary tangles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   799 E C3543859:neurofibrillary tangle [Cell Component]
   770   C1515981:And [Idea or Concept]

Phrase: "immunoreactive with hyperphosphorylated tau antibodies."
Processing 00000000.tx.22: As judged by their paired helical filament ultrastructure, their reactivity in immunohistochemical analysis, and their hyperphosphorylated tau pattern in Western blot analysis, these tangles are strikingly similar (if not identical) to those present in AD (5). 

Phrase: "As"

Phrase: "judged by their paired helical filament ultrastructure,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   748   C0010851:Filament [Cell Component]
   748   C0041623:Ultrastructure [Idea or Concept]
   748   C1709450:Paired [Qualitative Concept]
   714   C0221191:Judge [Professional or Occupational Group]

Phrase: "their reactivity in immunohistochemical analysis,"

Phrase: "and"

Phrase: "their hyperphosphorylated tau pattern in Western blot analysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]

Phrase: "these tangles"

Phrase: "are"

Phrase: "strikingly similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similar [Qualitative Concept]

Phrase: "("

Phrase: "if"

Phrase: "not identical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205280:Identical [Qualitative Concept]

Phrase: ")"

Phrase: "to those present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "in AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.23: Surprisingly, a detailed anti-A immunohistochemical survey of different brain areas from all available FDD autopsy cases (three family members from different generations, including the case analyzed in the present study (5)) unequivocally identified A co-deposited with ADan mainly in vascular and perivascular amyloid lesions, although on a smaller scale the co-deposition was also observed in parenchymal preamyloid deposits (5). 

Phrase: "Surprisingly,"

Phrase: "a detailed anti-A immunohistochemical survey of different brain areas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0038951:Survey [Intellectual Product]

Phrase: "from all available FDD autopsy cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   799   C0004398:Autopsy [Diagnostic Procedure]
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]

Phrase: "(three family members from different generations,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0086282:Family Members [Family Group]
   756 E C1611821:Family Member [Intellectual Product]
   753   C0015576:Family [Family Group]
   753   C0680022:members [Population Group]
   753   C1704727:Family [Conceptual Entity]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "analyzed in the present study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0936012:Analyzed [Research Activity]
   760   C2603343:Study [Research Activity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ")"

Phrase: "unequivocally identified A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-deposited with ADan mainly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:deposited [Functional Concept]

Phrase: "in vascular"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005847:vascular [Body Part, Organ, or Organ Component]
  1000   C1558950:VASCULAR [Finding]
  1000   C1801960:Vascular [Qualitative Concept]
   944 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   944 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C0005767:Blood [Tissue]
   900 E C0005768:blood [Body Substance]
   900 E C0229664:Blood [Body Substance]
   900 E C0392895:Bloods [Population Group]
   884 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "perivascular amyloid lesions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0221198:lesions [Finding]
   793 E C1546698:Lesion [Intellectual Product]

Phrase: "although on a smaller scale"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0175659:Scale [Medical Device]
   760   C0349674:Scale [Intellectual Product]
   760   C0547044:Smaller [Qualitative Concept]
   760   C0700321:Smaller [Quantitative Concept]
   760   C1947916:Scale [Activity]
   760   C3536777:Scale [Manufactured Object]

Phrase: "the co-deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "observed in parenchymal preamyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333562:Deposits [Functional Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.24: The fact that A co-deposition was a constant feature of all three FDD cases available argues against a coincidental nonspecific interaction between two hydrophobic peptides. 

Phrase: "The fact"

Phrase: "that A co-deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0011560:Amyloid deposition [Pathologic Function]
   913   C1705760:Amyloid Deposition [Finding]
   827   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "a constant feature of all three FDD cases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C1521970:Feature [Qualitative Concept]
   739   C1706388:Feature [Conceptual Entity]
   739   C2346469:Feature [Qualitative Concept]
   739   C2348519:Feature [Qualitative Concept]

Phrase: "available"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]

Phrase: "argues against a coincidental nonspecific interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205370:Non-specific [Qualitative Concept]
   753   C0750540:Nonspecific [Idea or Concept]
   753   C1704675:Interaction [Functional Concept]

Phrase: "between two hydrophobic peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.25: FDD patients are carriers of a genetic defect in the coding region of the BRI2 gene located in the long arm of chromosome 13. 

Phrase: "FDD patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C1861735:Dementia, familial Danish [Disease or Syndrome]
   708   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]

Phrase: "are"

Phrase: "carriers of a genetic defect"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0007294:Genetic Carriers [Finding]
           carriers
   726 E C0560175:Carrier [Finding]
   726 E C1706209:Carrier [Medical Device]
   726 E C3273162:Carrier [Intellectual Product]

Phrase: "in the coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the BRI2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "located in the long arm of chromosome 13."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C1276871:Long arm of chromosome [Cell Component]
   819   C1520537:Chromosome 13 Long Arm [Nucleotide Sequence]
   800   C0449721:Arm of chromosome [Nucleotide Sequence]
           Chromosome Arm
   770   C0008655:Chromosome 13 [Cell Component]
   770   C0575519:Long arm [Finding]
   744   C0008633:Chromosome [Cell Component]
   744   C0205166:Long [Qualitative Concept]
   744   C0446516:Arm [Body Location or Region]
   744   C1269078:Arm [Body Part, Organ, or Organ Component]
   744   C1269612:Arm [Body Location or Region]
   744   C1706317:Long [Qualitative Concept]
Processing 00000000.tx.26: The wild type BRI2 gene (also known as ITM2B) encodes a 266-residue type II single-spanning transmembrane protein (BRI2) (6-8), which under normal conditions is proteolytically processed by a furin-like protease that produces a single cleavage between Arg243 and Glu244, releasing a C-terminal 23-residue peptide (9). 

Phrase: "The wild type BRI2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "(also"

Phrase: "known as ITM2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205309:Known [Qualitative Concept]
   790   C1416512:ITM2B [Gene or Genome]

Phrase: ")"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a 266-residue type II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441730:Type II [Classification]

Phrase: "single-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037179:Single [Population Group]
  1000   C0087136:single [Finding]
  1000   C0205171:Single [Quantitative Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "transmembrane protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1167322:transmembrane [Cell Component]
   861   C2752508:transmembrane [Cell Component]

Phrase: "(BRI2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416512:BRI2 [Gene or Genome]

Phrase: ")"

Phrase: "(6-8"

Phrase: ")"

Phrase: ","

Phrase: "which under normal conditions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C0231162:Normal condition [Finding]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "is"

Phrase: "proteolytically"

Phrase: "processed by a furin-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0919550:FURIN [Gene or Genome]
   770   C1522240:Processed [Phenomenon or Process]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "like protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "that"

Phrase: "produces"

Phrase: "a single cleavage between Arg243"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "Glu244,"

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "a C-terminal 23-residue peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.27: In patients affected with FDD, a decamer duplication insertion (TTTAATTTGT) between codons 265 and 266 in the BRI2 gene 3' (just one codon before the normal stop codon 267) produces a frameshift that eliminates the stop signal and generates a longer than normal precursor, namely ADanPP. 

Phrase: "In patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "affected with FDD,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C1861735:Dementia, familial Danish [Disease or Syndrome]
   797   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0392760:Affected [Functional Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "a decamer duplication insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021107:Insertion [Therapeutic or Preventive Procedure]
   827   C0441587:Insertion [Health Care Activity]
   827   C1512796:Insertion [Genetic Function]
   827   C1883719:Insertion [Functional Concept]

Phrase: "(TTTAATTTGT"

Phrase: ")"

Phrase: "between codons 265"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "and"

Phrase: "266 in the BRI2 gene 3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017337:Gene [Gene or Genome]
   753   C1416512:BRI2 [Gene or Genome]

Phrase: "(just one codon before the normal stop codon 267"

Phrase: ")"

Phrase: "produces"

Phrase: "a frameshift"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079380:Frameshift [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "eliminates"

Phrase: "the stop signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "generates"

Phrase: "a longer than normal precursor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0205166:Long [Qualitative Concept]
   726   C1706317:Long [Qualitative Concept]

Phrase: "namely ADanPP."
Processing 00000000.tx.28: Furin-like proteolytic processing of ADanPP at the same Arg243-Glu244 peptide bond results in the release of a 34-amino acid-long C-terminal peptide ADan, which deposits in the form of amyloid fibrils in different brain regions of FDD patients, particularly in limbic structures (4). 

Phrase: "Furin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "like proteolytic processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514570:Proteolytic Processing [Molecular Function]
   861   C1709694:Processing [Activity]

Phrase: "of ADanPP"

Phrase: "at the same Arg243-Glu244 peptide bond results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C1274040:Result [Functional Concept]
   766   C1546471:Result [Idea or Concept]
   766   C2825142:Result [Finding]

Phrase: "in the release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of a 34-amino acid-long C-terminal peptide ADan,"

Phrase: "which"

Phrase: "deposits in the form of amyloid fibrils"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C2936349:Amyloid Deposits [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0225328:fibrils [Cell Component]
   748   C0333562:Deposit [Functional Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1522492:Form [Functional Concept]
   714 E C1948066:Fibril [Physical Object]

Phrase: "in different brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:brain regions [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "of FDD patients,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C1861735:Dementia, familial Danish [Disease or Syndrome]
   708   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]

Phrase: "particularly in limbic structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:structures [Spatial Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.29: The 10-nucleotide duplication insertion observed in FDD patients is not the only BRI2 genetic defect that is linked to a neurodegenerative disorder. 

Phrase: "The 10-nucleotide duplication insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0021107:Insertion [Therapeutic or Preventive Procedure]
   812   C0441587:Insertion [Health Care Activity]
   812   C1512796:Insertion [Genetic Function]
   812   C1883719:Insertion [Functional Concept]

Phrase: "observed in FDD patients"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1861735:Dementia, familial Danish [Disease or Syndrome]
   783   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0015576:familial [Family Group]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241888:Familial [Functional Concept]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C1441672:Observed [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the only BRI2 genetic defect"
Meta Candidates (Total=20; Excluded=14; Pruned=0; Remaining=6)
   833   C0000768:Birth Defect [Congenital Abnormality]
   833   C1737329:Birth defect [Congenital Abnormality]
   812   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   812   C0314603:Genetic [Functional Concept]
   812   C1457869:Defect [Functional Concept]
   812   C1861101:DEFECT [Disease or Syndrome]
   756 E C0005615:Birth [Organism Function]
   756 E C0035150:Reproduction [Organism Function]
   756 E C0079946:origin [Classification]
   756 E C0439659:Origin [Temporal Concept]
   756 E C1550512:origin [Intellectual Product]
   756 E C1550722:birth [Idea or Concept]
   756 E C3245487:birth [Intellectual Product]
   729 E C0454729:Natal [Geographic Area]
   729 E C0559522:Genital [Body System]
   729 E C1546649:Genital [Intellectual Product]
   729 E C1550642:Genital [Body Substance]
   719 E C0205313:Original [Idea or Concept]
   719 E C2347409:Original [Occupational Activity]
   701 E C0598240:originality [Mental Process]

Phrase: "that"

Phrase: "is"

Phrase: "linked to a neurodegenerative disorder."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   760   C0012634:Disorder [Disease or Syndrome]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.30: A single point mutation at the stop codon of the same gene was previously found to be associated with familial British dementia (FBD) (6). 

Phrase: "A single point mutation at the stop codon of the same gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   751   C0596611:Gene Mutation [Genetic Function]
   736   C0026882:Mutation [Genetic Function]
   736   C1552961:Point [Quantitative Concept]
   736   C1705285:Mutation [Cell or Molecular Dysfunction]
   736   C2347617:point [Quantitative Concept]

Phrase: "was"

Phrase: "previously"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with familial British dementia (FBD)"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C1867773:Dementia, familial British [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C0596227:British [Population Group]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.31: This early onset disorder, clinically characterized by progressive dementia, cerebellar ataxia, and spastic paraparesis, was first described by Worster-Drought et al. 

Phrase: "This early onset disorder,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0814120:early onset disorder [Disease or Syndrome]
   901   C0277793:onset disorder [Temporal Concept]
   827   C0012634:Disorder [Disease or Syndrome]
   734   C1833334:Early-onset [Finding]

Phrase: "clinically"

Phrase: "characterized by progressive dementia,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0743039:Dementia, progressive [Disease or Syndrome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0205329:Progressive [Functional Concept]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
   770   C1880022:Characterized [Activity]

Phrase: "cerebellar ataxia,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007758:Cerebellar Ataxia [Sign or Symptom]
   861   C0004134:Ataxia [Sign or Symptom]
   861   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellar [Tissue]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: "and"

Phrase: "spastic paraparesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037771:Paraparesis, Spastic [Sign or Symptom]
   861   C0221166:Paraparesis [Sign or Symptom]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "described by Worster-Drought et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0013140:Drought [Natural Phenomenon or Process]
   753   C1552738:described [Idea or Concept]
Processing 00000000.tx.32: (1933) as a familial presenile dementia with spastic paralysis (10-13). 

Phrase: "(1933"

Phrase: ")"

Phrase: "as a familial presenile dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   901   C0011265:Pre-senile dementia [Mental or Behavioral Dysfunction]
           dementia
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "with spastic paralysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085621:Spastic paralysis [Pathologic Function]
   861   C0443306:Spastic [Sign or Symptom]
   861   C0522224:Paralysis [Finding]

Phrase: "(10-13"

Phrase: ")."
Processing 00000000.tx.33: The neuropathology of FBD is remarkably similar to that of FDD and AD, particularly in regard to the presence of neurofibrillary tangles ultrastructurally composed of classical paired helical filaments (14, 15). 

Phrase: "The neuropathology of FBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   753   C1540677:neuropathology [Pathologic Function]
   753   C1555824:Neuropathology [Intellectual Product]

Phrase: "is"

Phrase: "remarkably similar to that of FDD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "particularly in regard to the presence of neurofibrillary tangles ultrastructurally"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   726 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "composed of classical paired helical filaments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   753   C0439858:Classical [Qualitative Concept]
   753   C0443177:Classical [Functional Concept]
   753   C1709450:Paired [Qualitative Concept]
   719   C0010851:Filament [Cell Component]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.34: As in FDD, the stop to Arg point mutation in FBD also eliminates the BRI2 stop codon and generates a longer than normal precursor ABriPP. 

Phrase: "As in FDD,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1861735:Dementia, familial Danish [Disease or Syndrome]
   797   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "the stop to Arg point mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1947925:Stop [Activity]
   753   C2746065:Stop [Temporal Concept]

Phrase: "in FBD also"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   923   C1867773:Dementia, familial British [Disease or Syndrome]
   875   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   812   C0011265:dementia [Mental or Behavioral Dysfunction]
   812   C0015576:familial [Family Group]
   812   C0241888:Familial [Functional Concept]
   812   C0497327:Dementia [Mental or Behavioral Dysfunction]
   812   C0596227:British [Population Group]
   741 E C1704727:Family [Conceptual Entity]
   712 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "eliminates"

Phrase: "the BRI2 stop codon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0242611:Stop Codon [Nucleotide Sequence]
   827   C0009221:Codon [Nucleotide Sequence]
   827   C1095825:Codon [Plant]

Phrase: "and"

Phrase: "generates"

Phrase: "a longer than normal precursor ABriPP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0205166:Long [Qualitative Concept]
   719   C1706317:Long [Qualitative Concept]
Processing 00000000.tx.35: FBD amyloid deposits in the form of cerebral amyloid angiopathy, preamyloid lesions, and amyloid plaques are composed of ABri, an amyloid subunit that is also generated by furin proteolytic processing and shares 100% identity with ADan in its first 22 amino acids but that is completely different in its 12 C-terminal residues (6). 

Phrase: "FBD amyloid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1867773:Dementia, familial British [Disease or Syndrome]
   708   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]

Phrase: "deposits in the form of cerebral amyloid angiopathy,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0085220:Cerebral Amyloid Angiopathy [Disease or Syndrome]
   770   C2931784:Amyloid angiopathy [Disease or Syndrome]
   767   C2936349:Amyloid Deposits [Acquired Abnormality]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0042373:Angiopathy [Disease or Syndrome]
   744   C0333562:Deposit [Functional Concept]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1522492:Form [Functional Concept]

Phrase: "preamyloid lesions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "and"

Phrase: "amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "composed of ABri,"

Phrase: "an amyloid subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "also"

Phrase: "generated by furin proteolytic processing"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1514570:Proteolytic Processing [Molecular Function]
   760   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0597304:Proteolytic [Molecular Function]
   760   C0919550:FURIN [Gene or Genome]
   760   C1709694:Processing [Activity]
   760   C1947941:proteolytic [Enzyme]
   760   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "100% identity with ADan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0424215:Identity [Mental Process]
   770   C2003939:Identity [Finding]

Phrase: "in its first 22 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "but"

Phrase: "that"

Phrase: "is"

Phrase: "completely different in its 12 C-terminal residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.36: Interestingly and despite the similarities between FDD and FBD, detailed immunohistochemical studies never found A co-localized with ABri deposits (15, 16). 

Phrase: "Interestingly"

Phrase: "and despite the similarities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515981:And [Idea or Concept]
   737   C2348205:Similarity [Qualitative Concept]

Phrase: "between FDD"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "FBD,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1867773:Dementia, familial British [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C0596227:British [Population Group]
   755 E C1704727:Family [Conceptual Entity]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "detailed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "immunohistochemical studies never found A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-localized with ABri deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333562:Deposits [Functional Concept]
   760   C0392752:Localized [Spatial Concept]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.37: We describe herein the isolation and biochemical characterization of ADan and A species deposited in both vessels and parenchymal FDD lesions. 

Phrase: "We"

Phrase: "describe"

Phrase: "herein"

Phrase: "the isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "biochemical characterization of ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "deposited in both vessels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0005847:Vessels [Body Part, Organ, or Organ Component]
   770   C0333562:deposited [Functional Concept]
   737 E C1511228:Vessel [Tissue]

Phrase: "and"

Phrase: "parenchymal FDD lesions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0221198:lesions [Finding]
   771 E C1546698:Lesion [Intellectual Product]
   717   C1861735:Dementia, familial Danish [Disease or Syndrome]
Processing 00000000.tx.38: Nonfibrillar preamyloid lesions were strikingly less complex than their fibrillar counterparts, poorly oligomerized, only partially post-translationally modified, and minimally proteolytically degraded. 

Phrase: "Nonfibrillar preamyloid lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0221198:lesions [Finding]
   793 E C1546698:Lesion [Intellectual Product]

Phrase: "were"

Phrase: "strikingly less complex than their fibrillar counterparts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "oligomerized"

Phrase: ","

Phrase: "only partially post-translationally"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0205171:Only [Quantitative Concept]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C1720467:Only [Intellectual Product]
   741 E C1514253:Postal [Functional Concept]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "minimally proteolytically"

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.39: Peptides ending at residue 42 constituted the main A species in both amyloid and preamyloid deposits. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "ending at residue 42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444930:ending [Spatial Concept]
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]
   770   C2746065:Ending [Temporal Concept]

Phrase: "constituted"

Phrase: "the main A species in both amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "preamyloid deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]
Processing 00000000.tx.40: Surprisingly, and against the dogma that A peptides ending at residue 40 are always the main components of cerebrovascular lesions in A-related cerebral amyloidosis, A-(X-42) species were the predominant A components in FDD deposits. 

Phrase: "Surprisingly,"

Phrase: "and against the dogma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "that A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ending at residue 40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439509:/40 [Temporal Concept]
   770   C0444930:ending [Spatial Concept]
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]
   770   C2746065:Ending [Temporal Concept]

Phrase: "are"

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "the main components of cerebrovascular lesions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0449432:Components [Manufactured Object]
   725   C1563245:Lesioned component [Finding]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "in A-related cerebral amyloidosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(X-42"

Phrase: ")"

Phrase: "species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "the predominant A components in FDD deposits."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0449432:Components [Manufactured Object]
   708 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.41: Of note, a specific interaction between synthetic ADan and A-(X-42) peptides was demonstrated by ligand blot analysis, pointing to this peptide-peptide interaction as the potential mechanism for their co-localization in vivo.  

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "a specific interaction between synthetic ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(X-42"

Phrase: ")"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "demonstrated by ligand blot analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0023688:Ligand [Chemical]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "pointing to this peptide-peptide interaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1704675:Interaction [Functional Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "as the potential mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "for their co-localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.42: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES DISCUSSION REFERENCES  Materials Mouse monoclonals 4G8 (anti-A-(17-24)) and 6E10 (anti-A-(1-17)) were purchased from Signet Laboratories (Dedham, MA); 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials Mouse monoclonals 4G8"

Phrase: "(anti-A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(17-24"

Phrase: ")"

Phrase: ")"

Phrase: "and"

Phrase: "6E10"

Phrase: "(anti-A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ")"

Phrase: "were"

Phrase: "purchased from Signet Laboratories"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0869011:purchased [Activity]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "(Dedham,"

Phrase: "MA"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.43: mouse monoclonal 6F/3D (anti-A-(8-17)) was from Dako Corp. 

Phrase: "mouse monoclonal 6F/3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450363:3D [Spatial Concept]
   812   C2986797:3D [Functional Concept]

Phrase: "(anti-A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(8-17"

Phrase: ")"

Phrase: ")"

Phrase: "was from Dako Corp."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0683758:Corp. [Organization]
   770   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.44: (Carpinteria, CA); 

Phrase: "(Carpinteria,"

Phrase: "CA)"

Phrase: ";"
Processing 00000000.tx.45: mouse monoclonal AT8 (anti-tau phosphorylated Ser202/Thr205) was from Innogenetics (Gent, Belgium). 

Phrase: "mouse monoclonal AT8"

Phrase: "(anti-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "phosphorylated"

Phrase: "Ser202/Thr205"

Phrase: ")"

Phrase: "was from Innogenetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "(Gent,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")."
Processing 00000000.tx.46: Rabbit polyclonal anti-A40 and anti-A42 antibodies were obtained from BIOSOURCE International (Camarillo, CA). 

Phrase: "Rabbit polyclonal anti-A40"

Phrase: "and"

Phrase: "anti-A42 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from BIOSOURCE"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: "(Camarillo,"

Phrase: "CA)."
Processing 00000000.tx.47: Rabbit polyclonal antibodies anti-ADan (Ab 5282, raised against ADan C-terminal amino acids 22-34) and anti-ABri (Ab 338, raised against ABri C-terminal amino acids 22-34) were prepared in our laboratory (4, 6), and the IgG fractions were further purified using Gamma-bind G-Sepharose (Amersham Biosciences) using the manufacturer's standard protocol. 

Phrase: "Rabbit polyclonal antibodies anti-ADan"

Phrase: "(Ab 5282,"

Phrase: "raised against ADan C-terminal amino acids 22-34"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0001128:Acids [Chemical]
   742   C0007776:Cortex [Body Part, Organ, or Organ Component]
   742   C0205088:Terminal [Temporal Concept]
   742   C0442818:Raised [Quantitative Concept]
   742   C1176472:Cortex [Body Part, Organ, or Organ Component]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C2700441:Cortex [Plant]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "anti-ABri"

Phrase: "(Ab 338,"

Phrase: "raised against ABri C-terminal amino acids 22-34"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0001128:Acids [Chemical]
   742   C0007776:Cortex [Body Part, Organ, or Organ Component]
   742   C0205088:Terminal [Temporal Concept]
   742   C0442818:Raised [Quantitative Concept]
   742   C1176472:Cortex [Body Part, Organ, or Organ Component]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C2700441:Cortex [Plant]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "prepared in our laboratory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]
   737   C1521827:Prepare [Functional Concept]

Phrase: "(4,"

Phrase: "6"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the IgG fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Gamma-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017011:Gamma [Natural Phenomenon or Process]
  1000   C1552644:Gamma [Intellectual Product]
  1000   C2349976:Gamma [Quantitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "G-Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Sepharose [Carbohydrate]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the manufacturer's standard protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.48: Paramagnetic beads coated with anti-rabbit and anti-mouse IgG (Dynabeads M-280) were from Dynal Biotech (Brown Deer, WI). 

Phrase: "Paramagnetic beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "coated with anti-rabbit"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0034493:Rabbit [Mammal]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "anti-mouse IgG (Dynabeads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "M-"

Phrase: "280"

Phrase: ")"

Phrase: "were from Dynal Biotech"

Phrase: "(Brown Deer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011133:Deer [Mammal]

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.49: Micro-reverse-phase chromatography tips (Zip-Tip C4) were purchased from Millipore Corp. 

Phrase: "Micro-reverse-phase chromatography tips (Zip-Tip C4)"

Phrase: "were"

Phrase: "purchased from Millipore Corp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0683758:Corp. [Organization]
   770   C0869011:purchased [Activity]
Processing 00000000.tx.50: (Billerica, MA). 

Phrase: "(Billerica,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.51: SDS removal reagent SDS-OUT was from Pierce. 

Phrase: "SDS removal reagent SDS-OUT"

Phrase: "was from Pierce."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.52: Chemicals were from Sigma. 

Phrase: "Chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.53: Complete protease inhibitor mixture was purchased from Roche Applied Science. 

Phrase: "Complete protease inhibitor mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "purchased from Roche Applied Science."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0681834:Applied Science [Research Activity]
   760   C0036397:Science [Occupation or Discipline]
   760   C0185125:Applied [Health Care Activity]
   760   C0331965:Roche [Health Care Related Organization]
   760   C0869011:purchased [Activity]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.54: Protein content was measured by the BCA protein assay (Pierce) employing bovine serum albumin as a standard. 

Phrase: "Protein content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "measured by the BCA protein assay"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243073:assay [Qualitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1332420:bca [Gene or Genome]
   753   C1510438:Assay [Laboratory Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "bovine serum albumin as a standard."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0229671:Serum [Body Substance]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
Processing 00000000.tx.55: Synthetic peptides A-(1-42) (DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA), A-(4-42) (FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA), ADan-(1-34) (pEASNCFAIRHFENKFAVETLICFNLFLNSQEKHY; where pE represents pyroglutamate), and ABri-(1-34) (pEASNCFAIRHFENKFAVETLICSRTVKKNIIEEN), the last two featuring N-terminal pyroglutamate and internal disulfide bonds between cysteine residues at positions 5 and 22, were synthesized at the W. 

Phrase: "Synthetic peptides A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   701   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA"

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "(FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA"

Phrase: ")"

Phrase: ","

Phrase: "ADan-"

Phrase: "(1-34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(pEASNCFAIRHFENKFAVETLICFNLFLNSQEKHY"

Phrase: "; where pE"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "pyroglutamate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ABri-"

Phrase: "(1-34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(pEASNCFAIRHFENKFAVETLICSRTVKKNIIEEN"

Phrase: ")"

Phrase: ","

Phrase: "the last two featuring N-terminal pyroglutamate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "internal disulfide bonds between cysteine residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1511997:Disulfide Bond [Amino Acid Sequence]
   753   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "at positions 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "22,"

Phrase: "were"

Phrase: "synthesized at the W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883254:Synthesized [Activity]
Processing 00000000.tx.56: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.57: Keck Facility at Yale University using N-tert-butyloxycarbonyl chemistry and purified by reverse-phase high performance liquid chromatography, their molecular mass was corroborated by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, and their concentrations were assessed by amino acid analysis. 

Phrase: "Keck Facility at Yale University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1547538:Facility [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "N-tert-butyloxycarbonyl chemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0007996:Chemistry [Occupation or Discipline]
   812   C0079107:chemistry [Classification]
   812   C0201682:Chemistry [Laboratory Procedure]

Phrase: "and"

Phrase: "purified by reverse-phase high performance liquid chromatography,"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   833   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   833   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   833   C1579831:High performance liquid chromatography [Functional Concept]
   819   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   793   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   770   C0008565:Liquid Chromatography [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0205250:High [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0302908:Liquid [Substance]
   744   C0597198:Performance [Individual Behavior]
   744   C1299351:High [Qualitative Concept]
   744   C1304698:Liquid [Finding]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1555029:Reverse [Idea or Concept]
   744   C1561501:Liquid NOS [Substance]
   744   C1882330:Performance [Activity]
   744   C1998793:Purified [Functional Concept]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "their molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]

Phrase: "was"

Phrase: "corroborated"

Phrase: "by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry,"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "their concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "assessed by amino acid analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1516048:Assessed [Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.58: Clinical Data Frozen brain tissue was available from a male patient who developed blurred vision, nystagmus, positive Romberg's sign, and mild memory loss at the age of 25. 

Phrase: "Clinical Data Frozen brain tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0440746:Brain tissue [Tissue]
   840   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C0040300:Tissue [Tissue]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "available from a male patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]

Phrase: "who"

Phrase: "developed"

Phrase: "blurred vision,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0344232:Blurred vision [Sign or Symptom]
   861   C0042789:Vision [Organism Function]
   861   C2707266:Vision [Clinical Attribute]
   827   C1511231:Blur [Qualitative Concept]

Phrase: "nystagmus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028738:Nystagmus [Disease or Syndrome]
  1000   C1963184:NYSTAGMUS [Finding]

Phrase: "positive Romberg's sign,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0240914:Positive Romberg sign [Finding]
   901   C0278127:Romberg sign [Finding]
   827   C0311392:Sign [Finding]
   827   C1547188:Sign [Idea or Concept]

Phrase: "and"

Phrase: "mild memory loss at the age of 25."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1857318:Mild memory loss [Finding]
   789   C0002622:Loss of memory [Mental or Behavioral Dysfunction]
           Memory loss
   789   C0751295:LOSS OF MEMORY [Sign or Symptom]
           Memory Loss
   744   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.59: He underwent bilateral vitrectomy a few years later. 

Phrase: "He"

Phrase: "underwent"

Phrase: "bilateral vitrectomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042903:Vitrectomy [Therapeutic or Preventive Procedure]

Phrase: "a few years later."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.60: Transient ischemic attacks occurred at the age of 31. 

Phrase: "Transient ischemic attacks"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0007787:Transient ischaemic attacks [Disease or Syndrome]
   884   C0745413:ischemic attack [Disease or Syndrome]
   827   C0040704:Transient [Population Group]
   827   C0205374:Transient [Temporal Concept]
   827   C0475224:Ischaemic [Functional Concept]
   827   C1261512:attacks [Social Behavior]
   827   C1304680:attacks [Finding]
   793 E C0277793:Attack, NOS [Temporal Concept]

Phrase: "occurred at the age of 31."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0450355:31 [Intellectual Product]
   753   C1709305:Occurred [Activity]
   719 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.61: After the development of double vision, ataxia, and dementia with threatening behavior, he died at the age of 43 from bronchopneumonia (5). 

Phrase: "After the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of double vision,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0012569:Double Vision [Disease or Syndrome]
   861   C0042789:Vision [Organism Function]
   861   C0205173:Double [Functional Concept]
   861   C1705764:Double [Activity]
   861   C1705765:Double [Qualitative Concept]
   861   C2707266:Vision [Clinical Attribute]

Phrase: "ataxia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004134:Ataxia [Sign or Symptom]
   928 E C0234366:Ataxic [Sign or Symptom]

Phrase: "and"

Phrase: "dementia with threatening behavior,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "he"

Phrase: "died at the age of 43"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011065:Died [Organism Function]
   753   C1546956:Died [Finding]

Phrase: "from bronchopneumonia"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0006285:Bronchopneumonia [Disease or Syndrome]
   944 E C0006271:Bronchiolitides [Disease or Syndrome]
   944 E C0264380:Catarrhal pneumonia [Disease or Syndrome]
   944 E C1275589:Lobular pneumonia [Disease or Syndrome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.62: In this patient, the TTTAATTTGT decamer insertion at codon 265 of the BRI2 gene, characteristic of FDD, was previously confirmed and reported (4), and his ApoE genotype, tested as described below, was found to be 4/3. 

Phrase: "In this patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "the TTTAATTTGT decamer insertion at codon 265 of the BRI2 gene,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C1955829:Gene Insertion [Cell or Molecular Dysfunction]
   738   C0021107:Insertion [Therapeutic or Preventive Procedure]
   738   C0441587:Insertion [Health Care Activity]
   738   C1512796:Insertion [Genetic Function]
   738   C1883719:Insertion [Functional Concept]

Phrase: "characteristic of FDD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristic [Qualitative Concept]

Phrase: "was"

Phrase: "previously"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "his ApoE genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "as"

Phrase: "described below,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "4/3."
Processing 00000000.tx.63: Immunohistochemistry Immunohistochemical investigations were carried out in three previously reported cases of FDD (5) using 7-m-thick sections of formalin-fixed paraffin-embedded tissue samples. 

Phrase: "Immunohistochemistry Immunohistochemical investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261322:Investigations [Health Care Activity]
   793 E C1552578:investigation [Idea or Concept]
   743 E C1517586:Investigational [Qualitative Concept]
   743 E C3245491:investigational [Intellectual Product]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in three previously reported cases of FDD"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   782   C1861735:Dementia, familial Danish [Disease or Syndrome]
   757   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   741   C0007320:case reported [Intellectual Product]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0015576:familial [Family Group]
   739   C0205449:Three [Quantitative Concept]
   739   C0241888:Familial [Functional Concept]
   739   C0439787:Out [Spatial Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C0684224:Reported [Intellectual Product]
   739   C0700287:Reported [Health Care Activity]
   739   C0849355:Out [Qualitative Concept]
   739   C0868928:Cases [Functional Concept]
   739   C1533148:Cases [Quantitative Concept]
   739   C3496591:Reported [Clinical Attribute]
   724 E C0085973:Case Report [Intellectual Product]
   706 E C1706255:CASE [Medical Device]
   706 E C1706256:Case [Conceptual Entity]
   706 E C3273238:Report [Intellectual Product]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "7-"

Phrase: "m-"

Phrase: "thick sections of formalin-fixed paraffin-embedded tissue samples."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   745   C2316368:Tissue section [Tissue]
   728   C1522472:section sample [Substance]
           Section
   708   C0205155:Section [Spatial Concept]
   708   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   708   C1552923:Section [Quantitative Concept]
   708   C1705191:Section [Physical Object]
Processing 00000000.tx.64: The antibodies used included anti-ADan polyclonal 5282 (1:2,000), anti-A monoclonal 6F/3D (1:100), and the anti-tau monoclonal AT8 (1:600) recognizing phosphorylated Ser202/Thr205. 

Phrase: "The antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "included anti-ADan polyclonal 5282"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332257:included [Functional Concept]
   804   C3538986:INCLUDED [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2,000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "anti-A monoclonal 6F/3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450363:3D [Spatial Concept]
   804   C2986797:3D [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the anti-tau monoclonal AT8"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "600"

Phrase: ")"

Phrase: "recognizing"

Phrase: "phosphorylated Ser202/Thr205."
Processing 00000000.tx.65: For confocal microscopy, 20-m tissue sections were prepared for double staining with the 5282 and 6F/3D antibodies. 

Phrase: "For confocal microscopy,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "20-m tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C2316368:Tissue section [Tissue]
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "prepared for double staining"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205173:Double [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   770   C1705764:Double [Activity]
   770   C1705765:Double [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   737   C1521827:Prepare [Functional Concept]

Phrase: "with the 5282"

Phrase: "and"

Phrase: "6F/3D antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.66: Tissue sections were pretreated with 99% formic acid (FA) and a pressure cooker in citrate buffer. 

Phrase: "Tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C2316368:Tissue section [Tissue]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "pretreated with 99% formic acid (FA)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0885348:formic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "a pressure cooker in citrate buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441035:Cooker [Manufactured Object]
Processing 00000000.tx.67: Sections were initially incubated with the 5282 antibody followed by the appropriate secondary antibody and ABC complex (Dako). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "incubated with the 5282 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "followed by the appropriate secondary antibody"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C1548787:Appropriate [Qualitative Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "ABC complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Dako"

Phrase: ")."
Processing 00000000.tx.68: Antibody 5282 binding was visualized by applying the tetramethylrhodamine signal amplification kit (PerkinElmer Life Sciences). 

Phrase: "Antibody 5282 binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "visualized by applying"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0234621:Visualized [Functional Concept]
   756   C0185125:Apply [Health Care Activity]
   756   C1632850:Apply [Functional Concept]
   756   C1879355:Apply [Functional Concept]

Phrase: "the tetramethylrhodamine signal amplification kit (PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   818   C0005526:Life Sciences [Occupation or Discipline]
   795   C0036397:Sciences [Occupation or Discipline]
   795   C0376558:Life [Idea or Concept]
   712 E C0595998:lives [Finding]

Phrase: ")."
Processing 00000000.tx.69: This step was followed by incubating the sections with the 6F/3D antibody overnight and treating with the appropriate secondary antibody and the ABC complex. 

Phrase: "This step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1261552:Step [Conceptual Entity]
  1000   C1704379:Step [Functional Concept]
  1000   C1705117:Step [Quantitative Concept]
  1000   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "followed by incubating"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C1439852:incubating [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "the sections with the 6F/3D antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "treating with the appropriate secondary antibody"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332293:treating [Therapeutic or Preventive Procedure]
   753   C1522326:Treating [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "the ABC complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.70: Antibody binding was visualized with the fluorescein signal amplification kit (PerkinElmer Life Sciences). 

Phrase: "Antibody binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "visualized with the fluorescein signal amplification kit (PerkinElmer Life Sciences"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   760   C0005526:Life Sciences [Occupation or Discipline]
   739   C0036397:Sciences [Occupation or Discipline]
   739   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0234621:Visualized [Functional Concept]
   739   C0376558:Life [Idea or Concept]
   739   C0812225:KIT [Medical Device]
   739   C1150635:KIT [Molecular Function]
   739   C1517480:Amplification [Molecular Biology Research Technique]
   739   C1521871:Amplification [Phenomenon or Process]
   739   C1705212:Kit [Medical Device]
   739   C1705213:KIT [Medical Device]
   739   C1705759:Amplification [Cell or Molecular Dysfunction]
   739   C1710082:Signal [Phenomenon or Process]
   739   C3273202:Kit [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.71: A Leica TCS SP confocal microscope running TCS NT control software or a Leica DMRE upright microscope using a three-channel scan head and argon/krypton laser were used for the confocal studies. 

Phrase: "A Leica TCS SP confocal microscope running TCS NT control software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "or"

Phrase: "a Leica DMRE upright microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0181839:Microscope [Medical Device]
   812   C1706379:Microscope [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a three-channel scan head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0018670:Head [Body Location or Region]
   812   C1281590:Head [Body Part, Organ, or Organ Component]
   812   C1706305:Head [Manufactured Object]
   756 E C0205096:Cephalic [Spatial Concept]

Phrase: "and"

Phrase: "argon/krypton laser"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   913   C0392247:Argon laser [Medical Device]
   901   C0392274:Krypton laser [Medical Device]
   827   C0003781:Argon [Element, Ion, or Isotope]
   827   C0022792:Krypton [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0023089:Laser [Manufactured Object]
   827   C0458142:Laser [Phenomenon or Process]
   827   C1023865:Laser [Plant]
   827   C1706315:Laser [Medical Device]
   827   C1948015:Argon [Eukaryote]

Phrase: "were"

Phrase: "used for the confocal studies."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   781   C0869040:Use studies [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C1947944:Use [Intellectual Product]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.72: Sequential Tissue Fractionation Leptomeningeal vessels and frontal cortex were used for the biochemical studies described below. 

Phrase: "Sequential Tissue Fractionation Leptomeningeal vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0005847:Vessels [Body Part, Organ, or Organ Component]
   771 E C1511228:Vessel [Tissue]
   733 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "used for the biochemical studies"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   781   C0869040:Use studies [Research Activity]
   760   C0205474:Biochemical [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C1947944:Use [Intellectual Product]
   726 E C2603343:Study [Research Activity]

Phrase: "described below."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]
Processing 00000000.tx.73: Frontal cortex was further dissected into gray and white matter, whereas large vessels were separately analyzed. 

Phrase: "Frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "dissected into gray"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205239:dissected [Functional Concept]
   790   C0556636:gray [Quantitative Concept]
   790   C1269776:Gray [Qualitative Concept]

Phrase: "and"

Phrase: "white matter,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0682708:White matter [Tissue]
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: "whereas"

Phrase: "large vessels"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0225990:Large vessels [Body Part, Organ, or Organ Component]
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "separately"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.74: The extraction strategy took advantage of the differential solubility properties of preamyloid (usually poorly soluble in 10 mM phosphate buffer, pH 7.4, containing 2.7 mM KCl and 137 mM NaCl (PBS) but soluble in 2% SDS) and amyloid structures (soluble in 70-98% FA). 

Phrase: "The extraction strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "advantage of the differential solubility properties of preamyloid"

Phrase: "(usually poorly soluble in 10 mM phosphate buffer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2.7 mM KCl"

Phrase: "and"

Phrase: "137 mM NaCl (PBS)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1720830:PBS [Disease or Syndrome]
   812   C1823521:PBS [Gene or Genome]

Phrase: "but"

Phrase: "soluble in 2% SDS)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "amyloid structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "(soluble in 70-98% FA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.75: Samples (typically 2.5 g of gray matter) were homogenized in 12.5 ml of cold PBS containing 2x protease inhibitor mixture (Complete) using a Dounce glass homogenizer immersed on ice. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "(typically 2.5 g of gray matter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "homogenized in 12.5 ml of cold PBS containing 2x protease inhibitor mixture"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   763   C0250870:Protease Inhibitor 5 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   763   C0919445:PROTEASE INHIBITOR 5 [Gene or Genome]
   763   C1418546:PROTEASE INHIBITOR 12 [Gene or Genome]
   750   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   750   C3536890:Protease Inhibitor [Pharmacologic Substance]
   735   C0009264:Cold [Natural Phenomenon or Process]
   735   C0009443:Cold [Disease or Syndrome]
   735   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   735   C0234192:Cold [Physiologic Function]
   735   C0332256:Containing [Functional Concept]
   735   C0439526:/mL [Quantitative Concept]
   735   C0439962:Mixture [Substance]
   735   C1720830:PBS [Disease or Syndrome]
   735   C1823521:PBS [Gene or Genome]
   735   C1947941:Protease [Enzyme]
   735   C1999216:Inhibitor [Qualitative Concept]
   735   C2700400:Containing [Activity]

Phrase: "(Complete"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205197:Complete [Qualitative Concept]
  1000   C0725685:COMPLEAT [Food]
   928 E C0439812:Completeness [Qualitative Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Dounce glass homogenizer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0181200:homogenizer [Medical Device]

Phrase: "immersed on ice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020746:Ice [Inorganic Chemical]
Processing 00000000.tx.76: After homogenization, small vessels were collected by filtration through a 70-m nylon mesh, combined with the dissected leptomeningeal vessels (typical yield 250 mg of vessels/2.5 g of gray matter) and further extracted as a vessel fraction (12.5 ml of PBS-2x protease inhibitors/250 mg of vessels), whereas the filtrates were subjected to ultracentrifugation in a XL100K ultracentrifuge (Beckman Coulter) using a Beckman 70.1 Ti rotor at 112,000 x g for 1 h at 4C. 

Phrase: "After homogenization,"

Phrase: "small vessels"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0225988:Small vessels, NOS [Body Part, Organ, or Organ Component]
  1000   C1282841:Small vessels [Body Part, Organ, or Organ Component]
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "collected by filtration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016107:filtration [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "through a 70-m nylon mesh,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441210:Nylon mesh [Medical Device]
   812   C0181805:Mesh [Medical Device]
   812   C1135584:MeSH [Intellectual Product]
   812   C1552983:Mesh [Quantitative Concept]

Phrase: "combined with the dissected leptomeningeal vessels"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0005847:Vessels [Body Part, Organ, or Organ Component]
   753   C0205195:Combined [Qualitative Concept]
   753   C0205239:dissected [Functional Concept]
   753   C0228126:leptomeningeal [Body Part, Organ, or Organ Component]
   753   C0521401:Leptomeningeal [Body Location or Region]
   719 E C0336789:Combine [Manufactured Object]
   719 E C1511228:Vessel [Tissue]

Phrase: "(typical yield 250 mg of vessels/2.5 g"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1300563:mg/g [Quantitative Concept]
   762   C2346927:Mg+2 [Element, Ion, or Isotope,Pharmacologic Substance]
           Mg++
   742   C0439269:mg% [Quantitative Concept]
   742   C1960952:mg % [Quantitative Concept]

Phrase: "of gray matter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018220:Gray matter [Tissue]
   861   C0556636:gray [Quantitative Concept]
   861   C1269776:Gray [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "extracted as a vessel fraction"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0005847:Vessel [Body Part, Organ, or Organ Component]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1511228:Vessel [Tissue]
   760   C1554103:Fraction [Idea or Concept]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]
   704 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(12.5 ml of PBS-2x protease inhibitors/250 mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C2984062:mg/5 ml [Quantitative Concept]
   757   C0439294:mg ml [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]

Phrase: "of vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the filtrates"

Phrase: "were"

Phrase: "subjected to ultracentrifugation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0041609:Ultracentrifugation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "in a XL100K ultracentrifuge"

Phrase: "(Beckman Coulter"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Beckman 70.1 Ti rotor at 112,000 x g"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.77: The resultant supernatants were analyzed as PBS-extracted fractions, and the pellets were resuspended in 20 mM Tris, pH 7.4, containing 2% SDS (Bio-Rad) centrifuged as above although raising the temperature to 10 C to avoid SDS crystallization, and the resultant supernatants were analyzed as SDS-extracted (preamyloid-rich) fractions. 

Phrase: "The resultant supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "analyzed as PBS-extracted fractions,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0936012:Analyzed [Research Activity]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C3541890:EXTRACTED [Finding]
   726 E C1554103:Fraction [Idea or Concept]
   726 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "the pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in 20 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2% SDS (Bio-Rad)"

Phrase: "centrifuged as above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "although"

Phrase: "raising"

Phrase: "the temperature to 10 C to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005903:temperature [Organism Attribute]
   753   C0039476:*Temperature [Quantitative Concept]

Phrase: "avoid"

Phrase: "SDS crystallization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010423:Crystallization [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the resultant supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "analyzed as SDS-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "(preamyloid-rich) fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.78: Finally, the Congo red-positive SDS-insoluble material enriched in amyloid fibrils was further extracted in 70% (v/v) FA in water and centrifuged at 14,000 rpm using a 5417R microcentrifuge (Eppendorf, Westbury, NY), and the supernatants were analyzed as FA-extracted (amyloid) fractions. 

Phrase: "Finally,"

Phrase: "the Congo red-positive SDS-insoluble material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Material [Substance]

Phrase: "enriched in amyloid fibrils"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0225328:fibrils [Cell Component]
   770   C0359583:enriched [Food]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C1948066:Fibril [Physical Object]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "extracted in 70%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "(v/v) FA in water"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0885348:formic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "centrifuged at 14,000 rpm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0582523:rpm [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 5417R microcentrifuge"

Phrase: "(Eppendorf,"

Phrase: "Westbury,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "analyzed as FA-extracted"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0885348:formic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analyzed [Research Activity]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "(amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.79: Immunoprecipitation Experiments Tissue-extracted ADan or A PeptidesFifty microliters of paramagnetic beads coated with either goat anti-rabbit IgG or anti-mouse IgG (Dynabeads M-280; Dynal) were allowed to interact with 6 g of purified IgG from antiserum 5282 or a combination of 3 g each of 4G8 and 6E10 for the immunoprecipitation of ADan and A, respectively. 

Phrase: "Immunoprecipitation Experiments Tissue-extracted ADan"

Phrase: "or"

Phrase: "A PeptidesFifty microliters of paramagnetic beads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439243:microliter [Quantitative Concept]

Phrase: "coated with either goat anti-rabbit IgG"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   774   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0018019:goat [Mammal]
   748   C0034493:Rabbit [Mammal]
   748   C1265549:goat [Mammal]
   748   C1510458:Goat [Mammal]
   748   C1522408:Coated [Qualitative Concept]
   714 E C0453946:Coat [Manufactured Object]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "anti-mouse IgG (Dynabeads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "M-"

Phrase: "280"

Phrase: "; Dynal"

Phrase: ")"

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with 6 g of purified IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439267:g% [Quantitative Concept]
   748   C1998793:Purified [Functional Concept]

Phrase: "from antiserum 5282"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "a combination of 3 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "each of 4G8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "and"

Phrase: "6E10 for the immunoprecipitation of ADan"

Phrase: "and"

Phrase: "A,"

Phrase: "respectively."
Processing 00000000.tx.80: After washing three times in PBS, beads were blocked in 0.1% (w/v) bovine serum albumin in PBS. 

Phrase: "After"

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "three times in PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "blocked in 0.1%"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "bovine serum albumin in PBS."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   806   C0728877:serum albumin [Laboratory or Test Result]
   797 E C0523465:Albumin - serum [Laboratory Procedure]
   760   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0007452:Bovine [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C1140701:bovine [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
Processing 00000000.tx.81: Antibody-coated beads were incubated with either 20  l (4% of the total fraction) of FA-extracted amyloid fraction previously neutralized in 800 l of 0.5 M Tris-base, pH 11, or 20% of the total volume of each PBS-soluble or SDS-extracted fraction. 

Phrase: "Antibody-coated beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "incubated with either 20  l (4% of the total fraction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   775   C0439160:Fraction of total [Quantitative Concept]
   757   C1264633:Fraction of [Quantitative Concept]
           Fraction
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "of FA-extracted amyloid fraction previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1264633:Fraction [Quantitative Concept]
   799   C1554103:Fraction [Idea or Concept]

Phrase: "neutralized in 800 l of 0.5 M Tris-base,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0041175:Tris-base [Organic Chemical,Pharmacologic Substance]
           TRIS
   760   C0444499:0/5 [Quantitative Concept]
   757   C1440942:M-5 [Immunologic Factor]
   739   C0002055:base [Inorganic Chemical]
   739   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   739   C0178499:Base [Chemical Viewed Functionally]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441923:M+ [Intellectual Product]
   739   C0814229:TRI [Intellectual Product]
   739   C1880279:Base [Biomedical or Dental Material]

Phrase: "pH 11,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "or"

Phrase: "20% of the total volume of each PBS-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0449468:Total Volume [Quantitative Concept]
           *Volume
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C1720830:PBS [Disease or Syndrome]
   744   C1823521:PBS [Gene or Genome]
   744   C2700258:Volume [Laboratory Procedure]

Phrase: "soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "or"

Phrase: "SDS-extracted fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.82: In the case of the SDS-extracted fractions, SDS was mostly removed prior to immunoprecipitation with SDS-OUT SDS precipitation reagent employing the supplier's specifications. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of the SDS-extracted fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "SDS"

Phrase: "was"

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "removed prior to immunoprecipitation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   770   C0849355:Removed [Qualitative Concept]
   770   C2826257:PRIOR [Event]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "with SDS-OUT SDS precipitation reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "the supplier's specifications."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348235:Specifications [Conceptual Entity]
Processing 00000000.tx.83: Elution of the bound material from the beads was performed by different methods, according to the technique used for the studies that followed. 

Phrase: "Elution of the bound material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441565:Elution [Laboratory Procedure]

Phrase: "from the beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "was"

Phrase: "performed by different methods,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1705242:Different [Qualitative Concept]
   737 E C0871511:METHOD [Intellectual Product]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "according to the technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449851:Technique [Functional Concept]
   916 E C0025664:techniques [Intellectual Product]

Phrase: "used for the studies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "followed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.84: For MALDI-TOF mass spectrometry analysis, beads were subsequently washed three times with PBS and three times with water, and the bound peptides were eluted in 5 l of a 4:4:1 mixture of isopropyl alcohol/water/formic acid (17). 

Phrase: "For MALDI-TOF mass spectrometry analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   842   C1718396:Time of analysis [Temporal Concept]
   803   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   788   C0002778:Analysis [Laboratory Procedure]
   788   C0936012:Analysis [Research Activity]
   788   C1524024:analysis [Functional Concept]
   738   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]

Phrase: "beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "three times with water,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "the bound peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "eluted in 5 l of a 4"

Phrase: ":"

Phrase: "4"

Phrase: ":"

Phrase: "1 mixture of isopropyl alcohol/water/formic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439962:Mixture [Substance]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.85: For Western blot analysis, beads were suspended in 20 l of Tris-Tricine SDS sample buffer (Bio-Rad) containing 10% (v/v) -mercaptoethanol (Sigma) and directly applied onto the 16% Tris-Tricine gels for SDS-PAGE analysis (17). 

Phrase: "For Western blot analysis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "suspended in 20 l of Tris-Tricine SDS sample buffer"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   757   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0077068:tricine [Organic Chemical]
   739   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   739   C0370003:Sample [Substance]
   739   C0814229:TRI [Intellectual Product]
   739   C1553389:suspended [Idea or Concept]
   739   C1553403:suspended [Idea or Concept]
   739   C1705537:Suspended [Functional Concept]
   739   C2347026:Sample [Conceptual Entity]

Phrase: "(Bio-Rad)"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10%"

Phrase: "(v/v) -mercaptoethanol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025402:Mercaptoethanol [Organic Chemical]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "applied onto the 16% Tris-Tricine gels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077068:tricine [Organic Chemical]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0185125:Applied [Health Care Activity]
   748   C0814229:TRI [Intellectual Product]
   714 E C1382104:Gel [Substance]
   714 E C1632850:Apply [Functional Concept]
   714 E C1879355:Apply [Functional Concept]

Phrase: "for SDS-PAGE analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.86: In some cases, 5 l of 1 M dithiothreitol (Sigma) was used for sample reduction instead of -mercaptoethanol. 

Phrase: "In some cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "5 l of 1 M dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348935:.5 L [Quantitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "used for sample reduction"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0370003:Sample [Substance]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   770   C1273517:used [Finding]
   770   C2347026:Sample [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "instead of -mercaptoethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]
Processing 00000000.tx.87: To verify the existence of peptide-peptide interactions between A and ADan, immunoprecipitation experiments using either anti-ADan or anti-A antibodies were carried out in SDS extracts from cerebral vessels using the same immunoprecipitation protocol described above. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the existence of peptide-peptide interactions"

Phrase: "between A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ADan,"

Phrase: "immunoprecipitation experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either anti-ADan"

Phrase: "or"

Phrase: "anti-A antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in SDS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "extracts from cerebral vessels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0225992:Cerebral vessels [Body System]
   833   C1283832:Cerebral vessels [Body Part, Organ, or Organ Component]
   770   C0005847:Vessels [Body Part, Organ, or Organ Component]
   770   C2828366:Extract [Substance]
   737 E C1511228:Vessel [Tissue]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same immunoprecipitation protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.88: Samples immunoprecipitated with the mixture of 4G8 plus 6E10 anti-A antibodies were probed in Western blot analysis with anti-ADan antibody (Ab 5282), and conversely, samples immunoprecipitated with anti-ADan antibody were probed for A with either a mixture of 4G8 plus 6E10, anti-A40, or anti-A42 antibodies. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "immunoprecipitated with the mixture of 4G8 plus 6E10 anti-A antibodies"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   754   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0332287:Plus [Qualitative Concept]
   738   C0439962:Mixture [Substance]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   704 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   704   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "probed in Western blot analysis"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "with anti-ADan antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Ab 5282"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "conversely,"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "immunoprecipitated with anti-ADan antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "probed for A"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "with either"

Phrase: "a mixture of 4G8 plus 6E10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439962:Mixture [Substance]

Phrase: "anti-A40,"

Phrase: "or"

Phrase: "anti-A42 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.89: Immunoreactivity was detected by chemiluminescence, as described below. 

Phrase: "Immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "detected by chemiluminescence,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   790   C0442726:Detected [Finding]
   790   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "described below."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]
Processing 00000000.tx.90: Circulating Soluble ADanPlasma from two carriers of the FDD genetic defect (44 and 24 years old) as well as from 10 noncarriers was analyzed by immunoprecipitation. 

Phrase: "Circulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175630:Circulating [Functional Concept]

Phrase: "Soluble ADanPlasma from two carriers of the FDD genetic defect"

Phrase: "(44"

Phrase: "and"

Phrase: "24 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "old)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580836:Old [Temporal Concept]

Phrase: "as well as from 10 noncarriers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]
   719   C2986416:Noncarrier [Conceptual Entity]

Phrase: "was"

Phrase: "analyzed by immunoprecipitation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.91: Fifty microliters of goat anti-rabbit IgG-coated paramagnetic beads were allowed to interact with antibody 5282, as described (17). 

Phrase: "Fifty microliters of goat anti-rabbit IgG-coated paramagnetic beads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0439243:microliter [Quantitative Concept]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with antibody 5282,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.92: After washing and blocking as before, beads were incubated with 1 ml of a 1:1 dilution of plasma in radioimmuno-precipitation assay buffer (1% Triton X-100 in 50 mM Tris, pH 8.0, containing 150 mM NaCl, 0.5% cholic acid, 0.1% SDS, 5 mM EDTA, and Complete protease inhibitor). 

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "and"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "as"

Phrase: "before,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "incubated with 1 ml of a 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439526:/mL [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: ":"

Phrase: "1 dilution of plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079240:Dilution [Laboratory Procedure]
   770   C1948037:Dilution [Functional Concept]

Phrase: "in radioimmuno-precipitation assay buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(1% Triton X-100 in 50 mM Tris,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   767   C0078589:X 50 [Organic Chemical]
   744   C0242759:Triton [Geographic Area]

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.5% cholic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0055568:Cholic Acid [Biologically Active Substance,Pharmacologic Substance,Steroid]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "0.1% SDS,"

Phrase: "5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Complete protease inhibitor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   901   C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.93: Bound peptides were eluted for MALDI-TOF mass spectrometry or Western blot analysis as described above. 

Phrase: "Bound peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "eluted"

Phrase: "for MALDI-TOF mass spectrometry"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "or"

Phrase: "Western blot analysis as described above."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]
Processing 00000000.tx.94: MALDI-TOF Analysis Before mass spectrometry analysis, extracted peptides from PBS, SDS, and FA fractions were further purified by immunoprecipitation, as described above. 

Phrase: "MALDI-TOF Analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   834   C1718396:Time of analysis [Temporal Concept]
   791   C0002778:Analysis [Laboratory Procedure]
   791   C0936012:Analysis [Research Activity]
   791   C1524024:analysis [Functional Concept]
   707   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: "Before mass spectrometry analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]

Phrase: "extracted peptides from PBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "SDS,"

Phrase: "and"

Phrase: "FA fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "purified by immunoprecipitation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C1998793:Purified [Functional Concept]

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.95: Due to the abundance of ADan in FA fractions, immunoprecipitation was not necessary for its identification by mass spectrometry. 

Phrase: "Due to the abundance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346714:Abundance [Qualitative Concept]

Phrase: "of ADan"

Phrase: "in FA fractions,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "not necessary for its identification"

Phrase: "by mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.96: In some cases, FA extracts were alternatively purified by micro-reverse-phase chromatography using Zip-TipC4 according to the manufacturer's protocol, utilizing 90% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid in water for elution. 

Phrase: "In some cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "FA extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C2828366:Extract [Substance]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: "were"

Phrase: "alternatively"

Phrase: "purified by micro-reverse-phase chromatography"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0085672:MICRO [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C1553035:Micro [Quantitative Concept]
   753   C1555029:Reverse [Idea or Concept]
   753   C1998793:Purified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Zip-TipC4 according to the manufacturer's protocol,"

Phrase: "utilizing"

Phrase: "90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "(v/v) acetonitrile,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0050456:acetonitrile [Organic Chemical]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "0.1%"

Phrase: "(v/v) trifluoroacetic acid in water"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "for elution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]
Processing 00000000.tx.97: MALDI-TOF mass spectrometry analysis was performed at the New York University Protein Analysis Facility. 

Phrase: "MALDI-TOF mass spectrometry analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   842   C1718396:Time of analysis [Temporal Concept]
   803   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   788   C0002778:Analysis [Laboratory Procedure]
   788   C0936012:Analysis [Research Activity]
   788   C1524024:analysis [Functional Concept]
   738   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]

Phrase: "was"

Phrase: "performed at the New York University Protein Analysis Facility."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0027976:New York [Geographic Area]
   764   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0041740:University [Manufactured Object,Organization]
   742   C0205314:New [Temporal Concept]
   742   C0884358:Performed [Functional Concept]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1547538:Facility [Idea or Concept]
   708 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.98: Samples were analyzed with 10 mg/ml -cyano-4-hydroxycinnamic acid in a 50% acetonitrile and 0.1% trifluoroacetic acid (Sigma) matrix (feasible for <10,000-Da mass range) on a Micromass Tof-Spec-2E MALDI-TOF mass spectrometer in linear mode using standard instrument settings (17). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed with 10 mg/ml -cyano-4-hydroxycinnamic acid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0439294:mg ml [Quantitative Concept]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0439269:mg% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C0936012:Analyzed [Research Activity]
   742   C1960952:mg % [Quantitative Concept]
   742   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in a 50% acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050456:acetonitrile [Organic Chemical]

Phrase: "and"

Phrase: "0.1% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]

Phrase: "(feasible for"

Phrase: "<10,000-Da mass range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "on a Micromass Tof-Spec-2E MALDI-TOF mass spectrometer"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C2348791:Time-of-Flight [Quantitative Concept]
   795   C0183396:Mass Spectrometer [Medical Device]
   786   C0040223:Time [Temporal Concept]
   786   C0183395:Spectrometer [Medical Device]
   786   C0577559:Mass [Finding]
   786   C1306372:*Mass [Quantitative Concept]
   786   C1555977:Flight [Intellectual Product]
   786   C1710143:Spectrometer [Manufactured Object]
   786   C2610507:flight [Phenomenon or Process]
   786   C3152252:Mass [Quantitative Concept]
   786   C3541383:Time [Temporal Concept]
   730 E C0442043:Temporal [Spatial Concept]
   730 E C2362314:Temporal [Temporal Concept]
   702 E C1632851:Times [Quantitative Concept]

Phrase: "in linear mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1513371:Mode [Functional Concept]
   861   C1705738:Mode [Quantitative Concept]
   861   C2347637:Mode [Quantitative Concept]
   861   C2348146:Mode [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard instrument settings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0542559:setting [Functional Concept]
   793   C1318139:{Setting} [Quantitative Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.99: Under these experimental acidic conditions, which also render noncovalent binding unobservable (18), mostly monomeric species of ADan and A were detected. 

Phrase: "Under these experimental acidic conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "which also"

Phrase: "render"

Phrase: "noncovalent binding unobservable"

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "mostly monomeric species of ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.100: Internal and/or external calibration was carried out using human adrenocorticotropic hormone peptide 18-39 (average mass = 2,465.68 Da) and insulin (average mass = 5,733.49 Da) as standards. 

Phrase: "Internal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205102:Internal [Spatial Concept]
  1000   C1553872:Internal [Intellectual Product]
  1000   C1619620:Internal [Intellectual Product]

Phrase: "and/or"

Phrase: "external calibration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006751:Calibration [Quantitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "human adrenocorticotropic hormone peptide 18-39"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   839   C0001655:adrenocorticotropic peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
           Adrenocorticotrophic Hormone
   827   C1523997:Adrenocorticotropic Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C2825093:Adrenocorticotropic Hormone [Pharmacologic Substance]
   799   C0019932:Hormone [Hormone]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   799   C0086418:Human [Human]
   727 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(average mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "= 2,465.68 Da)"

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(average mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "= 5,733.49 Da) as standards."
Processing 00000000.tx.101: FindPept tool from the ExPASy Proteomics server (available on the World Wide Web at us.expasy.org/tools) was used to assign the experimental mass values to specific peptide sequences and to search for the presence of post-translational modifications. 

Phrase: "FindPept tool from the ExPASy Proteomics server"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0336791:Tool [Manufactured Object]
   748   C2827396:Tool [Manufactured Object]

Phrase: "(available on the World Wide Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0470187:Available [Functional Concept]

Phrase: "at us.expasy.org/tools"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0336791:Tool [Manufactured Object]
   779   C2827396:Tool [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assign"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516050:Assign [Functional Concept]

Phrase: "the experimental mass values to specific peptide sequences"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0042295:Values [Qualitative Concept]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "search for the presence of post-translational modifications."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0033666:Post-Translational Modifications [Molecular Function]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0687676:Post [Temporal Concept]
   744   C1519614:Translational [Genetic Function]
   744   C1552603:search [Intellectual Product]
   744   C1704687:Post [Manufactured Object]
   744   C1706202:Search [Activity]
   711   C0392747:Modification [Functional Concept]
   711   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.102: Western Blot Analysis Samples from each of the extracts, either before or after immunoprecipitation, were separated on a 16% Tris-Tricine SDS-PAGE and electrotransferred for 45 min at 400 mA onto polyvinylidene difluoride membranes (Immobilon-P; Millipore Corp.) using 10 mM 3-cyclohexylamino-1-propanesulfonic acid (Sigma) buffer, pH 11 containing 10% (v/v) methanol. 

Phrase: "Western Blot Analysis Samples from each of the extracts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1303103:analysis sample [Laboratory Procedure]
   708   C0370003:Sample [Substance]
   708   C2347026:Sample [Conceptual Entity]

Phrase: "either before"

Phrase: "or after immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "were"

Phrase: "separated on a 16% Tris-Tricine SDS-PAGE"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   744   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   744   C0077068:tricine [Organic Chemical]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0086972:Separated [Finding]
   744   C0443299:separated [Spatial Concept]
   744   C0687118:Separated [Functional Concept]
   744   C0814229:TRI [Intellectual Product]
   744   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "electrotransferred for 45 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "at 400 mA"

Phrase: "onto polyvinylidene difluoride membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
   734   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: "(Immobilon-P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123400:Immobilon P [Organic Chemical]

Phrase: "; Millipore Corp.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "10 mM 3-cyclohexylamino-1-propanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 11"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10%"

Phrase: "(v/v) methanol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]
Processing 00000000.tx.103: After blocking in 5% nonfat milk in PBS containing 0.1% Tween 20 (Sigma), the membranes were immunoreacted with the antibodies anti-ADan 5282 (2 g/ml), anti-A 4G8 (1 g/ml), anti-A 6E10 (1 g/ml), anti-A40 (0.05 g/ml), or anti-A42 (0.05 g/ml), followed by either anti-rabbit or anti-mouse horseradish peroxidase-labeled F(ab')2 (Amersham Biosciences). 

Phrase: "After"

Phrase: "blocking in 5% nonfat milk"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   760   C0026131:Milk [Body Substance]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C0349374:Milk [Food]
   760   C0444318:Milk [Substance]
   760   C2825079:Milk [Food]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
   704 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   704 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Tween 20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "immunoreacted with the antibodies anti-ADan 5282"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(2 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-A 4G8"

Phrase: "(1 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-A 6E10"

Phrase: "(1 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-A40"

Phrase: "(0.05 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-A42"

Phrase: "(0.05 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "followed by either anti-rabbit"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0034493:Rabbit [Mammal]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "or"

Phrase: "anti-mouse horseradish peroxidase-labeled F(ab')2"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   864   C0313107:Anti f [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   793   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   793   C0025914:Mouse [Mammal]
   793   C0025929:mouse [Mammal]
   793   C0026809:Mouse [Mammal]
   793   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0330510:Horseradish [Food]
   793   C0439133:(f) [Intellectual Product]
   793   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   793   C1110641:Horseradish [Plant]
   793   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   793   C1553038:[f] [Quantitative Concept]
   793   C1708632:Labeled [Qualitative Concept]
   760 E C0181496:Label [Manufactured Object]
   760 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.104: Signals were developed with Super Signal (Pierce) and exposed to Hyperfilm ECL (Amersham Biosciences). 

Phrase: "Signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "developed with Super Signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710082:Signal [Phenomenon or Process]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "and"

Phrase: "exposed to Hyperfilm ECL (Amersham Biosciences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C1332684:ECL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.105: To enhance A immunoreactivity, membranes after transfer were boiled in PBS for 5 min (19) before incubation with the specific anti-A antibodies. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "A immunoreactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "membranes after transfer"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "boiled in PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]

Phrase: "for 5 min (19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439084:>5 [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "before"

Phrase: "incubation with the specific anti-A antibodies."
Processing 00000000.tx.106: When necessary for reprobing, membranes were incubated in Restore Western blot stripping buffer (Pierce) for 15 min at room temperature, reblocked, and probed with another antibody. 

Phrase: "When"

Phrase: "necessary for reprobing,"

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "Restore"

Phrase: "Western blot stripping buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "reblocked"

Phrase: ","

Phrase: "and"

Phrase: "probed with another antibody."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.107: Ligand Blot Analysis Five micrograms each of synthetic ADan-(1-34) and ABri-(1-34) peptides were separated on a 16% Tris-Tricine SDS-PAGE and electrotransferred onto Immobilon-P membranes as described above. 

Phrase: "Ligand Blot Analysis Five micrograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439211:microgram [Quantitative Concept]

Phrase: "each of synthetic ADan-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1457900:Each [Quantitative Concept]
   770   C1883254:synthetic [Activity]

Phrase: "(1-34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "ABri-"

Phrase: "(1-34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "separated on a 16% Tris-Tricine SDS-PAGE"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   744   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   744   C0077068:tricine [Organic Chemical]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0086972:Separated [Finding]
   744   C0443299:separated [Spatial Concept]
   744   C0687118:Separated [Functional Concept]
   744   C0814229:TRI [Intellectual Product]
   744   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "electrotransferred onto Immobilon-P membranes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0123400:Immobilon P [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   760   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "as described above."
Processing 00000000.tx.108: After blocking with 5% nonfat milk in PBS, membranes were separately incubated at 37 C for 3 h with synthetic A-(1-42) and A-(4-42) peptides (1 g/ml in PBS/milk). 

Phrase: "After"

Phrase: "blocking with 5% nonfat milk"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   760   C0026131:Milk [Body Substance]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C0349374:Milk [Food]
   760   C0444318:Milk [Substance]
   760   C2825079:Milk [Food]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
   704 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   704 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "separately"

Phrase: "incubated at 37 C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C2700441:Cortex [Plant]

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with synthetic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(1 g/ml in PBS/milk"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.109: Bound A was assessed by overnight incubation at 4 C with a mixture of 4G8 and 6E10 (0.5 g/ml each in PBS/milk), followed by a 1-h incubation at room temperature with anti-mouse horseradish peroxidase-labeled F(ab')2, and chemiluminescence was detected as above. 

Phrase: "Bound A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "assessed by overnight incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439583:Overnight [Temporal Concept]
   770   C1516048:Assessed [Activity]

Phrase: "at 4 C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "with a mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "of 4G8"

Phrase: "and"

Phrase: "6E10"

Phrase: "(0.5 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "each in PBS/milk"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0026131:Milk [Body Substance]
   770   C0349374:Milk [Food]
   770   C0444318:Milk [Substance]
   770   C1457900:Each [Quantitative Concept]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   770   C2825079:Milk [Food]
   715 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   715 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "followed by a 1-h incubation"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332283:Followed by [Temporal Concept]
           followed
   783   C0700308:h 1 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with anti-mouse horseradish peroxidase-labeled F(ab')2,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   864   C0313107:Anti f [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   793   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   793   C0025914:Mouse [Mammal]
   793   C0025929:mouse [Mammal]
   793   C0026809:Mouse [Mammal]
   793   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0330510:Horseradish [Food]
   793   C0439133:(f) [Intellectual Product]
   793   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   793   C1110641:Horseradish [Plant]
   793   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   793   C1553038:[f] [Quantitative Concept]
   793   C1708632:Labeled [Qualitative Concept]
   760 E C0181496:Label [Manufactured Object]
   760 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "chemiluminescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162524:Chemiluminescence [Natural Phenomenon or Process]
  1000   C1450278:Chemiluminescence [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "detected as above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.110: Fifty nanograms of both ADan and ABri peptides were also subjected to Western blot analysis using a mixture of Ab 5282 (2 g/ml) and Ab 338 (1 g/ml) and used as controls. 

Phrase: "Fifty nanograms of both ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439212:nanograms [Quantitative Concept]

Phrase: "and"

Phrase: "ABri peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "also"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mixture of Ab 5282"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:Mixture [Substance]

Phrase: "(2 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "Ab 338"

Phrase: "(1 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.111: Amino Acid Sequence Analysis N-terminal amino acid sequence analysis of isolated amyloid species extracted in FA was carried out by automatic Edman degradation on a 494 Procise Protein Sequencer (Applied Biosystems). 

Phrase: "Amino Acid Sequence Analysis N-terminal amino acid sequence analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1706793:Amino-Terminal Amino Acid [Amino Acid Sequence]

Phrase: "of isolated amyloid species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "extracted in FA"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0885348:formic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0202406:Acid [Laboratory Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by automatic Edman degradation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205554:Automatic [Functional Concept]
   760   C0243125:degradation [Functional Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0699900:Degradation [Organism Function]
   760   C0849355:Out [Qualitative Concept]

Phrase: "on a 494 Procise Protein Sequencer"

Phrase: "(Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.112: Aliquots from FA-solubilized amyloid fractions were separated on 16% Tris-Tricine SDS-PAGE, transferred onto Immmobilon-P as described above, and visualized with 0.125% (w/v) Coomassie Blue R-250 in 50% (v/v) methanol. 

Phrase: "Aliquots from FA-solubilized amyloid fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "separated on 16% Tris-Tricine SDS-PAGE,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077068:tricine [Organic Chemical]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C0814229:TRI [Intellectual Product]
   748   C1704732:Page [Intellectual Product]

Phrase: "transferred onto Immmobilon-P"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "as described above,"

Phrase: "and"

Phrase: "visualized with 0.125%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0234621:Visualized [Functional Concept]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "Coomassie Blue R-250 in 50%"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0056271:Coomassie blue R 250 [Organic Chemical]
   790   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   753   C0205090:R- [Spatial Concept]
   753   C0684010:R. [Professional or Occupational Group]
   753   C1260957:Blue [Qualitative Concept]
   753   C2603358:R' [Clinical Attribute]

Phrase: "(v/v) methanol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]
Processing 00000000.tx.113: Relevant components were excised, and N-terminally sequenced. 

Phrase: "Relevant components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "excised"

Phrase: ","

Phrase: "and"

Phrase: "N-terminally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.114: View larger version (63K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(63K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.115: Immunohistochemical analysis of FDD lesions. 

Phrase: "Immunohistochemical analysis of FDD lesions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1441616:Immunohistochemical [Laboratory Procedure]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.116: A, ADan deposited in rather ill defined parenchymal plaques (double arrow) and blood vessels (arrow) in the hippocampus in an FDD case was detected with antibody 5282. 

Phrase: "A,"

Phrase: "ADan"

Phrase: "deposited in rather ill defined parenchymal plaques"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0231218:Ill [Sign or Symptom]
   748   C0333463:plaques [Acquired Abnormality]
   748   C0333562:deposited [Functional Concept]
   748   C1704788:Defined [Conceptual Entity]
   748   C3539106:Defined [Intellectual Product]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "(double arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "in the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "in an FDD case"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0868928:Case [Functional Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   756   C1861735:Dementia, familial Danish [Disease or Syndrome]
   708   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]

Phrase: "was"

Phrase: "detected with antibody 5282."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.117: Lesions in the frontal cortex are similar, although with less dramatic preamyloid load. 

Phrase: "Lesions in the frontal cortex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0221198:lesions [Finding]
   726 E C1546698:Lesion [Intellectual Product]

Phrase: "are"

Phrase: "similar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "although with less dramatic preamyloid load."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1550025:Load [Idea or Concept]
   753   C1704782:Load [Manufactured Object]
   753   C1708715:Load [Activity]
Processing 00000000.tx.118: Bar, 120 m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "120 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.119: B, tau immunohistochemistry (AT8 antibody) reveals numerous neurofibrillary tangles (arrow), neuropil threads (arrowhead), and abnormal neurites (double arrow) formed around amyloidladen blood vessels (asterisk). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "tau immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "(AT8 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "numerous neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "neuropil threads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "(arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "abnormal neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085103:Neurites [Cell Component]

Phrase: "(double arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "formed around amyloidladen blood vessels"
Meta Candidates (Total=15; Excluded=12; Pruned=0; Remaining=3)
   806   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   773 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   773 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   760   C0205431:Formed [Functional Concept]
   735 E C1558950:VASCULAR [Finding]
   735 E C1801960:Vascular [Qualitative Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]
   714 E C0005767:Blood [Tissue]
   714 E C0005768:blood [Body Substance]
   714 E C0229664:Blood [Body Substance]
   714 E C0392895:Bloods [Population Group]

Phrase: "(asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.120: Bar,60 m.  

Phrase: "Bar,60 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.121: ApoE Genotyping Genomic DNA was extracted from brain tissue using DNeasy Tissue kit (Qiagen, Valencia, CA), and the ApoE genotyping was performed as described (20), with minor modifications. 

Phrase: "ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "Genotyping"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]
   966 E C0017431:Genotype [Organism Attribute]

Phrase: "Genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "extracted from brain tissue"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0440746:Brain tissue [Tissue]
   833   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0040300:Tissue [Tissue]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1547928:Tissue [Intellectual Product]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DNeasy Tissue kit (Qiagen,"

Phrase: "Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA),"

Phrase: "and"

Phrase: "the ApoE genotyping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285573:Genotyping [Laboratory Procedure]

Phrase: "was"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "with minor modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.122: Briefly, 244-bp polymerase chain reaction products were generated using reverse primer F4 (5'-ACAGAATTCGCCCCGGCCTGGTACAC-3') and forward primer F6 (5'-TAAGCTTGGCACGGCTGCCAAGGA-3'), digested for 4 h at 37 C with 20 units of HhaI (Promega, Madison, WI), subjected to electrophoresis on nondenaturing 10% polyacrylamide gels, and visualized under UV light after staining with ethidium bromide. 

Phrase: "Briefly,"

Phrase: "244-bp polymerase chain reaction products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C1514468:Products [Entity]
   766 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "reverse primer F4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]

Phrase: "(5'-ACAGAATTCGCCCCGGCCTGGTACAC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "forward primer F6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1953382:Forward primer [Cell]

Phrase: "(5'-TAAGCTTGGCACGGCTGCCAAGGA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "digested for 4 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0868946:digested [Physiologic Function]

Phrase: "at 37 C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "with 20 units"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439148:Units [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "of HhaI"

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "subjected to electrophoresis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "on nondenaturing 10% polyacrylamide gels,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gels [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   779 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized under UV light"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0041625:UV Light [Natural Phenomenon or Process]
           UV
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C1306462:Light [Functional Concept]
   770   C1881376:Light [Qualitative Concept]
   770   C1961129:uV [Quantitative Concept]

Phrase: "after staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with ethidium bromide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.123: RESULTS FDD Main Histopathological FeaturesFig. 

Phrase: "RESULTS FDD Main Histopathological FeaturesFig."
Processing 00000000.tx.124: 1 illustrates the extent of ADan deposition (Fig. 1A) and associated tau pathology (Fig. 1B) in patients with FDD. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "illustrates"

Phrase: "the extent of ADan deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "associated tau pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with FDD."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.125: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.126: 1A, ADan forms loose, ill defined parenchymal diffuse (preamyloid) plaques (double arrow) and deposits in blood vessel walls (arrow) in FDD. 

Phrase: "1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "ADan"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "loose, ill defined parenchymal diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205219:Diffuse [Qualitative Concept]

Phrase: "(preamyloid"

Phrase: ")"

Phrase: "plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "(double arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "deposits in blood vessel walls"
Meta Candidates (Total=16; Excluded=8; Pruned=0; Remaining=8)
   862   C1180033:blood vessel walls [Body Part, Organ, or Organ Component]
   806   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
   806   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   806   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   760   C0333562:Deposit [Functional Concept]
   760   C0677535:Walls [Manufactured Object]
   751 E C1558950:VASCULAR [Finding]
   751 E C1801960:Vascular [Qualitative Concept]
   723 E C0005767:Blood [Tissue]
   723 E C0005768:blood [Body Substance]
   723 E C0229664:Blood [Body Substance]
   723 E C0392895:Bloods [Population Group]
   704 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
   700 E C0333275:Bloody [Qualitative Concept]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "in FDD."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.127: The parenchymal lesions are usually Thioflavin S/Congo red-negative and ultrastructurally appear as mostly amorphous (nonfibrillar) electron-dense material with sparse fibrils, whereas the vascular deposits are of amyloid nature. 

Phrase: "The parenchymal lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "are"

Phrase: "usually Thioflavin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "S/"

Phrase: "Congo red-negative"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205160:Negative [Qualitative Concept]
   827   C1513916:Negative [Finding]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]
   734   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "ultrastructurally"

Phrase: "appear as mostly amorphous"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0700364:APPEAR [Qualitative Concept]
   770   C0750554:mostly [Idea or Concept]
   770   C1979848:Amorphous [Qualitative Concept]

Phrase: "(nonfibrillar"

Phrase: ")"

Phrase: "electron-dense material with sparse fibrils,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C3546235:dense material [Cell Component]
   753   C0520510:Material [Substance]

Phrase: "whereas"

Phrase: "the vascular deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "are of amyloid nature."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0349590:Nature [Idea or Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1262865:Nature [Functional Concept]
   770   C1551058:Are [Quantitative Concept]
Processing 00000000.tx.128: The presence of A, sometimes co-localizing with ADan deposits, was previously localized immunohistochemically in three affected family members belonging to different generations (5) and is further illustrated below. 

Phrase: "The presence of A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "co-localizing with ADan deposits,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333562:Deposits [Functional Concept]
   760   C0392752:localizing [Spatial Concept]

Phrase: "was"

Phrase: "previously"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "immunohistochemically in three affected family members"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0086282:Family Members [Family Group]
   756 E C1611821:Family Member [Intellectual Product]
   753   C0015576:Family [Family Group]
   753   C0205449:Three [Quantitative Concept]
   753   C0392760:Affected [Functional Concept]
   753   C0680022:members [Population Group]
   753   C1314939:Affected [Functional Concept]
   753   C1704727:Family [Conceptual Entity]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "belonging to different generations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0079411:Generations [Temporal Concept]
   770   C1705242:Different [Qualitative Concept]
   767   C0687672:generation difference [Temporal Concept]
   742 E C0680440:generational differences [Social Behavior]
   737 E C3146294:Generation [Activity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "illustrated below."
Processing 00000000.tx.129: Soluble ADan Is Present in the Blood of Carriers of the FDD Genetic DefectWestern blot analysis of immunoprecipitated plasma samples obtained from two carriers of the FDD genetic defect revealed the presence of an 4-kDa component (Fig. 2A) immunoreactive with Ab 5282 (specific for the 12 C-terminal amino acid residues of ADan, a fragment not existent in the normal population). 

Phrase: "Soluble ADan"

Phrase: "Is"

Phrase: "Present in the Blood of Carriers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "of the FDD Genetic DefectWestern blot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   845   C0679560:genetic analysis [Laboratory Procedure]
   845   C0796344:Genetic Analysis [Laboratory Procedure]
   795   C0002778:Analysis [Laboratory Procedure]
   795   C0936012:Analysis [Research Activity]
   795   C1524024:analysis [Functional Concept]

Phrase: "of immunoprecipitated plasma samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0444263:Plasma sample [Body Substance]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "obtained from two carriers of the FDD genetic defect"
Meta Candidates (Total=22; Excluded=4; Pruned=0; Remaining=18)
   775   C1861735:Dementia, familial Danish [Disease or Syndrome]
   754   C0007294:Genetic Carriers [Finding]
           carriers
   754   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   738   C0011265:dementia [Mental or Behavioral Dysfunction]
   738   C0015576:familial [Family Group]
   738   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   738   C0205448:Two [Quantitative Concept]
   738   C0241888:Familial [Functional Concept]
   738   C0314603:Genetic [Functional Concept]
   738   C0497327:Dementia [Mental or Behavioral Dysfunction]
   738   C1301820:Obtained [Functional Concept]
   738   C1457869:Defect [Functional Concept]
   738   C1861101:DEFECT [Disease or Syndrome]
   728   C0000768:Birth Defect [Congenital Abnormality]
   728   C0870545:family of origin [Family Group]
   728   C1737329:Birth defect [Congenital Abnormality]
   708   C0234984:DEMENTIA ACQUIRED [Mental or Behavioral Dysfunction]
   704 E C0560175:Carrier [Finding]
   704 E C1706209:Carrier [Medical Device]
   704 E C1706701:Obtain [Activity]
   704 E C3273162:Carrier [Intellectual Product]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of an 4-kDa component"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "immunoreactive with Ab 5282"

Phrase: "(specific for the 12 C-terminal amino acid residues of ADan,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0205369:Specific [Qualitative Concept]
   738   C1552740:specific [Intellectual Product]

Phrase: "a fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "not existent in the normal population"

Phrase: ")."
Processing 00000000.tx.130: Soluble ADan was consistently monomeric in SDS-PAGE; 

Phrase: "Soluble ADan"

Phrase: "was"

Phrase: "consistently monomeric in SDS-PAGE"

Phrase: ";"
Processing 00000000.tx.131: in mass spectrometry, its m/z experimental value rendered a single peak of 4,063.4 (Fig. 2A) in good agreement with the expected mass of 4063.6, corresponding to the full-length peptide bearing glutamate at the N terminus and a single disulfide bond between cysteine residues 5 and 22. 

Phrase: "in mass spectrometry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "its"

Phrase: "m/"

Phrase: "z experimental value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522609:Value [Quantitative Concept]

Phrase: "rendered"

Phrase: "a single peak of 4,063.4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0444505:Peak [Quantitative Concept]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "in good agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680240:Agreement [Social Behavior]

Phrase: "with the expected mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "of 4063.6,"

Phrase: "corresponding to the full-length peptide bearing glutamate"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0443225:Full [Qualitative Concept]
   744   C1444754:Length [Quantitative Concept]
   744   C1704689:Bearing [Medical Device]
   744   C1706316:LENGTH [Research Activity]
   711 E C0004897:Bear [Mammal]

Phrase: "at the N terminus"

Phrase: "and"

Phrase: "a single disulfide bond between cysteine residues 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511997:Disulfide Bond [Amino Acid Sequence]
   767   C0759863:single bond [Organic Chemical,Pharmacologic Substance]
   744   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "22."
Processing 00000000.tx.132: Soluble ADan was not detected in plasma samples from noncarriers of the disease (n = 10) using identical experimental conditions (not shown). 

Phrase: "Soluble ADan"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in plasma samples"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C0444263:Plasma sample [Body Substance]
   770   C0032105:Plasma [Body Substance]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from noncarriers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986416:Noncarrier [Conceptual Entity]

Phrase: "of the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(n = 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "identical experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.133: Intact and N-terminally Post-translationally Modified ADan Are Predominant Components of Preamyloid and Amyloid DepositsFDD parenchymal samples and cerebral vessels were sequentially extracted in PBS, 2% SDS, and 70% FA and analyzed for the presence of ADan species by mass spectrometry and Western blot. 

Phrase: "Intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "and"

Phrase: "N-terminally Post-translationally Modified ADan"

Phrase: "Are"

Phrase: "Predominant Components of Preamyloid"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449432:Components [Manufactured Object]
   737 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "Amyloid DepositsFDD parenchymal samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "cerebral vessels"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0225992:Cerebral vessels [Body System]
  1000   C1283832:Cerebral vessels [Body Part, Organ, or Organ Component]
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "sequentially"

Phrase: "extracted in PBS,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "2% SDS,"

Phrase: "and"

Phrase: "70% FA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0885348:formic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "analyzed for the presence of ADan species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0936012:Analyzed [Research Activity]
   748   C1705920:Species [Conceptual Entity]

Phrase: "by mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "Western blot."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.134: In some cases, particularly in samples extracted with FA, which were more abundant, we also conducted N-terminal amino acid sequence analysis. 

Phrase: "In some cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "particularly in samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "extracted with FA,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0885348:formic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0202406:Acid [Laboratory Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "which"

Phrase: "were"

Phrase: "more abundant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundant [Qualitative Concept]

Phrase: "we also conducted N-terminal amino acid sequence analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751970:Amino Acid Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
Processing 00000000.tx.135: As expected, the vast majority of ADan was recovered from the amyloid extracts; 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the vast majority of ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "was"

Phrase: "recovered from the amyloid extracts"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0521108:recovered [Qualitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726 E C2004454:recover [Organism Function]
   726   C2828366:Extract [Substance]

Phrase: ";"
Processing 00000000.tx.136: however, using a combination of immunoprecipitation and Western blot/mass spectrometry, it was also possible to detect ADan species in all other fractions. 

Phrase: "however,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a combination of immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "Western blot/mass spectrometry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0037813:Mass Spectrometry [Laboratory Procedure]
   812   C0436196:Spectrometry [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "it"

Phrase: "was"

Phrase: "also possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332149:Possible [Qualitative Concept]
   827   C1705910:Possible [Qualitative Concept]
   827   C2362652:Possible [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "ADan species in all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705920:Species [Conceptual Entity]

Phrase: "other fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.137: Compared with the plasma specimens, there were noticeable differences in terms of degree of aggregation and N-terminal post-translational modifications. 

Phrase: "Compared with the plasma specimens,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0444263:Plasma specimen [Body Substance]
   760   C0032105:Plasma [Body Substance]
   760   C0370003:specimens [Substance]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1707455:Compared [Activity]
   726 E C2347026:Specimen [Conceptual Entity]

Phrase: "there"

Phrase: "were"

Phrase: "noticeable differences in terms of degree of aggregation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "N-terminal post-translational modifications."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0033666:Post-Translational Modifications [Molecular Function]
   804   C0687676:Post [Temporal Concept]
   804   C1519614:Translational [Genetic Function]
   804   C1704687:Post [Manufactured Object]
   771   C0392747:Modification [Functional Concept]
   771   C1554963:modification [Qualitative Concept]
   733 E C0040712:Translation [Intellectual Product]
   733 E C0597295:translation [Molecular Function]
   733 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.138: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 2B illustrates ADan species in PBS extracts. 

Phrase: "2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: "illustrates"

Phrase: "ADan species in PBS extracts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.140: PBS-soluble ADan was mainly monomeric, with some dimers barely visible in both parenchymal and vascular fractions, as indicated by the Western blot. 

Phrase: "PBS-soluble ADan"

Phrase: "was"

Phrase: "mainly monomeric,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "with some dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "barely visible in both parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205379:Visible [Qualitative Concept]

Phrase: "and"

Phrase: "vascular fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "as"

Phrase: "indicated by the Western blot."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C1444656:Indicated [Finding]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.141: Mass spectrometry revealed that these fractions were composed of a mixture of two ADan species differing in 18 mass units, 4045.2 for parenchyma/4045.3 for vessels (expected 4045.6) and 4063.5 for parenchyma/4062.7 for vessels (expected 4063.6), a difference equivalent to the mass of one molecule of water and probably corresponding to ADan-pE and ADan-E species in a 60:40 ratio (see below). 

Phrase: "Mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "these fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "composed of a mixture of two ADan species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205448:Two [Quantitative Concept]
   744   C0439962:Mixture [Substance]
   744   C1705920:Species [Conceptual Entity]

Phrase: "differing in 18 mass units,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0439148:Units [Quantitative Concept]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1519795:Units [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]
   726 E C1704753:Unit [Manufactured Object]
   726 E C1880519:Unit [Quantitative Concept]

Phrase: "4045.2 for parenchyma/4045.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "for vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "4045.6"

Phrase: ")"

Phrase: "and"

Phrase: "4063.5 for parenchyma/4062.7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "for vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "4063.6"

Phrase: ")"

Phrase: ","

Phrase: "a difference equivalent to the mass of one molecule of water"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0205163:Equivalent [Qualitative Concept]
   738   C0439185:equivalent [Quantitative Concept]

Phrase: "and"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "corresponding to ADan-pE"

Phrase: "and"

Phrase: "ADan-E species in a 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705920:Species [Conceptual Entity]

Phrase: ":"

Phrase: "40 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.142: Since parenchymal and vessels fractions were representative of the same amount of original tissue, it is apparent by the Western blot analysis that the PBS-soluble ADan species in FDD are more abundant in vessels than in brain parenchyma. 

Phrase: "Since"

Phrase: "parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "vessels fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "representative of the same amount of original tissue,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1882932:Representative [Activity]

Phrase: "it"

Phrase: "is"

Phrase: "apparent by the Western blot analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750489:apparent [Idea or Concept]

Phrase: "that"

Phrase: "the PBS-soluble ADan species in FDD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "more abundant in vessels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "than"

Phrase: "in brain parenchyma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0933845:Parenchyma [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.143: Similar results were obtained with the SDS-extracted fractions, although as judged by the monomer/dimer ratio, samples had less tendency to remain monomeric. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with the SDS-extracted fractions,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C1264633:Fractions [Quantitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C3541890:EXTRACTED [Finding]
   719 E C1554103:Fraction [Idea or Concept]
   719 E C1706701:Obtain [Activity]
   719 E C2828366:Extract [Substance]

Phrase: "although"

Phrase: "as"

Phrase: "judged by the monomer/dimer ratio,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0456603:Ratio [Quantitative Concept]
   753   C0596448:dimer [Chemical Viewed Structurally]
   753   C0596973:Monomer [Chemical Viewed Structurally]
   753   C1547037:Ratio [Intellectual Product]
   719   C0221191:Judge [Professional or Occupational Group]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "had"

Phrase: "less tendency to"

Phrase: "remain"

Phrase: "monomeric."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.144: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.145: 2C, ADan was predominantly dimeric in parenchymal extracts (ratio of monomers/dimers 1:3), whereas in vascular extracts, the monomeric form was still predominant (ratio of monomers/dimers 5:1). 

Phrase: "2C,"

Phrase: "ADan"

Phrase: "was"

Phrase: "predominantly dimeric in parenchymal extracts"

Phrase: "(ratio of monomers/dimers 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "whereas in vascular extracts,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0005847:vascular [Body Part, Organ, or Organ Component]
   770   C1558950:VASCULAR [Finding]
   770   C1801960:Vascular [Qualitative Concept]
   737   C2828366:Extract [Substance]
   715 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   715 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "the monomeric form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "still predominant"

Phrase: "(ratio of monomers/dimers 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.146: By mass spectrometry analysis, both extracts contained the same two ADan species seen in the PBS extracts and differing in 18 units of mass in a similar 60:40 ratio. 

Phrase: "By mass spectrometry analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]

Phrase: "both extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the same two ADan species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705920:Species [Conceptual Entity]

Phrase: "seen in the PBS extracts"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205397:Seen [Qualitative Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
   726   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "differing in 18 units of mass"

Phrase: "in a similar 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similar [Qualitative Concept]

Phrase: ":"

Phrase: "40 ratio."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.147: The experimental masses, 4043.6 for parenchyma/4045.6 for vessels and 4062.0 for parenchyma/4063.6 for vessels were in good agreement with the expected masses of the post-translationally modified ADan-pE (4045.6) and the wild-type ADan-E (4063.6), with a single disulfide bond between cysteine residues 5 and 22. 

Phrase: "The experimental masses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "4043.6 for parenchyma/4045.6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "for vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "4062.0 for parenchyma/4063.6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "for vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "were in good agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205170:Good [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]

Phrase: "with the expected masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "of the post-translationally modified ADan-pE (4045.6"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   795   C0392747:Modified [Functional Concept]
   795   C0687676:Post [Temporal Concept]
   795   C1704687:Post [Manufactured Object]
   724 E C1514253:Postal [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the wild-type ADan-E (4063.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   876   C1960442:Type 6 [Intellectual Product]
   827   C1883559:Wild Type [Organism Attribute]
   799   C0332307:Type [Qualitative Concept]
   799   C0445392:Wild [Intellectual Product]
   799   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "with a single disulfide bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0759863:single bond [Organic Chemical,Pharmacologic Substance]
   901   C1511997:Disulfide Bond [Amino Acid Sequence]
   827   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "between cysteine residues 5"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "22."
Processing 00000000.tx.148: Analysis of the FA extracts revealed more complexity in terms of composition and degree of aggregation than the other fractions. 

Phrase: "Analysis of the FA extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "more complexity in terms of composition"

Phrase: "and"

Phrase: "degree of aggregation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0441889:Degree [Qualitative Concept]
   790   C0449286:Degree [Quantitative Concept]
   790   C0542560:Degree [Intellectual Product]
   790   C1561545:degree [Quantitative Concept]
   790   C2348088:Degree [Quantitative Concept]

Phrase: "than the"

Phrase: "other fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.149: The interpretation of the mass spectrometry analysis was also more challenging due to the additional presence of mono-, di-, and triformylated species, probably on lysine and/or serine residues (21), artifactually generated during the extraction procedure. 

Phrase: "The interpretation of the mass spectrometry analysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0459471:Interpretation [Intellectual Product]
   748   C3173575:Interpretation [Clinical Attribute]

Phrase: "was"

Phrase: "also more"

Phrase: "challenging due to the additional presence of mono-,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1524062:Additional [Functional Concept]
   744   C1551432:Mono [Population Group]
   744   C1551969:Mono [Language]
   744   C3146286:Due [Idea or Concept]
   711   C0798503:Challenge [Clinical Attribute]
   711   C0805586:Challenge [Health Care Activity]
   711   C3274764:Challenge [Conceptual Entity]

Phrase: "di-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538902:DI [Gene or Genome]
  1000   C3541881:DI [Idea or Concept]

Phrase: "and"

Phrase: "triformylated species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "probably on lysine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0750492:Probably [Idea or Concept]

Phrase: "and/or"

Phrase: "serine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "artifactually"

Phrase: "generated during the extraction procedure."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0185115:extraction procedure [Therapeutic or Preventive Procedure]
           Extraction
   760   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0684295:extraction [Laboratory Procedure]
   760   C1948041:Procedure [Therapeutic or Preventive Procedure]
   760   C2700391:Procedure [Activity]
   760   C3146294:Generated [Activity]
   760   C3274430:PROCEDURE [Health Care Activity]
   760   C3538935:Procedure [Idea or Concept]
   760   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.150: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.151: 3, both parenchymal and vascular lesions were composed of a heterogeneous mixture of post-translationally modified and N- and C-terminally truncated ADan species. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "both parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "vascular lesions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1402315:Vascular lesions [Disease or Syndrome]
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "were"

Phrase: "composed of a heterogeneous mixture of post-translationally"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0019409:Heterogeneous [Qualitative Concept]
   744   C0439962:Mixture [Substance]
   744   C0687676:Post [Temporal Concept]
   744   C1704687:Post [Manufactured Object]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "and"

Phrase: "N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminally truncated ADan species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.152: The predominant components were ADan-(1-33)pE, ADan-(1-28)pE, and ADan-(1-34)pE, although the presence of ADan-(3-28), ADan-(1-27)pE, ADan-(1-30)pE, ADan-(3-33), ADan-(3-34), ADan-(1-33)E, and ADan-(1-34)E was consistently demonstrated (See Fig. 3A, mass spectrometry spectra and table). 

Phrase: "The predominant components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "ADan-"

Phrase: "(1-33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "pE,"

Phrase: "ADan-"

Phrase: "(1-28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "pE,"

Phrase: "and"

Phrase: "ADan-"

Phrase: "(1-34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "pE,"

Phrase: "although"

Phrase: "the presence of ADan-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(3-28"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "ADan-"

Phrase: "(1-27"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "pE,"

Phrase: "ADan-"

Phrase: "(1-30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "pE,"

Phrase: "ADan-"

Phrase: "(3-33"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "ADan-"

Phrase: "(3-34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "ADan-"

Phrase: "(1-33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "E,"

Phrase: "and"

Phrase: "ADan-"

Phrase: "(1-34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "E"

Phrase: "was"

Phrase: "consistently"

Phrase: "demonstrated"

Phrase: "("

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3A,"

Phrase: "mass spectrometry spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0037813:Mass Spectrum [Laboratory Procedure]
           Mass Spectrometry
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "and"

Phrase: "table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.153: This ample heterogeneity was also reflected in the extensive ADan aggregation observed in SDS-PAGE when compared with PBS and SDS extracts. 

Phrase: "This ample heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "reflected in the extensive ADan aggregation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205231:Extensive [Qualitative Concept]
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
   753   C0558058:reflected [Mental Process]

Phrase: "observed in SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1441672:Observed [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "when"

Phrase: "compared with PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1707455:Compared [Activity]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "SDS extracts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]
Processing 00000000.tx.154: Monomers, dimers, trimers, and larger aggregates were clearly highlighted in parenchymal FA extracts. 

Phrase: "Monomers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "dimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "trimers,"

Phrase: "and"

Phrase: "larger aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "clearly"

Phrase: "highlighted in parenchymal FA extracts."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0885348:formic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   719   C2828366:Extract [Substance]
Processing 00000000.tx.155: The aggregation pattern was even more prominent in FA extracts obtained from vessels (Fig. 3B) in which the bulk of amyloid deposition occurs in FDD patients. 

Phrase: "The aggregation pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "even more prominent in FA extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205402:Prominent [Qualitative Concept]

Phrase: "obtained from vessels"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0005847:Vessels [Body Part, Organ, or Organ Component]
   790   C1301820:Obtained [Functional Concept]
   756 E C1511228:Vessel [Tissue]
   756 E C1706701:Obtain [Activity]
   718 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "in which"

Phrase: "the bulk of amyloid deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012173:Bulk [Food]
   760   C1337615:Bulk [Biomedical or Dental Material]

Phrase: "occurs in FDD patients."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1861735:Dementia, familial Danish [Disease or Syndrome]
   783   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0015576:familial [Family Group]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241888:Familial [Functional Concept]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.156: The abundance of FA-soluble ADan species compared with their water-soluble counterparts was not only reflected in the intensity of the immunoreactivity of both parenchymal and vascular extracts but in the amount of protein necessary to visualize ADan species (1,500- and 5,000-fold more protein was required for the PBS and SDS extracts of parenchyma and vessels, respectively, than for the FA fractions). 

Phrase: "The abundance of FA-soluble ADan species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2346714:Abundance [Qualitative Concept]

Phrase: "compared with their water-soluble counterparts"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]
   753   C1707455:Compared [Activity]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]

Phrase: "was"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "reflected in the intensity of the immunoreactivity of both parenchymal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0522510:Intensity [Qualitative Concept]
   739   C0558058:reflected [Mental Process]
   739   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "vascular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "but in the amount of protein necessary to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0233535:but [Mental or Behavioral Dysfunction]
   744   C1265611:Amount [Quantitative Concept]

Phrase: "visualize"

Phrase: "ADan species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "(1,500-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "5,000-fold more protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "required for the PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514873:Required [Functional Concept]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "SDS"

Phrase: "extracts of parenchyma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0933845:Parenchyma [Body Part, Organ, or Organ Component]
   790   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "vessels,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "respectively,"

Phrase: "than"

Phrase: "for the FA fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: ")."
Processing 00000000.tx.157: The N-terminal heterogeneity of ADan peptides in FA-extracted fractions was confirmed by N-terminal sequence analysis in both parenchymal and vascular extracts. 

Phrase: "The N-terminal heterogeneity of ADan peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "in FA-extracted fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "confirmed by N-terminal sequence analysis"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C0750484:Confirmed [Idea or Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1519249:Sequence [Functional Concept]
   753   C1524024:analysis [Functional Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   719 E C1456348:Confirm [Qualitative Concept]

Phrase: "in both parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "vascular extracts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]
Processing 00000000.tx.158: The minor sequences retrieved, SNX-FAIR...and EASNXF..., corresponded to ADan starting at positions 3 and 1, respectively, in a 3:1 ratio. 

Phrase: "The minor sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "retrieved"

Phrase: ","

Phrase: "SNX-FAIR..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2911689:Fair [Qualitative Concept]

Phrase: "and"

Phrase: "EASNXF...,"

Phrase: "corresponded to ADan starting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0439659:Start [Temporal Concept]

Phrase: "at positions 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "respectively,"

Phrase: "in a 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1 ratio."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.159: Yield calculations revealed that these sequences represented about 10-15% of the material loaded into the sequencer cartridge, indicating that 85-90% of the material did not undergo Edman degradation and consistent with the presence of cyclic N-terminal pyroglutamate. 

Phrase: "Yield calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1441506:Calculation [Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "these sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "represented about 10-15% of the material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520510:Material [Substance]
   714   C1882932:Represent [Activity]

Phrase: "loaded into the sequencer cartridge,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0179630:Cartridge [Medical Device]
   760   C1708715:Loaded [Activity]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]

Phrase: "indicating"

Phrase: "that 85-90% of the material"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439083:>90 [Quantitative Concept]
   753   C0439087:<90 [Quantitative Concept]
   753   C0520510:Material [Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "undergo"

Phrase: "Edman degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "consistent with the presence of cyclic N-terminal pyroglutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.160: These results are in agreement with the relevance of the N-terminal pyroglutamate ADan species identified by mass spectrometry (Fig. 3) and with previous published data in leptomeningeal vessels (4). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with the relevance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347946:Relevance [Qualitative Concept]

Phrase: "of the N-terminal pyroglutamate ADan species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "identified by mass spectrometry"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0205396:Identified [Qualitative Concept]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and with previous published data"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0034037:Published [Occupational Activity]
   760   C0205156:Previous [Temporal Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1515981:And [Idea or Concept]
   760   C1552607:previous [Temporal Concept]
   760   C1704324:Published [Intellectual Product]
   760   C3245479:data [Medical Device]

Phrase: "in leptomeningeal vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.161: View larger version (37K): [in this window] [in a new window]  FIGURE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 2."
Processing 00000000.tx.162: Western blot and mass spectrometry analysis of plasma and nonfibrillar ADan deposits. 

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "mass spectrometry analysis of plasma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "nonfibrillar ADan deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]
Processing 00000000.tx.163: ADan molecules were immunoprecipitated using Dynabeads coated with anti-ADan Ab 5282 and subsequently eluted in either Tris-Tricine sample buffer containing dithiothreitol for the Western blot analysis or water/isopropyl alcohol/formic acid (4:4:1) for mass spectrometry via MALDI-TOF, as described under "Experimental Procedures." 

Phrase: "ADan molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Dynabeads"

Phrase: "coated with anti-ADan Ab 5282"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1522408:Coated [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "subsequently"

Phrase: "eluted in either Tris-Tricine sample buffer containing dithiothreitol"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   762   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   742   C0077068:tricine [Organic Chemical]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0332256:Containing [Functional Concept]
   742   C0370003:Sample [Substance]
   742   C0814229:TRI [Intellectual Product]
   742   C2347026:Sample [Conceptual Entity]
   742   C2700400:Containing [Activity]

Phrase: "for the Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "or"

Phrase: "water/isopropyl alcohol/formic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   840   C0885348:formic acid [Organic Chemical]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "(4"

Phrase: ":"

Phrase: "4"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "via MALDI-TOF,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C2348791:Time-of-Flight [Quantitative Concept]
   793   C1555977:Flight [Intellectual Product]
   793   C2610507:flight [Phenomenon or Process]
   723   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.164: A, soluble ADan immunoprecipitated from 0.5 ml of plasma. 

Phrase: "A,"

Phrase: "soluble ADan"

Phrase: "immunoprecipitated from 0.5 ml of plasma."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0444499:0/5 [Quantitative Concept]
   748   C0032105:Plasma [Body Substance]
   748   C0439526:/mL [Quantitative Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   714   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.165: B, PBS-extracted fractions from 500 mg of vessel-depleted frontal cortex and 50 mg of isolated microvessels and leptomeningeal vessels. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "PBS-extracted fractions from 500 mg of vessel-depleted frontal cortex"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C1264633:Fractions [Quantitative Concept]
           Fraction of
   704 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "50 mg of isolated microvessels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439269:mg% [Quantitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "leptomeningeal vessels."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.166: C, SDS-extracted fractions from 500 mg of vessel-depleted frontal cortex and 50 mg of isolated microvessels and leptomeningeal vessels. 

Phrase: "C,"

Phrase: "SDS-extracted fractions from 500 mg of vessel-depleted frontal cortex"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C1264633:Fractions [Quantitative Concept]
           Fraction of
   704 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "50 mg of isolated microvessels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439269:mg% [Quantitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "leptomeningeal vessels."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.167: Theoretical average masses and experimental ADan molecular masses bearing a single disulfide bond between cysteine residues 5 and 22 are shown in the bottom table. 

Phrase: "Theoretical average masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]
   793   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "experimental ADan molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   779   C0577559:Mass [Finding]
   779   C1306372:*Mass [Quantitative Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "a single disulfide bond between cysteine residues 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511997:Disulfide Bond [Amino Acid Sequence]
   767   C0759863:single bond [Organic Chemical,Pharmacologic Substance]
   744   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "22"

Phrase: "are"

Phrase: "shown in the bottom table."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039224:Table [Manufactured Object]
   760   C1511276:Bottom [Spatial Concept]
   760   C1552825:bottom [Idea or Concept]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.168: The y axis of the mass spectra show relative peak intensity based on the maximum ion counts, which are displayed to the right of each spectrum. 

Phrase: "The y axis of the mass spectra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0004457:Axis [Body Part, Organ, or Organ Component]
   748   C0999597:Axis [Mammal]
   748   C1522496:Axis [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "relative peak intensity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0444505:Peak [Quantitative Concept]
   827   C0522510:Intensity [Qualitative Concept]

Phrase: "based on the maximum ion counts,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   753   C0022023:Ion [Element, Ion, or Isotope]
   753   C0439157:counts [Quantitative Concept]
   753   C0806909:Maximum [Quantitative Concept]
   753   C1527178:Based [Functional Concept]
   753   C1552615:maximum [Quantitative Concept]
   753   C1700702:ION [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C2826546:MAXIMUM [Quantitative Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C0750480:Count [Activity]
   719 E C1705566:Count [Quantitative Concept]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "which"

Phrase: "are"

Phrase: "displayed to the right of each spectrum."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0205090:Right [Spatial Concept]
   748   C0870432:displayed [Functional Concept]
   748   C1883073:Spectrum [Quantitative Concept]
   748   C2827424:Spectrum [Conceptual Entity]
   714 E C1705417:Display [Manufactured Object]
Processing 00000000.tx.169: Mo, monomers; 

Phrase: "Mo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ";"
Processing 00000000.tx.170: Di, dimers.  

Phrase: "Di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538902:DI [Gene or Genome]
  1000   C3541881:DI [Idea or Concept]

Phrase: "dimers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]
Processing 00000000.tx.171: A42 Colocalizes with ADan Parenchymal and Vascular LesionsAll parenchymal and vascular extracts previously analyzed for ADan (PBS, SDS, and FA extracts) were also evaluated for the presence of A species via immunoprecipitation/mass spectrometry and immunoprecipitation/Western blot using four different anti-A antibodies: 4G8 (anti-A-(17-24)), 6E10 (anti-A-(1-17)), and the C-terminus-specific anti-A40 and anti-A42. 

Phrase: "A42"

Phrase: "Colocalizes with ADan"

Phrase: "Parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Vascular LesionsAll"

Phrase: "parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "vascular extracts previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "analyzed for ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "(PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "SDS,"

Phrase: "and"

Phrase: "FA extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C2828366:Extract [Substance]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "evaluated for the presence of A species"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0220825:Evaluated [Functional Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1705920:Species [Conceptual Entity]

Phrase: "via immunoprecipitation/mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0037813:Mass Spectrometry [Laboratory Procedure]
   827   C0436196:Spectrometry [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "immunoprecipitation/Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   901   C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "four different anti-A antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   853   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   836 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "4G8"

Phrase: "(anti-A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(17-24"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "6E10"

Phrase: "(anti-A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the C-terminus-specific anti-A40"

Phrase: "and"

Phrase: "anti-A42."
Processing 00000000.tx.172: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.173: 4 (A and B), A species were detectable in PBS extracts from parenchyma and vessels fractions. 

Phrase: "4"

Phrase: "(A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "detectable in PBS"

Phrase: "extracts from parenchyma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0933845:Parenchyma [Body Part, Organ, or Organ Component]
   790   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "vessels fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.174: Parenchymal extracts were immunoreactive with antibodies 4G8, 6E10, and anti-A42 but not with anti-A40. 

Phrase: "Parenchymal extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoreactive with antibodies 4G8,"

Phrase: "6E10,"

Phrase: "and"

Phrase: "anti-A42"

Phrase: "but"

Phrase: "not with anti-A40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1518422:Not [Functional Concept]
Processing 00000000.tx.175: Monomers and dimers of A-(X-42) were observed with an estimated monomer/dimer ratio of 1:2 (Fig. 4A). 

Phrase: "Monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "dimers of A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "(X-42"

Phrase: ")"

Phrase: "were"

Phrase: "observed with an estimated monomer/dimer ratio of 1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0456603:Ratio [Quantitative Concept]
   742   C0596448:dimer [Chemical Viewed Structurally]
   742   C0596973:Monomer [Chemical Viewed Structurally]
   742   C0750572:Estimated [Quantitative Concept]
   742   C1441672:Observed [Functional Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.176: Although a low signal was retrieved in the mass spectrometry, there was a peak with a mass suspected to correspond to the fragment A-(4-34) (experimental 3473.5; expected 3472.9); 

Phrase: "Although"

Phrase: "a low signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "retrieved in the mass spectrometry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]

Phrase: "there"

Phrase: "was"

Phrase: "a peak with a mass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0444505:Peak [Quantitative Concept]

Phrase: "suspected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332147:Suspected [Qualitative Concept]
  1000   C0750491:Suspected [Idea or Concept]
   966 E C1571873:Suspect [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correspond to the fragment A-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0332255:fragment [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "(4-34"

Phrase: ")"

Phrase: "(experimental 3473.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517586:Experimental [Qualitative Concept]

Phrase: ";"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "3472.9"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.177: no clear peaks of A-(X-42) were detected (Fig. 4, A and table). 

Phrase: "no clear peaks of A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0444505:peaks [Quantitative Concept]

Phrase: "(X-42"

Phrase: ")"

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.178: Vascular extracts, on the other hand, rendered a more defined picture both at the Western blot and mass spectrometry levels. 

Phrase: "Vascular extracts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "rendered"

Phrase: "a more defined picture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441468:picture [Manufactured Object]
   827   C0441469:Picture [Manufactured Object]

Phrase: "both at the Western blot"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C0238767:Both [Spatial Concept]
   760   C1705493:Western [Spatial Concept]
   760   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "mass spectrometry levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]
Processing 00000000.tx.179: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.180: 4B, A species were immunoreactive with all antibodies, including anti-A40. 

Phrase: "4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "immunoreactive with all antibodies,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "anti-A40."
Processing 00000000.tx.181: Several differences were spotted when compared with the parenchymal counterparts: (i) the signals for monomers and dimers were stronger, (ii) A40 immunoreactivity (although not strong) was seen with dimeric species, a signal not detected in parenchymal fractions, and (iii) the monomeric component detected by 6E10 and anti-A42 was clearly composed of two bands of very close molecular mass. 

Phrase: "Several differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "spotted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0329155:Spot [Fish]
   966   C1427618:SPOT [Gene or Genome]
   966   C1705203:Spot [Conceptual Entity]

Phrase: "when"

Phrase: "compared with the parenchymal counterparts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Compared [Activity]

Phrase: ":"

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the signals for monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "were"

Phrase: "stronger,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C0442821:Strong [Qualitative Concept]
   916 E C0237897:Strength [Quantitative Concept]
   916 E C0808080:Strength [Idea or Concept]
   916 E C1705922:Strength [Qualitative Concept]

Phrase: "(ii"

Phrase: ")"

Phrase: "A40 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "("

Phrase: "although"

Phrase: "not strong"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442821:Strong [Qualitative Concept]
   789 E C0237897:Strength [Quantitative Concept]
   789 E C0808080:Strength [Idea or Concept]
   789 E C1705922:Strength [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "seen with dimeric species,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205397:Seen [Qualitative Concept]
   770   C1705920:Species [Conceptual Entity]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "a signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in parenchymal fractions,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C1264633:Fractions [Quantitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "and ("

Phrase: "iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "the monomeric component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]

Phrase: "detected by 6E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "anti-A42"

Phrase: "was"

Phrase: "clearly"

Phrase: "composed of two bands of very"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0175723:Bands [Medical Device]
   753   C0205448:Two [Quantitative Concept]
   753   C0442824:Very [Qualitative Concept]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]

Phrase: "close"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Close [Functional Concept]

Phrase: "molecular mass."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
Processing 00000000.tx.182: As judged by mass spectrometry analysis, the major A species in the sample were A-(1-42), A-(4-42), and A-(1-40) (Fig. 4, B and table), the last being a minor component. 

Phrase: "As"

Phrase: "judged by mass spectrometry analysis,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1524024:analysis [Functional Concept]
   760   C3152252:Mass [Quantitative Concept]
   726   C0221191:Judge [Professional or Occupational Group]

Phrase: "the major A species in the sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the last"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517741:Last [Qualitative Concept]

Phrase: "being"

Phrase: "a minor component."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.183: Interestingly, the immunoprecipitation procedure using a mixture of 4G8 + 6E10 antibodies prior to the MALDI-TOF analysis also retrieved full-length ADan (both ADan-pE and ADan-E), suggestive of a protein-protein interaction between both peptides (see below). 

Phrase: "Interestingly,"

Phrase: "the immunoprecipitation procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mixture of 4G8 + 6E10 antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439962:Mixture [Substance]

Phrase: "prior to the MALDI-TOF analysis also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1718396:Time of analysis [Temporal Concept]
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "retrieved"

Phrase: "full-length ADan"

Phrase: "("

Phrase: "both ADan-pE"

Phrase: "and"

Phrase: "ADan-E"

Phrase: ")"

Phrase: ","

Phrase: "suggestive of a protein-protein interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332299:Suggestive of [Functional Concept]
           suggestive

Phrase: "between both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.184: The identification of A-(4-42) and A-(1-42), differing in 315 units of mass, strongly argues that these species are the components of the double band with the electrophoretic mobility of the monomeric species observed in the 4-kDa molecular mass of the Western blot with 6E10 and anti-A42 (Fig. 4B). 

Phrase: "The identification of A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "(4-42"

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "differing in 315 units of mass,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   822   C0439206:Unit of mass [Quantitative Concept]
   753   C0439148:Units [Quantitative Concept]
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]

Phrase: "strongly"

Phrase: "argues"

Phrase: "that"

Phrase: "these species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "the components of the double band"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "with the electrophoretic mobility"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0425245:Mobility [Finding]
   861   C0449580:Mobility [Qualitative Concept]
   789   C0013855:Electrophoreses [Laboratory Procedure]
   789 E C0231435:Mobile [Functional Concept]
   789 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "of the monomeric species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "observed in the 4-kDa molecular mass of the Western blot"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   756   C0949466:Western Blot [Laboratory Procedure]
   756   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   738   C0577559:Mass [Finding]
   738   C1306372:*Mass [Quantitative Concept]
   738   C1441672:Observed [Functional Concept]
   738   C1521991:Molecular [Qualitative Concept]
   738   C1532717:kDa [Quantitative Concept]
   738   C1705493:Western [Spatial Concept]

Phrase: "with 6E10"

Phrase: "and"

Phrase: "anti-A42"

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.185: View larger version (50K): [in this window] [in a new window]  FIGURE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(50K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 3."
Processing 00000000.tx.186: Western blot and mass spectrometry analysis of fibrillar ADan. 

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "mass spectrometry analysis of fibrillar ADan."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.187: ADan molecules were extracted in 70% FA, lyophilized, redissolved in Tris-Tricine sample buffer containing dithiothreitol, and directly analyzed by Western blot. 

Phrase: "ADan molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "extracted in 70% FA,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0885348:formic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "lyophilized"

Phrase: ","

Phrase: "redissolved in Tris-Tricine sample buffer containing dithiothreitol,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   744   C0077068:tricine [Organic Chemical]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0332256:Containing [Functional Concept]
   744   C0370003:Sample [Substance]
   744   C0814229:TRI [Intellectual Product]
   744   C2347026:Sample [Conceptual Entity]
   744   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "analyzed by Western blot."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.188: For MALDI-TOF analysis, ADan molecules were desalted by a ZipTip micro-reverse-phase column, eluted with 90% (v/v) acetonitrile, 0.1% trifluoroacetic acid in water, as described under "Experimental Procedures." 

Phrase: "For MALDI-TOF analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   834   C1718396:Time of analysis [Temporal Concept]
   791   C0002778:Analysis [Laboratory Procedure]
   791   C0936012:Analysis [Research Activity]
   791   C1524024:analysis [Functional Concept]
   707   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: "ADan molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "desalted by a ZipTip micro-reverse-phase column,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0085672:MICRO [Laboratory Procedure]
   744   C0205390:Phase [Temporal Concept]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1553035:Micro [Quantitative Concept]
   744   C1555029:Reverse [Idea or Concept]
   744   C1706132:Column [Idea or Concept]

Phrase: "eluted with 90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]

Phrase: "(v/v) acetonitrile,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0050456:acetonitrile [Organic Chemical]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "0.1% trifluoroacetic acid in water,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.189: A, parenchymal FA extracts from microvessel-depleted frontal cortex after PBS and SDS extractions. 

Phrase: "A,"

Phrase: "parenchymal FA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0885348:formic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "extracts from microvessel-depleted frontal cortex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   753   C0007776:Cortex [Body Part, Organ, or Organ Component]
   753   C0205123:Frontal [Spatial Concept]
   753   C0333668:Depleted [Functional Concept]
   753   C1176472:Cortex [Body Part, Organ, or Organ Component]
   753   C2350570:Microvessel [Body Part, Organ, or Organ Component]
   753   C2700441:Cortex [Plant]
   753   C2828366:Extract [Substance]

Phrase: "after PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "SDS extractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0185115:extractions [Therapeutic or Preventive Procedure]
   827 E C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.190: Western blots represent 1.5 mg of frontal cortex, whereas mass spectrometry spectra represent 22.5 mg of frontal cortex. 

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "1.5 mg of frontal cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "mass spectrometry spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0037813:Mass Spectrum [Laboratory Procedure]
           Mass Spectrometry
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "22.5 mg of frontal cortex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.191: B, vessel extracts in FA-isolated microvessels and leptomeningeal vessels after PBS and SDS extractions. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "vessel"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005847:Vessel [Body Part, Organ, or Organ Component]
  1000   C1511228:Vessel [Tissue]
   944 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "extracts in FA-isolated microvessels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0885348:formic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0205409:Isolated [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C2350570:Microvessels [Body Part, Organ, or Organ Component]
   753   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "leptomeningeal vessels after PBS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0005847:Vessels [Body Part, Organ, or Organ Component]
   737 E C1511228:Vessel [Tissue]

Phrase: "and"

Phrase: "SDS extractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0185115:extractions [Therapeutic or Preventive Procedure]
   827 E C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.192: Western blots represent 0.5 mg of frontal cortex, whereas mass spectrometry spectra represent 22.5 mg of frontal cortex. 

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "0.5 mg of frontal cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "mass spectrometry spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0037813:Mass Spectrum [Laboratory Procedure]
           Mass Spectrometry
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "22.5 mg of frontal cortex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.193: Peaks corresponding in mass to formylated species are indicated by asterisks (*, single formylation; **, double formylation; ***, triple formylation). 

Phrase: "Peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:peaks [Quantitative Concept]

Phrase: "corresponding in mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0577559:Mass [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C3152252:Mass [Quantitative Concept]

Phrase: "to formylated species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "indicated by asterisks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C2945706:asterisks [Conceptual Entity]

Phrase: "("

Phrase: "*,"

Phrase: "single formylation"

Phrase: ";"

Phrase: "*"

Phrase: "*,"

Phrase: "double formylation"

Phrase: ";"

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "triple formylation"

Phrase: ")."
Processing 00000000.tx.194: Theoretical average masses and experimental ADan molecular masses bearing a single disulfide bond between cysteine residues 5 and 22 are shown in the bottom table. 

Phrase: "Theoretical average masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]
   793   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "experimental ADan molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   779   C0577559:Mass [Finding]
   779   C1306372:*Mass [Quantitative Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "a single disulfide bond between cysteine residues 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511997:Disulfide Bond [Amino Acid Sequence]
   767   C0759863:single bond [Organic Chemical,Pharmacologic Substance]
   744   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "22"

Phrase: "are"

Phrase: "shown in the bottom table."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039224:Table [Manufactured Object]
   760   C1511276:Bottom [Spatial Concept]
   760   C1552825:bottom [Idea or Concept]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.195: The arrowheads indicate electrophoretic mobility of ADan monomers, dimers, and trimers.  

Phrase: "The arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: "indicate"

Phrase: "electrophoretic mobility of ADan monomers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "dimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "trimers."
Processing 00000000.tx.196: When the SDS extracts were analyzed by the same procedures, the results obtained were similar to those in the PBS extracts, although (i) under the same protein load, the immunoreactive signals were stronger, suggesting a relative enrichment on A species, and (ii) the dimeric forms were more relevant. 

Phrase: "When"

Phrase: "the SDS extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "analyzed by the same procedures,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0025664:procedures [Intellectual Product]
   760   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0445247:Same [Qualitative Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C2700391:procedures [Activity]
   726 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   726 E C3274430:PROCEDURE [Health Care Activity]
   726 E C3538935:Procedure [Idea or Concept]
   726 E C3539779:Procedure [Intellectual Product]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "were"

Phrase: "similar to those in the PBS extracts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "although"

Phrase: "(i) under the same protein load,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the immunoreactive signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "stronger,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C0442821:Strong [Qualitative Concept]
   916 E C0237897:Strength [Quantitative Concept]
   916 E C0808080:Strength [Idea or Concept]
   916 E C1705922:Strength [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a relative enrichment on A species,"

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "the dimeric forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "more relevant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.197: Parenchymal extracts were immunoreactive with 4G8, 6E10, and anti-A42 but not with anti-A40 (Fig. 4C). 

Phrase: "Parenchymal extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoreactive with 4G8,"

Phrase: "6E10,"

Phrase: "and"

Phrase: "anti-A42"

Phrase: "but"

Phrase: "not with anti-A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1518422:Not [Functional Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.198: Monomeric species, especially those immunoreactive with 6E10, seemed to be composed of more than one band in Western blot, very similar to the pattern shown in Fig. 

Phrase: "Monomeric species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "especially"

Phrase: "those immunoreactive with 6E10,"

Phrase: "seemed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "composed of more"

Phrase: "than one band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "in Western blot,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "very similar to the pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.199: 4B. 

Phrase: "4B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]
Processing 00000000.tx.200: Mass spectrometry indicated that this extracts mainly contained A-(1-42) and its N-terminally truncated derivative A-(4-42), whereas A-(1-40) was a minor component (Fig. 4, C and table). 

Phrase: "Mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "this extracts mainly contained A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "its N-terminally truncated derivative A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "a minor component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.201: The double peaks obtained in this sample originate in the presence of A peptides bearing oxidized Met35 (Met sulfoxide; +16 mass units), most probably a technical artifact due to the use of formic acid to process this sample for mass spectrometry. 

Phrase: "The double peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "obtained in this sample"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C1277697:Sample obtained [Finding]
   770   C0370003:Sample [Substance]
   770   C1301820:Obtained [Functional Concept]
   770   C2347026:Sample [Conceptual Entity]
   737 E C1706701:Obtain [Activity]

Phrase: "originate in the presence of A peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "oxidized Met35"

Phrase: "(Met sulfoxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "; +16 mass units"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "most probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0750492:Probably [Idea or Concept]

Phrase: "a technical artifact due to the use of formic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0085089:Artefact [Human-caused Phenomenon or Process]
   739   C1879740:ARTIFACT [Phenomenon or Process]

Phrase: "to process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "this sample for mass spectrometry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.202: In vitro pretreatment of synthetic A40 and A42 with formic acid produced similar effect (not shown). 

Phrase: "In vitro pretreatment of synthetic A40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1550147:Pretreatment [Substance]
   753   C2709094:pre treatment [Temporal Concept]
   753   C3539075:Pretreatment [Temporal Concept]
   753   C3539076:Pretreatment [Activity]

Phrase: "and"

Phrase: "A42 with formic acid"

Phrase: "produced"

Phrase: "similar effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.203: A species in vessel extracts were immunoreactive with all of the antibodies tested (Fig. 4D). 

Phrase: "A species in vessel extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoreactive with all of the antibodies"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.204: As curiously observed with the PBS-fractions (Fig. 4B), (i) A40 immunoreactivity was also limited to dimeric species, and (ii) the monomeric component detected by 6E10 and anti-A42 was also composed of two bands of very close molecular mass (as shown in Fig. 4, B and C). 

Phrase: "As"

Phrase: "curiously"

Phrase: "observed with the PBS-fractions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C1264633:Fractions [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "(i) A40 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "also"

Phrase: "limited to dimeric species,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0439801:Limited [Functional Concept]
   770   C1705920:Species [Conceptual Entity]
   770   C3542948:Limited [Intellectual Product]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "the monomeric component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]

Phrase: "detected by 6E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "anti-A42"

Phrase: "was"

Phrase: "also"

Phrase: "composed of two bands of very"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0175723:Bands [Medical Device]
   753   C0205448:Two [Quantitative Concept]
   753   C0442824:Very [Qualitative Concept]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]

Phrase: "close"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Close [Functional Concept]

Phrase: "molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]

Phrase: "("

Phrase: "as"

Phrase: "shown in Fig. 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C"

Phrase: ")."
Processing 00000000.tx.205: In general terms, the dimeric species were more prominent than in the PBS fractions. 

Phrase: "In general terms,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0278060:GENERAL TERMS [Finding]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "the dimeric species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "more prominent than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205402:Prominent [Qualitative Concept]

Phrase: "in the PBS fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.206: Mass spectrometry identified A-(1-42) and A-(4-42) as the major components whereas A-(1-40) was a minor constituent of the extract. 

Phrase: "Mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "as the major components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "whereas"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "a minor constituent of the extract."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0729650:constituent [Substance]
Processing 00000000.tx.207: As illustrated above with the PBS fractions, immunoprecipitation with the anti-A antibodies also retrieved a minor amount of full-length ADan (Fig. 4D). 

Phrase: "As"

Phrase: "illustrated above with the PBS fractions,"

Phrase: "immunoprecipitation with the anti-A antibodies also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "retrieved"

Phrase: "a minor amount of full-length ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.208: View larger version (40K): [in this window] [in a new window]  FIGURE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 4."
Processing 00000000.tx.209: Western blot and mass spectrometry analysis of nonfibrillar A. 

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "mass spectrometry analysis of nonfibrillar A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.210: A species were immunoprecipitated with Dynabeads coated with a mixture of 4G8 and 6E10. 

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "immunoprecipitated with Dynabeads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "coated with a mixture of 4G8"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0439962:Mixture [Substance]
   753   C1522408:Coated [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "6E10."
Processing 00000000.tx.211: Bound peptides were eluted and analyzed either by Western blot using a panel of anti-A antibodies (4G8, 6E10, anti-A40, and anti-A42) or by MALDI-TOF mass spectrometry as described under "Experimental Procedures." 

Phrase: "Bound peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "eluted"

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "either by Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a panel of anti-A antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441833:Panel [Idea or Concept]
   753   C1999270:Panel [Intellectual Product]
   753   C3537156:Panel [Manufactured Object]

Phrase: "(4G8,"

Phrase: "6E10,"

Phrase: "anti-A40,"

Phrase: "and"

Phrase: "anti-A42"

Phrase: ")"

Phrase: "or"

Phrase: "by MALDI-TOF mass spectrometry"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.212: Shown are PBS-extracted fractions from 500 mg of microvessel-depleted frontal cortex (A) and 50 mg of isolated microvessels and leptomeningeal vessels equivalent to 500 mg of frontal cortex (B). 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "PBS-extracted fractions from 500 mg of microvessel-depleted frontal cortex"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C1264633:Fractions [Quantitative Concept]
           Fraction of
   704 E C1554103:Fraction [Idea or Concept]

Phrase: "(A"

Phrase: ")"

Phrase: "and"

Phrase: "50 mg of isolated microvessels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439269:mg% [Quantitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "leptomeningeal vessels equivalent to 500 mg of frontal cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205163:Equivalent [Qualitative Concept]
   742   C0439185:equivalent [Quantitative Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.213: SDS-extracted fractions from 500 mg of microvessel-depleted frontal cortex (C) and 50 mg of isolated microvessels and leptomeningeal vessels equivalent to 500 mg of frontal cortex (D). 

Phrase: "SDS-extracted fractions from 500 mg of microvessel-depleted frontal cortex (C)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C1264633:Fractions [Quantitative Concept]
           Fraction of
   704 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "50 mg of isolated microvessels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439269:mg% [Quantitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "leptomeningeal vessels equivalent to 500 mg of frontal cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205163:Equivalent [Qualitative Concept]
   742   C0439185:equivalent [Quantitative Concept]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.214: Theoretical average masses and experimental A molecular masses are shown in the bottom table. 

Phrase: "Theoretical average masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]
   793   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "experimental A molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   779   C0577559:Mass [Finding]
   779   C1306372:*Mass [Quantitative Concept]

Phrase: "are"

Phrase: "shown in the bottom table."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039224:Table [Manufactured Object]
   760   C1511276:Bottom [Spatial Concept]
   760   C1552825:bottom [Idea or Concept]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.215: Mo, monomers; 

Phrase: "Mo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ";"
Processing 00000000.tx.216: Di, dimers. 

Phrase: "Di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538902:DI [Gene or Genome]
  1000   C3541881:DI [Idea or Concept]

Phrase: "dimers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]
Processing 00000000.tx.217: #, peaks of mass spectra present in the negative controls (without brain extracts) and considered to be nonspecific. 

Phrase: "#,"

Phrase: "peaks of mass spectra"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0037813:Mass Spectrum [Laboratory Procedure]
   770   C0444505:Peak [Quantitative Concept]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]
   737   C1883073:Spectrum [Quantitative Concept]
   737   C2827424:Spectrum [Conceptual Entity]

Phrase: "present in the negative controls"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   773   C1639518:% negative control [Quantitative Concept]
   773   C1947986:Negative Control [Conceptual Entity]
   760   C0150312:Present [Quantitative Concept]
   760   C0205160:Negative [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1513916:Negative [Finding]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "without brain extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: ")"

Phrase: "and"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "nonspecific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205370:Non-specific [Qualitative Concept]
  1000   C0750540:Nonspecific [Idea or Concept]
Processing 00000000.tx.218: , peaks also obtained in negative controls (using brain extracts but uncoated Dynabeads) and considered nonspecific.  

Phrase: ","

Phrase: "peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "also"

Phrase: "obtained in negative controls"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   799   C1639518:% negative control [Quantitative Concept]
   799   C1947986:Negative Control [Conceptual Entity]
   770   C0205160:Negative [Qualitative Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737 E C1706701:Obtain [Activity]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "brain extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "but"

Phrase: "uncoated Dynabeads"

Phrase: ")"

Phrase: "and"

Phrase: "considered nonspecific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0750540:Nonspecific [Idea or Concept]
Processing 00000000.tx.219: View larger version (42K): [in this window] [in a new window]  FIGURE 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 5."
Processing 00000000.tx.220: Western blot and mass spectrometry analysis of fibrillar A. 

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "mass spectrometry analysis of fibrillar A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.221: A species were extracted in 70% FA, lyophilized, redissolved in Tris-Tricine sample buffer containing dithiothreitol, and directly analyzed by Western blot against 4G8, 6E10, anti-A40, and anti-A42. 

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "extracted in 70% FA,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0885348:formic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "lyophilized"

Phrase: ","

Phrase: "redissolved in Tris-Tricine sample buffer containing dithiothreitol,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   744   C0077068:tricine [Organic Chemical]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0332256:Containing [Functional Concept]
   744   C0370003:Sample [Substance]
   744   C0814229:TRI [Intellectual Product]
   744   C2347026:Sample [Conceptual Entity]
   744   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "analyzed by Western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "against 4G8,"

Phrase: "6E10,"

Phrase: "anti-A40,"

Phrase: "and"

Phrase: "anti-A42."
Processing 00000000.tx.222: For MALDI-TOF analysis, A molecules were immunoprecipitated with Dynabeads coated with a mixture of 4G8 and 6E10 antibodies, eluted with a mixture of water/isopropyl alcohol/formic acid (4:4:1), and analyzed by mass spectrometry as described under "Experimental Procedures." 

Phrase: "For MALDI-TOF analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   834   C1718396:Time of analysis [Temporal Concept]
   791   C0002778:Analysis [Laboratory Procedure]
   791   C0936012:Analysis [Research Activity]
   791   C1524024:analysis [Functional Concept]
   707   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: "A molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with Dynabeads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "coated with a mixture of 4G8"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0439962:Mixture [Substance]
   753   C1522408:Coated [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "6E10 antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "eluted with a mixture of water/isopropyl alcohol/formic acid"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   760   C0022237:Isopropyl Alcohol [Organic Chemical,Pharmacologic Substance]
   760   C0885348:formic acid [Organic Chemical]
   739   C0001128:Acid [Chemical]
   739   C0001962:ALCOHOL [Organic Chemical]
   739   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   739   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0439962:Mixture [Substance]
   739   C0599638:WATER [Substance]
   739   C1550678:Water [Inorganic Chemical]
   739   C2945717:isopropyl [Chemical Viewed Structurally]

Phrase: "(4"

Phrase: ":"

Phrase: "4"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "analyzed by mass spectrometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C0936012:Analyzed [Research Activity]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.223: A, parenchymal FA extracts from microvessel-depleted frontal cortex after PBS and SDS extractions. 

Phrase: "A,"

Phrase: "parenchymal FA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0885348:formic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "extracts from microvessel-depleted frontal cortex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   753   C0007776:Cortex [Body Part, Organ, or Organ Component]
   753   C0205123:Frontal [Spatial Concept]
   753   C0333668:Depleted [Functional Concept]
   753   C1176472:Cortex [Body Part, Organ, or Organ Component]
   753   C2350570:Microvessel [Body Part, Organ, or Organ Component]
   753   C2700441:Cortex [Plant]
   753   C2828366:Extract [Substance]

Phrase: "after PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "SDS extractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0185115:extractions [Therapeutic or Preventive Procedure]
   827 E C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.224: Western blots represent 1.5 mg of frontal cortex, whereas mass spectrometry spectra represent 15 mg of frontal cortex. 

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "1.5 mg of frontal cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "mass spectrometry spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0037813:Mass Spectrum [Laboratory Procedure]
           Mass Spectrometry
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "15 mg of frontal cortex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439269:mg% [Quantitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.225: B, vessel extracts in FA-isolated microvessels and leptomeningeal vessels after PBS and SDS extractions. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "vessel"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005847:Vessel [Body Part, Organ, or Organ Component]
  1000   C1511228:Vessel [Tissue]
   944 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "extracts in FA-isolated microvessels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0885348:formic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0205409:Isolated [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C2350570:Microvessels [Body Part, Organ, or Organ Component]
   753   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "leptomeningeal vessels after PBS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0005847:Vessels [Body Part, Organ, or Organ Component]
   737 E C1511228:Vessel [Tissue]

Phrase: "and"

Phrase: "SDS extractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0185115:extractions [Therapeutic or Preventive Procedure]
   827 E C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.226: Western blots represent 0.5 mg of frontal cortex, whereas mass spectra represent 1.5 mg of vessels (equivalent to 15 mg of frontal cortex). 

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "0.5 mg of frontal cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "mass spectra"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0037813:Mass Spectrum [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "1.5 mg of vessels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439269:mg% [Quantitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(equivalent to 15 mg of frontal cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205163:Equivalent [Qualitative Concept]
   748   C0439185:equivalent [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.227: Formylated species are indicated by an asterisk. 

Phrase: "Formylated species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "indicated by an asterisk."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444656:Indicated [Finding]
   770   C2945706:asterisk [Conceptual Entity]
Processing 00000000.tx.228: Ox,A species oxidized at Met35. 

Phrase: "Ox,A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "oxidized at Met35."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0030011:oxidize [Molecular Function]
Processing 00000000.tx.229: Theoretical average masses and experimental A molecular masses are shown in the bottom table. 

Phrase: "Theoretical average masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]
   793   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "experimental A molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   779   C0577559:Mass [Finding]
   779   C1306372:*Mass [Quantitative Concept]

Phrase: "are"

Phrase: "shown in the bottom table."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039224:Table [Manufactured Object]
   760   C1511276:Bottom [Spatial Concept]
   760   C1552825:bottom [Idea or Concept]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.230: Arrowheads, electrophoretic mobility of A monomers and dimers. 

Phrase: "Arrowheads,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: "electrophoretic mobility of A monomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "and"

Phrase: "dimers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]
Processing 00000000.tx.231: , peaks of mass spectra present in the negative controls (using brain extracts but uncoated Dynabeads) and considered nonspecific.  

Phrase: ","

Phrase: "peaks of mass spectra"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0037813:Mass Spectrum [Laboratory Procedure]
   770   C0444505:Peak [Quantitative Concept]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]
   737   C1883073:Spectrum [Quantitative Concept]
   737   C2827424:Spectrum [Conceptual Entity]

Phrase: "present in the negative controls"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   773   C1639518:% negative control [Quantitative Concept]
   773   C1947986:Negative Control [Conceptual Entity]
   760   C0150312:Present [Quantitative Concept]
   760   C0205160:Negative [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1513916:Negative [Finding]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "brain extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "but"

Phrase: "uncoated Dynabeads"

Phrase: ")"

Phrase: "and"

Phrase: "considered nonspecific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0750540:Nonspecific [Idea or Concept]
Processing 00000000.tx.232: Formic acid retrieved mainly polymerized A species in both parenchymal and vascular lesions. 

Phrase: "Formic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0885348:formic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "retrieved"

Phrase: "mainly polymerized A species in both parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "vascular lesions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1402315:Vascular lesions [Disease or Syndrome]
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.233: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.234: 5A, parenchymal extracts were immunoreactive with 4G8, 6E10, and anti-A42 antibodies but were not recognized by anti-A40. 

Phrase: "5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: "parenchymal extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoreactive with 4G8,"

Phrase: "6E10,"

Phrase: "and"

Phrase: "anti-A42 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "but"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recognized by anti-A40."
Processing 00000000.tx.235: A species were mainly dimeric, although a small proportion of higher oligomers was visible with both 4G8 and anti-A42. 

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "mainly dimeric,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0596448:dimer [Chemical Viewed Structurally]

Phrase: "although"

Phrase: "a small proportion of higher oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "was"

Phrase: "visible with both 4G8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205379:Visible [Qualitative Concept]

Phrase: "and"

Phrase: "anti-A42."
Processing 00000000.tx.236: When the same sample was analyzed by mass spectrometry, the most prominent signal corresponded to an experimental m/z of 4200.0, consistent with the theoretical protonated mass of 4199.8 for A-(4-42). 

Phrase: "When"

Phrase: "the same sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "analyzed by mass spectrometry,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C0936012:Analyzed [Research Activity]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "the most prominent signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "corresponded to an experimental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517586:Experimental [Qualitative Concept]

Phrase: "m/"

Phrase: "z of 4200.0,"

Phrase: "consistent with the theoretical protonated mass of 4199.8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
   726   C2983632:Mass Consistency [Qualitative Concept]

Phrase: "for A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")."
Processing 00000000.tx.237: Both, A-(1-42) and A-(1-40) were also present in the sample, although A-(1-40) was a minute contributor to the composition of the FA extract, data consistent with the lack of immunoreactive signal in the Western blots. 

Phrase: "Both,"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "present in the sample,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0150312:Present [Quantitative Concept]
   770   C0370003:Sample [Substance]
   770   C0449450:Present [Idea or Concept]
   770   C2347026:Sample [Conceptual Entity]

Phrase: "although"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "a minute contributor to the composition of the FA extract,"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "consistent with the lack of immunoreactive signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in the Western blots."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.238: Two additional peaks differing in +16 and +28 mass units with A-(4-42) were also observed. 

Phrase: "Two additional peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:peaks [Quantitative Concept]

Phrase: "differing"

Phrase: "in +16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: "and +"

Phrase: "28 mass units with A-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0439148:Units [Quantitative Concept]
   760   C1519795:Units [Quantitative Concept]
   726 E C1704753:Unit [Manufactured Object]
   726 E C1880519:Unit [Quantitative Concept]

Phrase: "(4-42"

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.239: Both experimental masses matched the expected values for A-(4-42) (Met sulfoxide) and A-(4-42) (formylated). 

Phrase: "Both experimental masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: "the expected values for A-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0042295:Values [Qualitative Concept]
   760   C1517001:Expected [Idea or Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "(4-42"

Phrase: ")"

Phrase: "(Met sulfoxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "(formylated"

Phrase: ")."
Processing 00000000.tx.240: Since samples were exposed to FA during the extraction procedure and prior to the mass spectrometry analysis, these A derivatives may well represent undesirable secondary products of the specimen treatment rather than actual post-translationally modified components present in the lesions. 

Phrase: "Since"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to FA during the extraction procedure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   778   C0885348:formic acid [Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]

Phrase: "and prior to the mass spectrometry analysis,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0037813:Mass Spectrometry [Laboratory Procedure]
   778   C0332152:Prior to [Temporal Concept]
           Prior
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0436196:Spectrometry [Laboratory Procedure]
   748   C0577559:Mass [Finding]
   748   C0936012:Analysis [Research Activity]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1524024:analysis [Functional Concept]
   748   C2826257:PRIOR [Event]
   748   C3152252:Mass [Quantitative Concept]

Phrase: "these A derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "may"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "undesirable secondary products of the specimen treatment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "rather than"

Phrase: "actual post-translationally modified components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0449432:Components [Manufactured Object]
   771 E C1705248:Component [Conceptual Entity]

Phrase: "present in the lesions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0150312:Present [Quantitative Concept]
   770   C0221198:lesions [Finding]
   770   C0449450:Present [Idea or Concept]
   737 E C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.241: Alternatively, these oxidized A42 species may represent existent in vivo neurotoxic subproducts of oxidative stress, as previously proposed (22). 

Phrase: "Alternatively,"

Phrase: "these oxidized A42 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "existent in vivo neurotoxic subproducts of oxidative stress,"

Phrase: "as"

Phrase: "previously"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.242: View larger version (74K): [in this window] [in a new window]  FIGURE 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(74K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 6."
Processing 00000000.tx.243: Co-localization of ADan and A might be related to a specific interaction between deposited peptides. 

Phrase: "Co-localization of ADan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "be"

Phrase: "related to a specific interaction"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205369:Specific [Qualitative Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1552740:specific [Intellectual Product]
   760   C1704675:Interaction [Functional Concept]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "between deposited peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.244: A-C, confocal images of neocortical blood vessels (arrow) show deposition of both ADan (red) and A (green), although the co-localization is not complete. 

Phrase: "A-C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "confocal images of neocortical blood vessels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "deposition of both ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposition [Functional Concept]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the co-localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "complete."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]
Processing 00000000.tx.245: Please note that in this particular area, the parenchymal protein deposit is primarily ADan (double arrow). 

Phrase: "Please"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that in this particular area,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "the parenchymal protein deposit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposit [Functional Concept]

Phrase: "is"

Phrase: "primarily ADan"

Phrase: "(double arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.246: For confocal microscopy, the objective was x20. 

Phrase: "For confocal microscopy,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "the objective"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018017:Objective [Intellectual Product]
  1000   C1571702:Objective [Qualitative Concept]

Phrase: "was"

Phrase: "x20."
Processing 00000000.tx.247: D, pull-down experiments of ADan and A in SDS-soluble fractions from isolated vessels in FDD. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "pull-down experiments of ADan"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "A in SDS-soluble fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from isolated vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "in FDD."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.248: The presence of ADan was detected with Ab 5282 after immunoprecipitation (IP) with a mixture of anti-A antibodies 4G8 and 6E10 (left). 

Phrase: "The presence of ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected with Ab 5282"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "after immunoprecipitation (IP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with a mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "of anti-A antibodies 4G8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "6E10"

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.249: Conversely, A-(X-42) is detectable by the mixture 4G8/6E10 and by the C terminus-specific anti-A42 antibody (right) after amyloid species were immunoprecipitated by Ab 5282-coated paramagnetic beads. 

Phrase: "Conversely,"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(X-42"

Phrase: ")"

Phrase: "is"

Phrase: "detectable by the mixture 4G8/6E10"

Phrase: "and by the C terminus-specific anti-A42 antibody"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0007776:Cortex [Body Part, Organ, or Organ Component]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0205369:Specific [Qualitative Concept]
   742   C1176472:Cortex [Body Part, Organ, or Organ Component]
   742   C1515981:And [Idea or Concept]
   742   C1552740:specific [Intellectual Product]
   742   C2700441:Cortex [Plant]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "after"

Phrase: "amyloid species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "immunoprecipitated by Ab 5282-coated paramagnetic beads."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0991566:Beads [Biomedical or Dental Material]
   748   C1522408:Coated [Qualitative Concept]
   714   C0301871:Immunoprecipitate [Immunologic Factor]
   714 E C0453946:Coat [Manufactured Object]
   714 E C2346972:Bead [Spatial Concept]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.250: Mo, monomers; 

Phrase: "Mo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ";"
Processing 00000000.tx.251: Di, dimers.  

Phrase: "Di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538902:DI [Gene or Genome]
  1000   C3541881:DI [Idea or Concept]

Phrase: "dimers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]
Processing 00000000.tx.252: View larger version (29K): [in this window] [in a new window]  FIGURE 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 7."
Processing 00000000.tx.253: Ligand blot analysis. 

Phrase: "Ligand blot analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.254: Synthetic A-(1-42) and A-(4-42) peptides were used as ligands against synthetic ADan peptides resolved in 16% Tris-Tricine SDS-PAGE. 

Phrase: "Synthetic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "used as ligands"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0023688:Ligands [Chemical]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "against synthetic ADan peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "resolved in 16% Tris-Tricine SDS-PAGE."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077068:tricine [Organic Chemical]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]
   748   C1514893:Resolved [Idea or Concept]
   748   C1704732:Page [Intellectual Product]
   748   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.255: Synthetic ABri peptides were used as controls. 

Phrase: "Synthetic ABri peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.256: Bound A molecules were detected by a mixture of 4G8/6E10 anti-A antibodies, whereas oligomerization of ADan and ABri peptides was assessed with a mixture of anti-ADan and anti-ABri antibodies, Ab 5282/Ab 338, respectively. 

Phrase: "Bound A molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "detected by a mixture of 4G8/6E10 anti-A antibodies,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   757   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   741 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0439962:Mixture [Substance]
   739   C0442726:Detected [Finding]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1511790:Detected [Therapeutic or Preventive Procedure]
   706 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "oligomerization of ADan"

Phrase: "and"

Phrase: "ABri peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "assessed with a mixture of anti-ADan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439962:Mixture [Substance]
   748   C1516048:Assessed [Activity]

Phrase: "and"

Phrase: "anti-ABri antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Ab 5282/Ab 338,"

Phrase: "respectively."
Processing 00000000.tx.257: Mo, monomers; 

Phrase: "Mo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ";"
Processing 00000000.tx.258: Di, dimers; 

Phrase: "Di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538902:DI [Gene or Genome]
  1000   C3541881:DI [Idea or Concept]

Phrase: "dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: ";"
Processing 00000000.tx.259: Tri, trimers.  

Phrase: "Tri,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0814229:TRI [Intellectual Product]

Phrase: "trimers."
Processing 00000000.tx.260: Vascular FA extracts showed a similar pattern as the parenchymal counterpart, although A species seemed to be present in a slightly higher degree of oligomerization. 

Phrase: "Vascular FA extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2828366:Extract [Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a similar pattern as the parenchymal counterpart,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "although"

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "seemed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in a slightly higher degree of oligomerization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]
Processing 00000000.tx.261: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.262: 5B, the vessel extracts were immunoreactive with all anti-A antibodies tested; 

Phrase: "5B,"

Phrase: "the vessel extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoreactive with all anti-A antibodies"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ";"
Processing 00000000.tx.263: 4G8 and anti-A42 reacted with dimers and larger oligomers, whereas anti-A40 was barely immunoreactive with the dimeric species. 

Phrase: "4G8"

Phrase: "and"

Phrase: "anti-A42"

Phrase: "reacted with dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "larger oligomers,"

Phrase: "whereas"

Phrase: "anti-A40"

Phrase: "was"

Phrase: "barely immunoreactive with the dimeric species."
Processing 00000000.tx.264: Mass spectrometry analysis of the same fractions revealed that A-(1-42) and its N-terminal truncated derivative A-(4-42) were the main A species with experimental masses matching their theoretical values, whereas minor A-(4-42) oxidized and formylated derivatives were also detected (Fig. 5, B and table). 

Phrase: "Mass spectrometry analysis of the same fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "its N-terminal truncated derivative A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "were"

Phrase: "the main A species with experimental masses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705920:Species [Conceptual Entity]

Phrase: "matching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:MATCHING [Research Activity]
  1000   C1708943:Matching [Qualitative Concept]

Phrase: "their theoretical values,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0042295:Values [Qualitative Concept]
   861   C0871935:Theoretical [Idea or Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "whereas"

Phrase: "minor A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: "and"

Phrase: "formylated derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "were"

Phrase: "also"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.265: As observed with ADan, the abundance of FA-soluble A species compared with their water-soluble counterparts was reflected in the intensity of the immunoreactivity of both parenchymal and vascular extracts and in the amount of protein required to visualize them (1,500- and 5,000-fold more protein for the PBS and SDS extracts of parenchyma and vessels, respectively, than for the FA fractions). 

Phrase: "As"

Phrase: "observed with ADan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "the abundance of FA-soluble A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2346714:Abundance [Qualitative Concept]

Phrase: "compared with their water-soluble counterparts"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]
   753   C1707455:Compared [Activity]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]

Phrase: "was"

Phrase: "reflected in the intensity of the immunoreactivity of both parenchymal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0522510:Intensity [Qualitative Concept]
   739   C0558058:reflected [Mental Process]
   739   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "vascular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "and in the amount of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1265611:Amount [Quantitative Concept]
   753   C1515981:And [Idea or Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "visualize"

Phrase: "them"

Phrase: "(1,500-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "5,000-fold more protein for the PBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "SDS"

Phrase: "extracts of parenchyma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0933845:Parenchyma [Body Part, Organ, or Organ Component]
   790   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "vessels,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "respectively,"

Phrase: "than"

Phrase: "for the FA fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: ")."
Processing 00000000.tx.266: Confocal microscopy demonstrates co-localization but not complete overlap between ADan and A staining of parenchymal lesions and blood vessels (Fig. 6, A-C), suggesting co-deposition on many areas. 

Phrase: "Confocal microscopy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "demonstrates"

Phrase: "co-localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "overlap between ADan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0185027:overlap [Therapeutic or Preventive Procedure]
   790   C1948020:Overlap [Conceptual Entity]

Phrase: "and"

Phrase: "A staining of parenchymal lesions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A-C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "co-deposition on many areas."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.267: In order to further test whether the partial co-localization of A and ADan was related at least in part to a specific peptide-peptide interaction, we conducted co-immunoprecipitation experiments with tissue extracts and ligand blot analysis with synthetic peptides. 

Phrase: "In order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "the partial co-localization of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "ADan"

Phrase: "was"

Phrase: "related at least"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "to a specific peptide-peptide interaction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704675:Interaction [Functional Concept]

Phrase: "we"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "co-immunoprecipitation experiments with tissue extracts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "ligand blot analysis with synthetic peptides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.268: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.269: 6D for vascular SDS extracts, a combination of anti-A antibodies 4G8 and 6E10 retrieved a mixture of monomeric and dimeric ADan immunoreactive with Ab 5282 (Fig. 6D, left). 

Phrase: "6D for vascular SDS extracts,"

Phrase: "a combination of anti-A antibodies 4G8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205195:Combination [Qualitative Concept]
   748   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "6E10"

Phrase: "retrieved"

Phrase: "a mixture of monomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "dimeric ADan"

Phrase: "immunoreactive with Ab 5282"

Phrase: "(Fig. 6D,"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.270: However, in the reverse experiment with the same vascular SDS-extracts, anti-ADan antibodies retrieved dimeric A that was reactive with the mixture 4G8 plus 6E10, with anti-A42 but not with anti-A40 antibodies (Fig. 6D, right). 

Phrase: "However,"

Phrase: "in the reverse experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "with the same vascular SDS-extracts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2828366:Extract [Substance]

Phrase: "anti-ADan antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "retrieved"

Phrase: "dimeric A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "was"

Phrase: "reactive with the mixture 4G8 plus 6E10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205332:Reactive [Qualitative Concept]

Phrase: "with anti-A42"

Phrase: "but"

Phrase: "not with anti-A40 antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1518422:Not [Functional Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 6D,"

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.271: Similar results were obtained with PBS extracts (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with PBS extracts"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C1301820:Obtained [Functional Concept]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   737 E C1706701:Obtain [Activity]
   737   C2828366:Extract [Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.272: FA extracts, on the contrary, rendered negative results despite the high concentration of both ADan and A, probably indicating that the interaction is susceptible to dissociation at low pH as previously seen in other protein-protein interactions (i.e. A-apolipoprotein J) (23). 

Phrase: "FA extracts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C2828366:Extract [Substance]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: "on the contrary,"

Phrase: "rendered negative results despite the high concentration of both ADan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "and"

Phrase: "A,"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "susceptible to dissociation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231204:Susceptible [Functional Concept]
   790   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "at low pH"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0728725:Low pH [Finding]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0205251:low [Qualitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "seen in other protein-protein interactions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   799   C0872079:Protein-Protein Interaction [Molecular Function]
           interactions protein
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205397:Seen [Qualitative Concept]
   719 E C0042789:see [Organism Function]
   719   C1704675:Interaction [Functional Concept]
   719 E C1947903:See [Activity]

Phrase: "(i.e. A-apolipoprotein J"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1413514:APOLIPOPROTEIN J [Gene or Genome]
   840   C2609437:Apolipoprotein J [Laboratory Procedure]
   804   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.273: To verify the specificity of the ADan-A interaction, ligand blot analysis using synthetic ADan and A homologues and synthetic ABri as a control was conducted in vitro. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the specificity of the ADan-A interaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "ligand blot analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synthetic ADan"

Phrase: "and"

Phrase: "A homologues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1334043:Homologue [Gene or Genome]

Phrase: "and"

Phrase: "synthetic ABri as a control"

Phrase: "was"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.274: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.275: 7, specific binding of A-(4-42) and A-(1-42) (the main A species found in FDD lesions) to ADan oligomers (particularly dimers) was clearly evident, whereas no interaction was observed with ADan monomers despite their abundance. 

Phrase: "7,"

Phrase: "specific binding of A-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205369:Specific [Qualitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1552740:specific [Intellectual Product]

Phrase: "(4-42"

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "("

Phrase: "the main A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "found in FDD lesions"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C1861735:Dementia, familial Danish [Disease or Syndrome]
   783   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0015576:familial [Family Group]
   753   C0150312:Found [Quantitative Concept]
   753   C0221198:lesions [Finding]
   753   C0241888:Familial [Functional Concept]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   719 E C0243095:Find [Finding]
   719 E C1546698:Lesion [Intellectual Product]

Phrase: ")"

Phrase: "to ADan oligomers"

Phrase: "(particularly dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596448:dimers [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "was"

Phrase: "clearly evident,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332120:Evidence [Functional Concept]

Phrase: "whereas"

Phrase: "no interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "observed with ADan monomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596973:monomers [Chemical Viewed Structurally]
   770   C1441672:Observed [Functional Concept]

Phrase: "despite their abundance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346714:Abundance [Qualitative Concept]
Processing 00000000.tx.276: In contrast to ADan, neither monomers nor oligomers of ABri peptides show binding interaction with either A-(4-42) or A-(1-42).  

Phrase: "In contrast to ADan,"

Phrase: "neither monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "nor"

Phrase: "oligomers of ABri peptides"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "binding interaction with either A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1704675:Interaction [Functional Concept]

Phrase: "(4-42"

Phrase: ")"

Phrase: "or"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.277: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES DISCUSSION REFERENCES  Immunohistochemical analyses of FDD cases indicate that vascular amyloid and parenchymal preamyloid deposits of ADan and A co-exist in the absence of compact plaques. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Immunohistochemical analyses of FDD cases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1441616:Immunohistochemical [Laboratory Procedure]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "indicate"

Phrase: "that vascular amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "parenchymal preamyloid deposits of ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposits [Functional Concept]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-exist in the absence of compact plaques."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0332197:absence [Quantitative Concept]
   744   C0333463:plaques [Acquired Abnormality]
   744   C1333134:Compact [Finding]
   744   C1689985:Absence [Anatomical Abnormality]
   744   C2987476:Exist [Conceptual Entity]
   711 E C0011389:Plaque [Disease or Syndrome]
   711 E C0332461:Plaque [Finding]
Processing 00000000.tx.278: The ADan/A compositions of both lesions were analyzed by Western blot, mass spectrometry, and amino acid sequence analysis after tissue dissection and separation of vessels from parenchymal specimens. 

Phrase: "The ADan/A compositions of both lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0486616:compositions [Clinical Attribute]
   714 E C1555710:composition [Idea or Concept]

Phrase: "were"

Phrase: "analyzed by Western blot,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "mass spectrometry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "amino acid sequence analysis after tissue dissection"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0751970:Amino Acid Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "separation of vessels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036679:Separation [Pathologic Function]
   790   C0237868:Separation [Social Behavior]
   790   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "from parenchymal specimens."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0370003:specimens [Substance]
   827 E C2347026:Specimen [Conceptual Entity]
Processing 00000000.tx.279: Accordingly, water-based solutions in the absence and presence of low concentrations of the anionic detergent SDS were used to extract mainly nonfibrillar components, whereas formic acid extraction was necessary to solubilize and analyze fibrillar deposits. 

Phrase: "Accordingly,"

Phrase: "water-based solutions in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0597683:water solution [Clinical Drug]
   753   C0037633:Solutions [Substance]
   719 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "presence of low concentrations of the anionic detergent SDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "mainly nonfibrillar components,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]

Phrase: "whereas"

Phrase: "formic acid extraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: "was"

Phrase: "necessary to"

Phrase: "solubilize"

Phrase: "and"

Phrase: "analyze"

Phrase: "fibrillar deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]
Processing 00000000.tx.280: Our biochemical data (Figs. 2, 3, 4, 5) show that FDD nonfibrillar and fibrillar lesions are heterogeneous mixtures of various ADan and A species. 

Phrase: "Our biochemical data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "(Figs. 2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that FDD"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "nonfibrillar"

Phrase: "and"

Phrase: "fibrillar lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "are"

Phrase: "heterogeneous mixtures of various ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:mixtures [Substance]

Phrase: "and"

Phrase: "A species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.281: The peptide composition, degree of oligomerization, predominant amyloid subunits, extent of post-translational modifications, and magnitude of N- and C-terminal proteolytic degradations reflect the complexity of the lesions. 

Phrase: "The peptide composition,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0486616:Composition [Clinical Attribute]
   861   C1555710:composition [Idea or Concept]

Phrase: "degree of oligomerization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0441889:Degree [Qualitative Concept]
   790   C0449286:Degree [Quantitative Concept]
   790   C0542560:Degree [Intellectual Product]
   790   C1561545:degree [Quantitative Concept]
   790   C2348088:Degree [Quantitative Concept]

Phrase: "predominant amyloid subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "extent of post-translational modifications,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "and"

Phrase: "magnitude of N-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449286:magnitude [Quantitative Concept]
   790   C1704240:Magnitude [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal proteolytic degradations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0243125:degradation [Functional Concept]
   779   C0699900:Degradation [Organism Function]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the complexity of the lesions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   781   C3640269:Lesion Complexity [Intellectual Product]
Processing 00000000.tx.282: View larger version (9K): [in this window] [in a new window]  FIGURE 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 8."
Processing 00000000.tx.283: ADan and A species in cerebral cortex of FDD brain. 

Phrase: "ADan"

Phrase: "and"

Phrase: "A species in cerebral cortex of FDD brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.284: The figure summarizes the ADan and A major and minor components of fibrillar and nonfibrillar deposits in FDD. 

Phrase: "The figure"

Phrase: "summarizes"

Phrase: "the ADan"

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "major"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205164:Major [Qualitative Concept]

Phrase: "and"

Phrase: "minor components of fibrillar"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449432:Components [Manufactured Object]
   737 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "nonfibrillar deposits in FDD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333562:Deposits [Functional Concept]
Processing 00000000.tx.285: Major proteolytic processing sites are indicated in large arrows, whereas small arrows with discontinuous lines indicate minor cleavage sites. 

Phrase: "Major proteolytic processing sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   844   C2985687:Processing Site [Spatial Concept]
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "indicated in large arrows,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0336721:arrows [Manufactured Object]
   770   C0549177:Large [Quantitative Concept]
   770   C1444656:Indicated [Finding]

Phrase: "whereas"

Phrase: "small arrows with discontinuous lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "minor cleavage sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.286: pE, pyroglutamate.  

Phrase: "pE,"

Phrase: "pyroglutamate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.287: In general terms, nonfibrillar deposits appeared less complex than the fibrillar counterparts, perhaps reflecting early intermediate states of the fibrillization process. 

Phrase: "In general terms,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0278060:GENERAL TERMS [Finding]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "nonfibrillar deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "less complex than the fibrillar counterparts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "perhaps"

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "early intermediate states of the fibrillization process."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C1301808:states [Geographic Area]
   714 E C1442792:State [Functional Concept]
   714 E C3148680:State [Geographic Area]
Processing 00000000.tx.288: The degree of oligomerization was limited only to dimeric forms, whereas the diversity of the ADan and A peptides was also highly restricted. 

Phrase: "The degree of oligomerization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "was"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "only to dimeric forms,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205171:Only [Quantitative Concept]
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   770   C1720467:Only [Intellectual Product]
   737 E C1522492:Form [Functional Concept]

Phrase: "whereas"

Phrase: "the diversity of the ADan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880371:Diversity [Qualitative Concept]

Phrase: "and"

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205250:Highly [Qualitative Concept]

Phrase: "restricted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restricted [Functional Concept]
Processing 00000000.tx.289: ADan species were limited to the nondegraded full-length ADan-(1-34), although in contrast to what is seen in plasma, 60% of these molecules were found to be post-translationally modified at their N terminus. 

Phrase: "ADan species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "limited to the nondegraded full-length ADan-"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0439801:Limited [Functional Concept]
   748   C0443225:Full [Qualitative Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   748   C3542948:Limited [Intellectual Product]
   714 E C1549649:Limit [Idea or Concept]
   714 E C2349209:Limit [Conceptual Entity]

Phrase: "(1-34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "although in contrast to what"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1979874:Contrast [Qualitative Concept]

Phrase: "is"

Phrase: "seen in plasma,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0032105:Plasma [Body Substance]
   790   C0205397:Seen [Qualitative Concept]
   790   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "60% of these molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0567416:molecules [Substance]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "post-translationally"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "modified at their N terminus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392747:Modified [Functional Concept]
Processing 00000000.tx.290: Cyclic pyroglutamate was previously observed in other brain amyloids (i.e. ABri in FBD) (6) and in truncated forms of the Alzheimer A peptide (24-26) as well as in some hormones and neuropeptides, including neurotensin and thyrotropin- and gonadotropin- releasing hormones, in which their biological activities largely depend on the existence of the N-terminal pyroglutamate (27). 

Phrase: "Cyclic pyroglutamate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "previously"

Phrase: "observed in other brain amyloids"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0002716:amyloids [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1441672:Observed [Functional Concept]
   726 E C0011560:Amyloid [Pathologic Function]
   726 E C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(i.e. ABri in FBD"

Phrase: ")"

Phrase: "(6"

Phrase: ")"

Phrase: "and in truncated forms of the Alzheimer A peptide"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0348078:forms [Qualitative Concept]
   742   C0376315:Forms [Manufactured Object]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1515981:And [Idea or Concept]
   708 E C1522492:Form [Functional Concept]

Phrase: "(24-26"

Phrase: ")"

Phrase: "as well as in some hormones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0019932:Hormones [Hormone]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "neuropeptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "neurotensin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "and"

Phrase: "thyrotropin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040160:Thyrotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1535531:Thyrotropin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "gonadotropin- releasing hormones,"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   983   C0023610:Gonadotrophin releasing hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   901   C0815016:releasing hormones [Hormone]
   827   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormones [Hormone]
   827   C1283071:Releasing [Functional Concept]
   827   C3536870:Gonadotropin [Pharmacologic Substance]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]
   743 E C0458083:Hormonal [Qualitative Concept]

Phrase: "in which"

Phrase: "their biological activities largely"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0205460:biological [Qualitative Concept]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "depend on the existence of the N-terminal pyroglutamate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0205088:Terminal [Temporal Concept]
   742   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   742   C0725813:depend [Medical Device]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.291: Although the final pyroglutamate product is the same, neuropeptides and amyloids differ in the amino acid that serves as a substrate for the post-translational modification. 

Phrase: "Although"

Phrase: "the final pyroglutamate product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "is"

Phrase: "the same, neuropeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "amyloids"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0002716:amyloids [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0011560:Amyloid [Pathologic Function]
   966 E C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "differ in the amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "serves as a substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]

Phrase: "for the post-translational modification."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modification [Molecular Function]
   827   C0392747:Modification [Functional Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1554963:modification [Qualitative Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.292: In many neuropeptides and peptide hormones, the N-terminal post-translational modification occurs at a glutamine residue, and the cyclization involves the nucleophilic attack of the -amino group on the amidated carboxyl group and the release of NH3 catalyzed by glutaminyl cyclase at neutral pH (28, 29). 

Phrase: "In many neuropeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "peptide hormones,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0597192:Peptide Hormones [Amino Acid, Peptide, or Protein,Hormone]
   983 E C1149477:peptide hormone [Molecular Function]
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "the N-terminal post-translational modification"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0033666:Post-Translational Modification [Molecular Function]
   804   C0392747:Modification [Functional Concept]
   804   C0687676:Post [Temporal Concept]
   804   C1519614:Translational [Genetic Function]
   804   C1554963:modification [Qualitative Concept]
   804   C1704687:Post [Manufactured Object]
   733 E C0040712:Translation [Intellectual Product]
   733 E C0597295:translation [Molecular Function]
   733 E C1514253:Postal [Functional Concept]

Phrase: "occurs at a glutamine residue,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1709305:Occur [Activity]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "the cyclization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010546:Cyclization [Natural Phenomenon or Process]

Phrase: "involves"

Phrase: "the nucleophilic attack of the -amino group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0277793:Attack, NOS [Temporal Concept]
   748   C1261512:attack [Social Behavior]
   748   C1304680:Attack [Finding]

Phrase: "on the amidated carboxyl group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0596260:Carboxyl Group [Organic Chemical]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "the release of NH3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "catalyzed by glutaminyl cyclase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0245636:glutaminyl cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1419183:GLUTAMINYL CYCLASE [Gene or Genome]

Phrase: "at neutral pH (28,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
   827   C2825492:Neutral [Phenomenon or Process]

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.293: In contrast, few examples are known for the post-translational modification from glutamic acid to pyroglutamate, which involve the loss of a molecule of water instead of deamidation. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "few examples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707959:Example [Conceptual Entity]

Phrase: "are"

Phrase: "known for the post-translational modification"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0033666:Post-Translational Modification [Molecular Function]
   753   C0205309:Known [Qualitative Concept]
   753   C0392747:Modification [Functional Concept]
   753   C0687676:Post [Temporal Concept]
   753   C1519614:Translational [Genetic Function]
   753   C1554963:modification [Qualitative Concept]
   753   C1704687:Post [Manufactured Object]

Phrase: "from glutamic acid to pyroglutamate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "which"

Phrase: "involve"

Phrase: "the loss of a molecule of water"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: "instead of deamidation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0872015:deamidation [Phenomenon or Process]
  1000   C1330964:Deamidation [Natural Phenomenon or Process]
Processing 00000000.tx.294: Among them are bovine and ovine -lipotropin and joining peptide derived from the proteolytic processing of their common precursor pro-opiomelanocortin (30, 31), ABri amyloid in FBD (6), and the A N-terminal truncated derivatives A-(3-X)pE and A-(11-X)pE in AD (24, 25, 32). 

Phrase: "Among them"

Phrase: "are"

Phrase: "bovine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007452:Bovine [Mammal]
  1000   C1140701:bovine [Mammal]

Phrase: "and"

Phrase: "ovine -lipotropin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023832:Lipotropin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "and"

Phrase: "joining peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "derived from the proteolytic processing of their common precursor pro-opiomelanocortin"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0033195:Pro-Opio-Melanocortin [Amino Acid, Peptide, or Protein,Hormone]
   756   C1337111:PROOPIOMELANOCORTIN [Gene or Genome]
   756   C1514570:Proteolytic Processing [Molecular Function]
   738   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0205214:Common [Quantitative Concept]
   738   C0597304:Proteolytic [Molecular Function]
   738   C1441547:Derived [Qualitative Concept]
   738   C1522138:Common [Functional Concept]
   738   C1709634:Precursor [Idea or Concept]
   738   C1709694:Processing [Activity]
   738   C1947941:proteolytic [Enzyme]
   738   C2987124:PRO [Intellectual Product]
   738   C3245511:common [Intellectual Product]
   738   C3245521:derived [Idea or Concept]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "ABri amyloid in FBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the A N-terminal truncated derivatives A-"

Phrase: "(3-X)pE"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(11-X)pE in AD"

Phrase: "(24,"

Phrase: "25,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.295: The process has been demonstrated in Aplysia neurons (33) and is not exclusive to the brain, since a similar conversion has been identified in peripheral organs affected with amyloid deposition in FBD (17). 

Phrase: "The process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated in Aplysia neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003577:Aplysia [Eukaryote]
   770   C0027882:Neurons [Cell]

Phrase: "(33"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "not exclusive to the brain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1548966:Exclusive [Idea or Concept]

Phrase: "since"

Phrase: "a similar conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439836:Conversion [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "identified in peripheral organs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0178784:organs [Body Part, Organ, or Organ Component]
   770   C0205100:Peripheral [Spatial Concept]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "affected with amyloid deposition"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   833   C1705760:Amyloid Deposition [Finding]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0333562:Deposition [Functional Concept]
   770   C0392760:Affected [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "in FBD"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1867773:Dementia, familial British [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C0596227:British [Population Group]
   755 E C1704727:Family [Conceptual Entity]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.296: Whether the same glutaminyl cyclase is responsible for the dehydration process in all these cases remains unknown. 

Phrase: "Whether"

Phrase: "the same glutaminyl cyclase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0245636:glutaminyl cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1419183:GLUTAMINYL CYCLASE [Gene or Genome]

Phrase: "is"

Phrase: "responsible for the dehydration process"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in all"

Phrase: "these cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "remains"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.297: Since this N-terminal modification was not detected in the soluble circulating ABri or ADan species, it is conceivable that cyclization occurs in situ at the sites of deposition. 

Phrase: "Since"

Phrase: "this N-terminal modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in the soluble circulating ABri"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0175630:Circulating [Functional Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]

Phrase: "or"

Phrase: "ADan species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "it"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that cyclization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010546:Cyclization [Natural Phenomenon or Process]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "in situ at the sites of deposition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0444498:In situ [Spatial Concept]
Processing 00000000.tx.298: The A peptides found in the nonfibrillar deposits were also restricted in diversity. 

Phrase: "The A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "found in the nonfibrillar deposits"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0150312:Found [Quantitative Concept]
   760   C0333562:Deposits [Functional Concept]
   726 E C0243095:Find [Finding]

Phrase: "were"

Phrase: "also"

Phrase: "restricted in diversity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443288:Restricted [Functional Concept]
   790   C1880371:Diversity [Qualitative Concept]
Processing 00000000.tx.299: A-(1-42) and the N-terminally truncated A-(4-42) were the major species in an 1:1 ratio, whereas A-(1-40) and A derivatives ending at position 34 were minor component of the extracts (Fig. 8). 

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "the N-terminally truncated A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "were"

Phrase: "the major species in an 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705920:Species [Conceptual Entity]

Phrase: ":"

Phrase: "1 ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "whereas"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "ending at position 34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444930:ending [Spatial Concept]
   770   C0733755:Position [Spatial Concept]
   770   C2746065:Ending [Temporal Concept]

Phrase: "were"

Phrase: "minor component of the extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.300: Although predominant species ending at position 42 were expected in the parenchymal extracts, their abundance in vascular components was surprising. 

Phrase: "Although"

Phrase: "predominant species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "ending at position 42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444930:ending [Spatial Concept]
   770   C0733755:Position [Spatial Concept]
   770   C2746065:Ending [Temporal Concept]

Phrase: "were"

Phrase: "expected in the parenchymal extracts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517001:Expected [Idea or Concept]
   726   C2828366:Extract [Substance]

Phrase: "their abundance in vascular components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346714:Abundance [Qualitative Concept]

Phrase: "was"

Phrase: "surprising."
Processing 00000000.tx.301: Limited published studies indicate that A-related parenchymal preamyloid lesions are enriched in species ending at position 42. 

Phrase: "Limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "published studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that A-related parenchymal preamyloid lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0221198:lesions [Finding]
   771 E C1546698:Lesion [Intellectual Product]

Phrase: "are"

Phrase: "enriched in species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0359583:enriched [Food]
   790   C1705920:Species [Conceptual Entity]

Phrase: "ending at position 42."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444930:ending [Spatial Concept]
   770   C0733755:Position [Spatial Concept]
   770   C2746065:Ending [Temporal Concept]
Processing 00000000.tx.302: The -secretase fragment A-(17-42), in particular, was previously identified as the main component of preamyloid lesions in AD (34), Down syndrome (35), and aged dogs (36), A-(1-42) and A-(4-42) being minor components in the last two cases. 

Phrase: "The -secretase fragment A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(17-42"

Phrase: ")"

Phrase: ","

Phrase: "in particular,"

Phrase: "was"

Phrase: "previously"

Phrase: "identified as the main component of preamyloid lesions"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0205225:Main [Qualitative Concept]
   744   C0205396:Identified [Qualitative Concept]
   744   C0221198:lesions [Finding]
   744   C0449432:Component [Manufactured Object]
   744   C1542147:Main [Qualitative Concept]
   744   C1550043:Identified [Finding]
   744   C1551388:Identified [Functional Concept]
   744   C1705248:Component [Conceptual Entity]
   725   C1563245:Lesioned component [Finding]
   711 E C1546698:Lesion [Intellectual Product]

Phrase: "in AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "Down syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "aged dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "being"

Phrase: "minor components in the last two cases."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0449432:Components [Manufactured Object]
   714 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.303: In FDD extracts, A-(17-42) was not detected, and although it could be argued that the present extraction conditions were milder than those previously reported (2% SDS versus 15% SDS), thereby precluding the retrieval of A-(17-42), this fragment was also undetected in the subsequent formic acid extracts. 

Phrase: "In FDD extracts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C2828366:Extract [Substance]
   756   C1861735:Dementia, familial Danish [Disease or Syndrome]
   708   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(17-42"

Phrase: ")"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "and"

Phrase: "although"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "argued"

Phrase: "that"

Phrase: "the present extraction conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "milder than those previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2945599:Mild [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(2% SDS"

Phrase: "versus"

Phrase: "15% SDS"

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "precluding"

Phrase: "the retrieval of A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514918:Retrieval [Health Care Activity]

Phrase: "(17-42"

Phrase: ")"

Phrase: ","

Phrase: "this fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "also undetected in the subsequent formic acid extracts."
Processing 00000000.tx.304: Although not through biochemical studies, the existence of other A species was also previously identified in preamyloid lesions based on classical immunohistochemical stainings and their immunoreactivity with specific antibodies. 

Phrase: "Although"

Phrase: "not through biochemical studies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205474:Biochemical [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1518422:Not [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "the existence of other A species"

Phrase: "was"

Phrase: "also previously"

Phrase: "identified in preamyloid lesions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205396:Identified [Qualitative Concept]
   770   C0221198:lesions [Finding]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   737 E C1546698:Lesion [Intellectual Product]

Phrase: "based on classical immunohistochemical stainings"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0439858:Classical [Qualitative Concept]
   760   C0443177:Classical [Functional Concept]
   760   C0487602:Stainings [Laboratory Procedure]
   760   C1441616:Immunohistochemical [Laboratory Procedure]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1704680:Staining [Finding]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "their immunoreactivity with specific antibodies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.305: Accordingly, A-(1-42) and A-(3-42)pE were reported to be major components in AD, Down syndrome, and normal aging preamyloid lesions, whereas antibodies recognizing position 17 were only weakly positive (37). 

Phrase: "Accordingly,"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(3-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "pE"

Phrase: "were"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "major components in AD,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "Down syndrome,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "and"

Phrase: "normal aging preamyloid lesions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0221198:lesions [Finding]
   779 E C1546698:Lesion [Intellectual Product]

Phrase: "whereas"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizing"

Phrase: "position 17"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "were"

Phrase: "only weakly positive"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0442730:Weakly positive [Finding]
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.306: Anti-A42 immunoreactivity was also found prevalent in parenchymal preamyloid deposits in the Dutch variant of familial AD (38). 

Phrase: "Anti-A42 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "prevalent in parenchymal preamyloid deposits"

Phrase: "in the Dutch variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "of familial AD"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.307: ADan and A species extracted with formic acid from amyloid deposits were more heterogeneous. 

Phrase: "ADan"

Phrase: "and"

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "extracted with formic acid"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0885348:formic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0202406:Acid [Laboratory Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "from amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "were"

Phrase: "more heterogeneous."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneous [Qualitative Concept]
Processing 00000000.tx.308: ADan was fully post-translationally modified at the N terminus (pyroglutamate), partially N- and C-terminally degraded at positions 3, 28, and 33, and heavily oligomerized (Figs. 3 and 8), whereas A, still mainly composed of A-(1-42) and A-(4-42) (with negligible A-(1-40)), showed more N-terminal degradation (ratio of A-(4-42)/A-(1-42) 9:1) and a higher degree of oligomerization (Figs. 5 and 8). 

Phrase: "ADan"

Phrase: "was"

Phrase: "fully post-translationally"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C1514253:Postal [Functional Concept]

Phrase: "modified at the N terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392747:Modified [Functional Concept]

Phrase: "(pyroglutamate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: ","

Phrase: "partially N-"

Phrase: "and"

Phrase: "C-terminally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "degraded at positions 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0733755:positions [Spatial Concept]
   770   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "28,"

Phrase: "and"

Phrase: "33,"

Phrase: "and"

Phrase: "heavily"

Phrase: "oligomerized"

Phrase: "(Figs. 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "8"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "A,"

Phrase: "still mainly"

Phrase: "composed of A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "("

Phrase: "with negligible A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "more N-terminal degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]

Phrase: "(ratio of A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456603:Ratio [Quantitative Concept]
   790   C1547037:Ratio [Intellectual Product]

Phrase: "(4-42"

Phrase: ")"

Phrase: "/A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "9"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "a higher degree of oligomerization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "(Figs. 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.309: Whether extensive proteolytic degradation and heavier oligomerization reflect critical necessary steps in the process of ADan amyloid formation or simply a futile cellular effort to end and clear the formation of fibrillar deposits is still under investigation. 

Phrase: "Whether"

Phrase: "extensive proteolytic degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "heavier oligomerization"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "critical necessary steps in the process of ADan amyloid formation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C1261552:steps [Conceptual Entity]
   706 E C1704379:Step [Functional Concept]
   706 E C1705117:Step [Quantitative Concept]
   706 E C2825408:Step [Manufactured Object]

Phrase: "or"

Phrase: "simply"

Phrase: "a futile cellular effort to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015264:Effort [Organism Function]

Phrase: "end"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]

Phrase: "and"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "the formation of fibrillar deposits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "still under investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1261322:Investigation [Health Care Activity]
   790   C1552578:investigation [Idea or Concept]
   718 E C1517586:Investigational [Qualitative Concept]
   718 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.310: In the case of A, the N-terminal degraded A-(4-42) is known to have a faster aggregation kinetics than the intact A-(1-42) (39). 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the N-terminal degraded A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a faster aggregation kinetics than the intact A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0022702:Kinetics [Natural Phenomenon or Process]
   744   C0220865:kinetics [Functional Concept]
   744   C2825046:Kinetics [Occupation or Discipline]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.311: The fact that the ADan proteolytic fragments were not detected in blood and that circulating soluble ADan peptides differ from the deposited homologues in that they consistently lack the chemically irreversible pyroglutamate modification at the N terminus is a clear indication that the circulating species do not represent a clearance mechanism from the cerebral deposits. 

Phrase: "The fact"

Phrase: "that"

Phrase: "the ADan proteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in blood"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C0005767:Blood [Tissue]
   790   C0005768:blood [Body Substance]
   790   C0229664:Blood [Body Substance]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   718 E C0333275:Bloody [Qualitative Concept]
   706 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   706 E C0392895:Bloods [Population Group]
   706 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   706 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "and"

Phrase: "that circulating soluble ADan peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "differ from the deposited homologues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333562:deposited [Functional Concept]
   726   C1334043:Homologue [Gene or Genome]

Phrase: "in"

Phrase: "that"

Phrase: "they consistently"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the chemically irreversible pyroglutamate modification at the N terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392747:Modification [Functional Concept]
   742   C1554963:modification [Qualitative Concept]

Phrase: "is"

Phrase: "a clear indication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392360:indication [Idea or Concept]
   861   C3146298:Indication [Functional Concept]

Phrase: "that"

Phrase: "the circulating species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a clearance mechanism from the cerebral deposits."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.312: In this sense, we previously reported similar findings for the soluble and deposited ABri species in FBD (17). 

Phrase: "In this sense,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "we previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "similar findings for the soluble"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "deposited ABri species in FBD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705920:Species [Conceptual Entity]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.313: As summarized in Fig. 

Phrase: "As"

Phrase: "summarized in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.314: 8, the proteolytic degradation of ADan and A reflects the activity of more than a single enzyme. 

Phrase: "8,"

Phrase: "the proteolytic degradation of ADan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the activity of more"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "than a single enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.315: A potential candidate for the C-terminal detyrosination of ADan is cathepsin A (carboxypeptidase A) (40), which is widely distributed in lysosomes and has broad specificity, releasing the C-terminal amino acid at optimum pH of 4.5-6.0. 

Phrase: "A potential candidate for the C-terminal detyrosination of ADan"

Phrase: "is"

Phrase: "cathepsin A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(carboxypeptidase A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "widely"

Phrase: "distributed in lysosomes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0024369:Lysosomes [Cell Component]
   790   C1704711:Distributed [Functional Concept]
   756 E C2984253:Lysosome [Functional Concept]
   706 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "has"

Phrase: "broad specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the C-terminal amino acid at optimum pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C2917660:Amino Acid [Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]

Phrase: "of 4.5-6.0."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450367:4 5 [Quantitative Concept]
Processing 00000000.tx.316: The cleavage at the ADan Ala2-Ser3 peptide bond seems to be catalyzed by a dipeptidyl-peptidase, in a similar fashion as deposited ABri amyloid in FBD (6). 

Phrase: "The cleavage at the ADan Ala2-Ser3 peptide bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "catalyzed by a dipeptidyl-peptidase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0022709:Dipeptidyl Peptidase A [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           dipeptidyl peptidase
   760   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1947941:Peptidase [Enzyme]

Phrase: "in a similar fashion"

Phrase: "as deposited ABri amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in FBD"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1867773:Dementia, familial British [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C0596227:British [Population Group]
   755 E C1704727:Family [Conceptual Entity]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.317: It is interesting to note that no proteolytic processing of ADan molecules was detected between cysteine residues 5 and 22, suggesting a protective effect of the disulfide bond, as reported for other proteins (41-43). 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "no proteolytic processing of ADan molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514570:Proteolytic Processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "was"

Phrase: "detected between cysteine residues 5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "22,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a protective effect of the disulfide bond,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "reported for other proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(41-43"

Phrase: ")."
Processing 00000000.tx.318: Degradation of A at peptide bond Glu3-Phe4 may result from either neprilysin or insulysin (insulin-degrading enzyme) degradation, as previously reported in A-related disorders (44, 45). 

Phrase: "Degradation of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "at peptide bond Glu3-Phe4"

Phrase: "may"

Phrase: "result from either neprilysin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1274040:Result [Functional Concept]
   770   C1366499:NEPRILYSIN [Gene or Genome]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "or"

Phrase: "insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "(insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "as"

Phrase: "previously"

Phrase: "reported in A-related disorders"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0012634:Disorders [Disease or Syndrome]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.319: However, these enzymes are not exclusive for the Glu3-Phe4 peptide bond processing and are known to cleave A at several other sites, generating degradation fragments that were not detected in FDD extracts. 

Phrase: "However,"

Phrase: "these enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "not exclusive for the Glu3-Phe4 peptide bond processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1548966:Exclusive [Idea or Concept]

Phrase: "and"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "A at several"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "other sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "generating"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in FDD extracts."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1861735:Dementia, familial Danish [Disease or Syndrome]
   783   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0015576:familial [Family Group]
   753   C0241888:Familial [Functional Concept]
   753   C0442726:Detected [Finding]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   719   C2828366:Extract [Substance]
Processing 00000000.tx.320: Another probable enzyme to consider is tripeptidyl-peptidase I, a lysosomal protease known to cleave the Glu3-Phe4 peptide bond in vitro and a known component of amyloid plaques (46, 47). 

Phrase: "Another probable enzyme to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "consider"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "is"

Phrase: "tripeptidyl-peptidase I,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0661884:tripeptidyl-peptidase I [Amino Acid, Peptide, or Protein,Enzyme]
           Tripeptidyl peptidase
  1000   C1540042:TRIPEPTIDYL PEPTIDASE I [Gene or Genome]
   901   C0077246:Tripeptidyl peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0021966:I- [Inorganic Chemical]
   827   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1947941:Peptidase [Enzyme]

Phrase: "a lysosomal protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "the Glu3-Phe4 peptide bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0678595:peptide bond [Natural Phenomenon or Process]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "a known component of amyloid plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1440087:Amyloid A component [Immunologic Factor]
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "(46,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.321: It is important to note that the same proteolytic activity also results from the use of bacterial collagenase I (EC 3.4.24.3; description available on the World Wide Web at us.expasy.org/enzyme). 

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the same proteolytic activity also"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C0597304:Proteolytic [Molecular Function]
   812   C1561536:*Activity [Idea or Concept]
   812   C1947941:proteolytic [Enzyme]

Phrase: "results from the use"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1947944:Use [Intellectual Product]
   770   C2825142:Result [Finding]

Phrase: "of bacterial collagenase I (EC 3.4.24.3"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   870   C3100979:bacterium 3.3 [Bacterium]
   866   C1515151:I 3.3 [Cell]
   845   C3100980:bacterium 3.4 [Bacterium]
   842   C3348309:bacterium 24 [Bacterium]
   836   C0255672:Collagenase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   836   C1417202:COLLAGENASE 3 [Gene or Genome]
   836   C1424188:I-4 [Gene or Genome]
   836   C1515147:I 4 [Cell]
   822   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   822   C1515146:I 3 [Cell]
   812   C0009053:Collagenase I [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0021966:I- [Inorganic Chemical]
   793   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0521009:Bacterial [Qualitative Concept]
   721 E C0004611:Bacteria [Bacterium]
   721 E C1510439:bacteria [Functional Concept]
   721 E C2347473:% Bacteria [Quantitative Concept]

Phrase: "; description"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678257:Description [Idea or Concept]

Phrase: "available on the World Wide Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0470187:Available [Functional Concept]

Phrase: "at us.expasy.org/enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ")."
Processing 00000000.tx.322: Using synthetic A40 and A42 as substrates, this enzyme was able to efficiently cleave both peptides at Glu3-Phe4 and Leu34-Met35 bonds in in vitro experiments.3 Although collagenase I has been commonly used in amyloid purification protocols to increase the yield of the extracted fibrils (48-52), we purposely avoided its use in our FDD isolation protocol in order to prevent unwanted artifacts. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synthetic A40"

Phrase: "and"

Phrase: "A42 as substrates,"

Phrase: "this enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "able to efficiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "cleave"

Phrase: "both peptides at Glu3-Phe4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "Leu34-Met35 bonds in in vitro experiments.3"

Phrase: "Although"

Phrase: "collagenase I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009053:Collagenase I [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "been"

Phrase: "commonly"

Phrase: "used in amyloid purification protocols to"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   767   C3258071:Protocol used [Finding]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0243114:purification [Functional Concept]
   753   C0442711:Protocols [Intellectual Product]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1273517:used [Finding]
   753   C1998793:Purification [Functional Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1507394:Protocol [Intellectual Product]
   719 E C1522729:Protocol [Intellectual Product]
   719 E C1947944:Use [Intellectual Product]
   719 E C2348563:Protocol [Intellectual Product]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the yield of the extracted fibrils"

Phrase: "(48-52"

Phrase: ")"

Phrase: ","

Phrase: "we purposely"

Phrase: "avoided"

Phrase: "its use in our FDD isolation protocol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0042153:use [Functional Concept]
   742   C0457083:Use [Functional Concept]
   742   C1947944:Use [Intellectual Product]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "unwanted artifacts."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0085089:Artifacts [Human-caused Phenomenon or Process]
   861   C0699801:artifacts [Manufactured Object]
   827 E C1879740:ARTIFACT [Phenomenon or Process]
Processing 00000000.tx.323: In sporadic and familial AD as well as in other A-related disorders, amyloid deposits in cerebral vessels are primarily constituted of fibrillar forms of A40, although the presence of A42 in detectable amounts is considered a common finding in these lesions (reviewed in Ref. 53). 

Phrase: "In sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "and"

Phrase: "familial AD"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "as well as in other A-related disorders,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0012634:Disorders [Disease or Syndrome]
   744   C0205170:Well [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C3146287:Well [Manufactured Object]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits in cerebral vessels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0225992:Cerebral vessels [Body System]
   833   C1283832:Cerebral vessels [Body Part, Organ, or Organ Component]
   770   C0005847:Vessels [Body Part, Organ, or Organ Component]
   770   C0333562:Deposit [Functional Concept]
   737 E C1511228:Vessel [Tissue]

Phrase: "are"

Phrase: "primarily"

Phrase: "constituted of fibrillar forms of A40,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "although"

Phrase: "the presence of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in detectable amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "a common finding in these lesions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0577301:Lesion finding [Finding]
   753   C0037088:Finding [Sign or Symptom]
   753   C0243095:Finding [Finding]
   753   C2825141:Finding [Finding]

Phrase: "("

Phrase: "reviewed in Ref. 53"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.324: Similarly, in the various transgenic models of A deposition, A40 is the main component of vascular deposits (54-56), including the recently published APP-Dutch mouse (57). 

Phrase: "Similarly,"

Phrase: "in the various transgenic models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1519606:Transgenic Model [Experimental Model of Disease]
   827   C3161035:Models [Intellectual Product]

Phrase: "of A deposition,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]

Phrase: "A40"

Phrase: "is"

Phrase: "the main component of vascular deposits"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]
   733   C0085430:Blood component [Therapeutic or Preventive Procedure]
   733   C0450129:Blood component [Body Substance]

Phrase: "(54-56"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the recently published APP-Dutch mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mouse [Mammal]
   804   C0025929:mouse [Mammal]
   804   C0026809:Mouse [Mammal]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.325: The fact that the main A components of the vascular FDD lesions were A-(X-42) species was somehow an unexpected finding of still unknown connotations for the disease pathogenesis. 

Phrase: "The fact"

Phrase: "that"

Phrase: "the main A components of the vascular FDD lesions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   738   C0449432:Components [Manufactured Object]
   704   C0085430:blood components [Therapeutic or Preventive Procedure]
   704   C0450129:blood components [Body Substance]
   704 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(X-42"

Phrase: ")"

Phrase: "species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "was"

Phrase: "somehow"

Phrase: "an unexpected finding of still unknown connotations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "for the disease pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.326: The importance of A42 for the formation of vascular deposits is also highlighted by the recent report on the chimeric BRI-A42 mice, which selectively overproduce A42 but not A40, and the demonstration of extensive A42 cerebral amyloid angiopathy, whereas the BRI-A40 chimeric mice overproducing A40 did not show overt amyloid pathology, calling into question the importance of A40 in the initiation of vascular amyloid deposits (58). 

Phrase: "The importance of A42"

Phrase: "for the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of vascular deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "highlighted by the recent report"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332185:Recent [Temporal Concept]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "on the chimeric BRI-A42 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "which selectively"

Phrase: "overproduce"

Phrase: "A42"

Phrase: "but"

Phrase: "not A40,"

Phrase: "and"

Phrase: "the demonstration of extensive A42 cerebral amyloid angiopathy,"

Phrase: "whereas"

Phrase: "the BRI-A40 chimeric mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "overproducing"

Phrase: "A40"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "overt amyloid pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "calling into"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0679006:Call [Mental Process]
   799   C1947967:Call [Functional Concept]

Phrase: "question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "the importance of A40"

Phrase: "in the initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "of vascular amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936349:Amyloid Deposits [Acquired Abnormality]
   827   C0333562:Deposits [Functional Concept]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.327: It is also not clear whether the co-localization of ADan with A reflects important aspects of the mechanism of amyloidogenesis or simply a conformational mimicry, by which one molecule induces another to adopt a similar structural conformation favoring oligomerization. 

Phrase: "It"

Phrase: "is"

Phrase: "also"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "the co-localization of ADan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "with A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "important aspects of the mechanism of amyloidogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]

Phrase: "or"

Phrase: "simply"

Phrase: "a conformational mimicry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0233577:Mimicry [Mental or Behavioral Dysfunction]

Phrase: "by which one molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "another to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a similar structural conformation favoring oligomerization."
Processing 00000000.tx.328: In this sense, dimers (not monomers) of A molecules were retrieved in co-immunoprecipitation experiments from tissue extracts and A-(1-42) and A-(4-42) bound to ADan dimers and higher oligomers (not monomers) in ligand blot analysis, suggesting conformational specificity. 

Phrase: "In this sense,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "("

Phrase: "not monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "of A molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "retrieved in co-immunoprecipitation experiments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "from tissue extracts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040291:Tissue Extracts [Biologically Active Substance]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   827   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4-42"

Phrase: ")"

Phrase: "bound to ADan dimers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332297:bound [Spatial Concept]
   770   C0596448:dimers [Chemical Viewed Structurally]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "higher oligomers"

Phrase: "("

Phrase: "not monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596973:monomers [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "in ligand blot analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "conformational specificity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.329: It is important to note that A was detected in neither parenchymal nor vascular ABri deposits in FBD (15, 16) nor identified as an A ligand in the ligand blot analysis shown in Fig. 

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in neither parenchymal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "nor"

Phrase: "vascular ABri"

Phrase: "deposits in FBD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C1867773:Dementia, familial British [Disease or Syndrome]
   797   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0333562:Deposit [Functional Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C0596227:British [Population Group]

Phrase: "(15,"

Phrase: "16"

Phrase: ")"

Phrase: "nor"

Phrase: "identified as an A ligand"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0023688:Ligand [Chemical]
   760   C0205396:Identified [Qualitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "in the ligand blot analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.330: 7 despite being ABri and ADan molecules identical in their 22 N-terminal residues. 

Phrase: "7 despite"

Phrase: "being"

Phrase: "ABri"

Phrase: "and"

Phrase: "ADan molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "identical in their 22 N-terminal residues."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.331: Mounting evidence indicates that plaque burden correlates poorly with degree of dementia and that soluble oligomers rather than the final amyloid fibrils are the harmful A species (59-62). 

Phrase: "Mounting evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that plaque burden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828008:Burden [Idea or Concept]

Phrase: "correlates"

Phrase: "poorly with degree of dementia"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0205169:Poorly [Qualitative Concept]
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "and"

Phrase: "that soluble oligomers"

Phrase: "rather than"

Phrase: "the final amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "are"

Phrase: "the harmful A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "(59-62"

Phrase: ")."
Processing 00000000.tx.332: This viewpoint is supported by the two hereditary disorders FBD and FDD (collectively known as chromosome 13 dementias) and by the Iowa variant of familial AD associated with the deposition of the mutant AD23N (63). 

Phrase: "This viewpoint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282411:Viewpoint [Intellectual Product]

Phrase: "is"

Phrase: "supported by the two hereditary disorders FBD"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   790   C1867773:Dementia, familial British [Disease or Syndrome]
   764   C0019247:hereditary disorders [Disease or Syndrome]
   762   C0497327:dementia disorders [Mental or Behavioral Dysfunction]
           Dementia
   762   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   745   C0277558:familial disorder [Disease or Syndrome]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0012634:Disorders [Disease or Syndrome]
   742   C0015576:familial [Family Group]
   742   C0205448:Two [Quantitative Concept]
   742   C0241888:Familial [Functional Concept]
   742   C0439660:Hereditary [Functional Concept]
   742   C0596227:British [Population Group]
   742   C1521721:Supported [Conceptual Entity]
   709   C0150232:Family support [Therapeutic or Preventive Procedure]
   708 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "FDD"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(collectively"

Phrase: "known as chromosome 13 dementias"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0008655:Chromosome 13 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C0205309:Known [Qualitative Concept]
   760   C0497327:Dementias [Mental or Behavioral Dysfunction]
   726 E C0011265:dementia [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "and by the Iowa variant of familial AD"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   762   C0277558:Familial disease [Disease or Syndrome]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0015576:familial [Family Group]
   742   C0022037:Iowa [Geographic Area]
   742   C0205419:Variant [Qualitative Concept]
   742   C0241888:Familial [Functional Concept]
   742   C1515981:And [Idea or Concept]
   742   C1555231:Iowa [Population Group]
   726 E C0344339:disease family [Finding]

Phrase: "associated with the deposition of the mutant AD23N"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0333562:Deposition [Functional Concept]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.333: Despite the structural differences among ABri, ADan, and A, the absence or limited number of compact plaques and extensive neurofibrillar degeneration with tangles identical to those found in Alzheimer brains are main features of these disorders. 

Phrase: "Despite the structural differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "among ABri,"

Phrase: "ADan,"

Phrase: "and"

Phrase: "A,"

Phrase: "the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "limited number of compact plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0449793:Number of plaques [Quantitative Concept]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "extensive neurofibrillar degeneration with tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "identical to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "found in Alzheimer brains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "main features of these disorders."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.334: Therefore, not only are different amyloid peptides associated with similar neuropathological changes, but these disorders call into question the importance of compact plaques in the mechanism of neuronal toxicity. 

Phrase: "Therefore,"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "are"

Phrase: "different amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with similar neuropathological changes,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C2348205:Similar [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1705241:Change [Quantitative Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "but"

Phrase: "these disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "call into"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0679006:Call [Mental Process]
   833   C1947967:Call [Functional Concept]

Phrase: "question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "the importance of compact plaques"

Phrase: "in the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "of neuronal toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.335: Compact plaques are absent in FDD, in the Iowa variant of familial AD, and in certain brain areas in FBD, whereas all disorders feature parenchymal preamyloid lesions as well as vascular and perivascular deposits, yet the final clinical outcome of these diseases is AD-like dementia. 

Phrase: "Compact plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "absent in FDD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "in the Iowa variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "of familial AD,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "and in certain brain areas"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0205146:areas [Spatial Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "in FBD,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1867773:Dementia, familial British [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C0596227:British [Population Group]
   755 E C1704727:Family [Conceptual Entity]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "whereas"

Phrase: "all disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "parenchymal preamyloid lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0221198:lesions [Finding]
   793 E C1546698:Lesion [Intellectual Product]

Phrase: "as well as"

Phrase: "vascular"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005847:vascular [Body Part, Organ, or Organ Component]
  1000   C1558950:VASCULAR [Finding]
  1000   C1801960:Vascular [Qualitative Concept]
   944 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   944 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C0005767:Blood [Tissue]
   900 E C0005768:blood [Body Substance]
   900 E C0229664:Blood [Body Substance]
   900 E C0392895:Bloods [Population Group]
   884 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "perivascular deposits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "yet"

Phrase: "the final clinical outcome of these diseases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0679250:diseases outcome [Finding]
   757 E C3542417:Disease Outcome [Intellectual Product]
   748   C1274040:Outcome [Functional Concept]

Phrase: "is"

Phrase: "AD-"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "like dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.336: Thus, if amyloid is of paramount importance in the development of dementia, it is certainly neither exclusive for A nor dependent on the presence of compact plaques. 

Phrase: "Thus,"

Phrase: "if"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is of paramount importance"

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "it"

Phrase: "is"

Phrase: "certainly"

Phrase: "neither exclusive for A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1548966:Exclusive [Idea or Concept]

Phrase: "nor"

Phrase: "dependent on the presence of compact plaques."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
Processing 00000000.tx.337: We propose that these disorders are suitable models to study early steps in peptide oligomerization/fibrillization and the role of preamyloid and vascular amyloid in the process of neurodegeneration.  

Phrase: "We"

Phrase: "propose"

Phrase: "that"

Phrase: "these disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "are"

Phrase: "suitable models to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Models [Intellectual Product]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "early steps in peptide oligomerization/fibrillization"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C1261552:steps [Conceptual Entity]
   719 E C1704379:Step [Functional Concept]
   719 E C1705117:Step [Quantitative Concept]
   719 E C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "the role of preamyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "vascular amyloid in the process of neurodegeneration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.338: FOOTNOTES  * This work was supported in part by National Institutes of Health Grants AG05891, AG08721, S10RR14662, and NS38777, by the Alzheimer Association, and by the Alzheimer's Disease Research program of the American Health Assistance Foundation. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institutes of Health Grants AG05891,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "AG08721,"

Phrase: "S10RR14662,"

Phrase: "and"

Phrase: "NS38777,"

Phrase: "by the Alzheimer Association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "and by the Alzheimer's Disease Research program of the American Health Assistance Foundation."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   762   C0679215:health and disease [Natural Phenomenon or Process]
           disease health
   750   C0002395:Alzheimer's Disease [Disease or Syndrome]
   750   C0683935:research program [Research Activity]
   750   C1521724:Alzheimer's Disease [Pathologic Function]
   749   C3242129:disease program [Health Care Related Organization]
   749   C3245490:disease program [Health Care Related Organization]
   735   C0012634:Disease [Disease or Syndrome]
   735   C0016617:Foundation [Organization]
   735   C0018684:Health [Idea or Concept]
   735   C0018896:Assistance [Social Behavior]
   735   C0035168:research [Research Activity]
   735   C0242481:Research [Research Activity]
   735   C0596070:American [Population Group]
   735   C1515981:And [Idea or Concept]
   735   C1709697:Program [Conceptual Entity]
   735   C2728259:Program [Pharmacologic Substance]
   735   C3484370:Program [Functional Concept]
   707   C2986512:Research Base [Organization]
Processing 00000000.tx.339: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.340: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0007776:Cortex [Body Part, Organ, or Organ Component]
   812   C1176472:Cortex [Body Part, Organ, or Organ Component]
   812   C2700441:Cortex [Plant]
Processing 00000000.tx.341: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.342: 1 To whom correspondence should be addressed: Depts. of Pathology and Psychiatry, New York University School of Medicine, 550 First Ave. 

Phrase: "1 To whom correspondence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282413:Correspondence [Intellectual Product]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Depts."

Phrase: "of Pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "New York University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "550 First Ave."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0108844:AVE [Therapeutic or Preventive Procedure]
Processing 00000000.tx.343: (TH-432), New York, NY 10016. 

Phrase: "(TH-432"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY 10016."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]
Processing 00000000.tx.344: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.345: 212-263-7997; 

Phrase: "212-263-7997"

Phrase: ";"
Processing 00000000.tx.346: Fax: 212-263-6751; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "212-263-6751"

Phrase: ";"
Processing 00000000.tx.347: E-mail: ghisoj01{at}popmail.med.nyu.edu . 2 The abbreviations used are: FDD, familial Danish dementia; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ghisoj01{at}popmail.med.nyu.edu . 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "FDD,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "familial Danish dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1861735:Dementia, familial Danish [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.348: ADan, Danish amyloid; 

Phrase: "ADan,"

Phrase: "Danish amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.349: ABri, British amyloid; 

Phrase: "ABri,"

Phrase: "British amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.350: AD, Alzheimer's disease; 

Phrase: "AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.351: FBD, familial British dementia; 

Phrase: "FBD,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1867773:Dementia, familial British [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C0596227:British [Population Group]
   755 E C1704727:Family [Conceptual Entity]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "familial British dementia"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1867773:Dementia, familial British [Disease or Syndrome]
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C0596227:British [Population Group]
   755 E C1704727:Family [Conceptual Entity]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.352: A, -amyloid; 

Phrase: "A, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.353: MALDI-TOF, matrix-assisted laser desorption ionization-time-of-flight; 

Phrase: "MALDI-TOF,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C2348791:Time-of-Flight [Quantitative Concept]
   793   C1555977:Flight [Intellectual Product]
   793   C2610507:flight [Phenomenon or Process]
   723   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: "matrix-assisted laser desorption ionization-time-of-flight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C2348791:Time-of-Flight [Quantitative Concept]
   793   C1555977:Flight [Intellectual Product]
   793   C2610507:flight [Phenomenon or Process]
   723   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.354: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.355: FA, formic acid; 

Phrase: "FA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0885348:formic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "formic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0885348:formic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.356: Ab, antibody; 

Phrase: "Ab,"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.357: Tricine, N-[2-hydroxy-1, 1-bis(hydroxymethyl)ethyl]glycine. 

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]
Processing 00000000.tx.358: 3 Y. 

Phrase: "3 Y."
Processing 00000000.tx.359: Tomidokoro, B. 

Phrase: "Tomidokoro,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.360: Frangione, and J. 

Phrase: "Frangione,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.361: Ghiso, unpublished observations.  

Phrase: "Ghiso,"

Phrase: "unpublished observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.362: ACKNOWLEDGMENTS  We thank Yun Lu of the New York University Protein Analysis Facility for MALDI-TOF mass spectrometry and Zhihong Zhao for the ApoE genotyping.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Yun Lu of the New York University Protein Analysis Facility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0024171:LU [Body System]
   739   C0024176:LU [Geographic Area]
   739   C2697939:LU [Quantitative Concept]

Phrase: "for MALDI-TOF mass spectrometry"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "Zhihong Zhao for the ApoE genotyping."
Processing 00000000.tx.363: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES DISCUSSION REFERENCES  Strmgren, E., Dalby, A., Dalby, M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Strmgren,"

Phrase: "E.,"

Phrase: "Dalby,"

Phrase: "A.,"

Phrase: "Dalby,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.364: A., and Ranheim, B. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Ranheim,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.365: (1970) Acta Neurol. 

Phrase: "(1970"

Phrase: ")"

Phrase: "Acta Neurol."
Processing 00000000.tx.366: Scand. 

Phrase: "Scand."
Processing 00000000.tx.367: 46, 261-262[Medline] [OrderarticleviaInfotrieve] Strmgren, E. 

Phrase: "46,"

Phrase: "261-262"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Strmgren,"

Phrase: "E."
Processing 00000000.tx.368: (1981) in Handbook of Clinical Neurology (Vinken, P. J., and Bruyn, G. W., eds) Vol. 

Phrase: "(1981"

Phrase: ")"

Phrase: "in Handbook"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596654:handbook [Intellectual Product]

Phrase: "of Clinical Neurology"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   861   C0205210:Clinical [Qualitative Concept]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "(Vinken,"

Phrase: "P. J.,"

Phrase: "and"

Phrase: "Bruyn,"

Phrase: "G. W., eds) Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0449468:VOL [Quantitative Concept]
   812   C0560268:vol% [Quantitative Concept]
   812   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.369: 42, pp. 

Phrase: "42,"

Phrase: "pp."
Processing 00000000.tx.370: 150-152, North Holland Publishing Co., Amsterdam Bek, T. 

Phrase: "150-152,"

Phrase: "North Holland Publishing Co.,"

Phrase: "Amsterdam Bek,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.371: (2000) Br. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.372: J. 

Phrase: "J."
Processing 00000000.tx.373: Ophtalmol. 

Phrase: "Ophtalmol."
Processing 00000000.tx.374: 84, 1298-1302[CrossRef] Vidal, R., Ghiso, J., Revesz, T., Rostagno, A., Kim, E., Holton, J., Bek, T., Bojsen-Moller, M., Braendgaard, H., Plant, G., and Frangione, B. 

Phrase: "84,"

Phrase: "1298-1302"

Phrase: "[CrossRef"

Phrase: "] Vidal,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Revesz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Rostagno,"

Phrase: "A.,"

Phrase: "Kim,"

Phrase: "E.,"

Phrase: "Holton,"

Phrase: "J.,"

Phrase: "Bek,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bojsen-Moller,"

Phrase: "M."

Phrase: ","

Phrase: "Braendgaard,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]
   907 E C0006038:Botany [Occupation or Discipline]
   888 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.375: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.376: Natl. 

Phrase: "Natl."
Processing 00000000.tx.377: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.378: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.379: U. 

Phrase: "U."
Processing 00000000.tx.380: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.381: A. 

Phrase: "A."
Processing 00000000.tx.382: 97, 4920-4925[Abstract/Free FullText] Holton, J., Lashley, T., Ghiso, J., Braendgaard, H., Vidal, R., Guerin, C., Gibb, G., Hanger, D. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "4920-4925"

Phrase: "[Abstract/Free FullText"

Phrase: "] Holton,"

Phrase: "J.,"

Phrase: "Lashley,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Braendgaard,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vidal,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Guerin,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Gibb,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hanger,"

Phrase: "D."
Processing 00000000.tx.383: P., Rostagno, A., Anderton, B., Strand, C., Ayling, H., Plant, G., Frangione, B., Bojsen-Moller, M., and Revesz, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rostagno,"

Phrase: "A.,"

Phrase: "Anderton,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Strand,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Ayling,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]
   907 E C0006038:Botany [Occupation or Discipline]
   888 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bojsen-Moller,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Revesz,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.384: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.385: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.386: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.387: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.388: 61, 254-267[Medline] [OrderarticleviaInfotrieve] Vidal, R., Frangione, B., Rostagno, A., Mead, S., Revesz, T., Plant, G., and Ghiso, J. 

Phrase: "61,"

Phrase: "254-267"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vidal,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rostagno,"

Phrase: "A.,"

Phrase: "Mead,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678406:mead [Food]

Phrase: "S."

Phrase: ","

Phrase: "Revesz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]
   907 E C0006038:Botany [Occupation or Discipline]
   888 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Ghiso,"

Phrase: "J."
Processing 00000000.tx.389: (1999) Nature 399, 776-781[CrossRef][Medline] [OrderarticleviaInfotrieve] Pittois, K., Deleersnijder, W., and Merregaert, J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 399,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "776-781"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pittois,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Deleersnijder,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Merregaert,"

Phrase: "J."
Processing 00000000.tx.390: (1998) Gene (Amst.) 

Phrase: "(1998"

Phrase: ")"

Phrase: "Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "(Amst."

Phrase: ")"
Processing 00000000.tx.391: 217, 141-149[CrossRef][Medline] [OrderarticleviaInfotrieve] Rostagno, A., Tomidokoro, Y., Lashley, T., Ng, D., Plant, G., Holton, J., Frangione, B., Revesz, T., Ghiso, J. 

Phrase: "217,"

Phrase: "141-149"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rostagno,"

Phrase: "A.,"

Phrase: "Tomidokoro,"

Phrase: "Y.,"

Phrase: "Lashley,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ng,"

Phrase: "D."

Phrase: ","

Phrase: "Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]
   907 E C0006038:Botany [Occupation or Discipline]
   888 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Holton,"

Phrase: "J.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Revesz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ghiso,"

Phrase: "J."
Processing 00000000.tx.392: (2005) Cell Mol Life Sci. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Cell Mol Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.393: 62, 1814-1825[CrossRef][Medline] [OrderarticleviaInfotrieve] Kim, S.-H., Wang, R., Gordon, D. 

Phrase: "62,"

Phrase: "1814-1825"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kim,"

Phrase: "S.-"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gordon,"

Phrase: "D."
Processing 00000000.tx.394: J., Bass, J., Steiner, D., Lynn, D. 

Phrase: "J.,"

Phrase: "Bass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004830:Bass [Fish]

Phrase: "J.,"

Phrase: "Steiner,"

Phrase: "D."

Phrase: ","

Phrase: "Lynn,"

Phrase: "D."
Processing 00000000.tx.395: G., Thinakaran, G., Meredith, S., and Sisodia, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Meredith,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.396: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.397: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.398: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.399: 2, 984-988[CrossRef][Medline] [OrderarticleviaInfotrieve] Worster-Drought, C., Hill, T., and McMenemey, W. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "984-988"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Worster-Drought,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013140:Drought [Natural Phenomenon or Process]

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "McMenemey,"

Phrase: "W."
Processing 00000000.tx.400: (1933) J. 

Phrase: "(1933"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.401: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.402: Psychopathol. 

Phrase: "Psychopathol."
Processing 00000000.tx.403: 14, 27-34 Worster-Drought, C., Greenfield, J. 

Phrase: "14,"

Phrase: "27-34 Worster-Drought,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013140:Drought [Natural Phenomenon or Process]

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Greenfield,"

Phrase: "J."
Processing 00000000.tx.404: G., and McMenemey, W. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "McMenemey,"

Phrase: "W."
Processing 00000000.tx.405: (1940) Brain 63, 237-254 Plant, G., Revesz, T., Barnard, R., Harding, A., and Gautier-Smith, P. 

Phrase: "(1940"

Phrase: ")"

Phrase: "Brain 63,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "237-254 Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0032098:Plant [Plant]
   734 E C0006038:Botany [Occupation or Discipline]
   716 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Revesz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Barnard,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Harding,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Gautier-Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.406: (1990) Brain 113, 721-747[Abstract] Mead, S., James Galton, M., Revesz, T., Doshi, R. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Brain 113,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "721-747"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mead,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678406:mead [Food]

Phrase: "S."

Phrase: ","

Phrase: "James Galton,"

Phrase: "M."

Phrase: ","

Phrase: "Revesz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Doshi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.407: B., Harwood, G., Pan, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Harwood,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "E."
Processing 00000000.tx.408: L., Ghiso, J., Frangione, B., and Plant, G. 

Phrase: "L., Ghiso,"

Phrase: "J.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]
   907 E C0006038:Botany [Occupation or Discipline]
   888 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.409: (2000) Brain 123, 975-986[Abstract/Free FullText] Holton, J., Ghiso, J., Lashley, T., Rostagno, A., Guerin, C., Gibb, G., Houlden, H., Ayling, H., Martinian, L., Anderton, B., Wood, N., Vidal, R., Plant, G., Frangione, B., and Revesz, T. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Brain 123,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "975-986"

Phrase: "[Abstract/Free FullText"

Phrase: "] Holton,"

Phrase: "J.,"

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Lashley,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Rostagno,"

Phrase: "A.,"

Phrase: "Guerin,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Gibb,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ayling,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Martinian,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Anderton,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Vidal,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]
   907 E C0006038:Botany [Occupation or Discipline]
   888 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Revesz,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.410: (2001) Am. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.411: J. 

Phrase: "J."
Processing 00000000.tx.412: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.413: 158, 515-526[Abstract/Free FullText] Revesz, T., Holton, J. 

Phrase: "158,"

Phrase: "515-526"

Phrase: "[Abstract/Free FullText"

Phrase: "] Revesz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Holton,"

Phrase: "J."
Processing 00000000.tx.414: L., Doshi, B., Anderton, B. 

Phrase: "L., Doshi,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.415: H., Scaravilli, F., and Plant, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Scaravilli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]
   907 E C0006038:Botany [Occupation or Discipline]
   888 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.416: (1999) Acta Neuropathol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.417: 97, 170-176[CrossRef][Medline] [OrderarticleviaInfotrieve] Ghiso, J., Plant, G., Revesz, T., Wisniewski, T., and Frangione, B. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "170-176"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ghiso,"

Phrase: "J.,"

Phrase: "Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]
   907 E C0006038:Botany [Occupation or Discipline]
   888 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Revesz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.418: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.419: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.420: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.421: 129, 74-75[CrossRef][Medline] [OrderarticleviaInfotrieve] Ghiso, J., Holton, J., Miravalle, L., Calero, M., Lashley, T., Vidal, R., Houlden, H., Wood, N., Neubert, T. 

Phrase: "129,"

Phrase: "74-75"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ghiso,"

Phrase: "J.,"

Phrase: "Holton,"

Phrase: "J.,"

Phrase: "Miravalle,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Calero,"

Phrase: "M."

Phrase: ","

Phrase: "Lashley,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Vidal,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Neubert,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.422: A., Rostagno, A., Plant, G., Revesz, T., and Frangione, B. 

Phrase: "A.,"

Phrase: "Rostagno,"

Phrase: "A.,"

Phrase: "Plant,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]
   907 E C0006038:Botany [Occupation or Discipline]
   888 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Revesz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.423: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.424: Biol. 

Phrase: "Biol."
Processing 00000000.tx.425: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.426: 276, 43909-43914[Abstract/Free FullText] Woods, A. 

Phrase: "276,"

Phrase: "43909-43914"

Phrase: "[Abstract/Free FullText"

Phrase: "] Woods,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0043217:Woods [Substance]
  1000   C0442548:Woods [Geographic Area]
   928 E C0144237:Sylvan [Organic Chemical]

Phrase: "A."
Processing 00000000.tx.427: S., Buchsbaum, J. 

Phrase: "S."

Phrase: ","

Phrase: "Buchsbaum,"

Phrase: "J."
Processing 00000000.tx.428: C., Worrall, T. 

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Worrall,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.429: S., Berg, J. 

Phrase: "S."

Phrase: ","

Phrase: "Berg,"

Phrase: "J."
Processing 00000000.tx.430: M., and Cotter, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Cotter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.431: J. 

Phrase: "J."
Processing 00000000.tx.432: (1995) Anal. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.433: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.434: 67, 4462-4465[CrossRef] Ida, N., Hartmann, T., Pantel, J., Schroder, J., Zerfass, R., Forstl, H., Sandbrink, R., Masters, C. 

Phrase: "67,"

Phrase: "4462-4465"

Phrase: "[CrossRef"

Phrase: "] Ida,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020789:IDA [Organic Chemical,Pharmacologic Substance]
  1000   C0063555:IdA [Organic Chemical,Pharmacologic Substance]
  1000   C2275731:Ida [Plant]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hartmann,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pantel,"

Phrase: "J.,"

Phrase: "Schroder,"

Phrase: "J.,"

Phrase: "Zerfass,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Forstl,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sandbrink,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.435: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.436: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.437: Biol. 

Phrase: "Biol."
Processing 00000000.tx.438: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.439: 271, 22908-22914[Abstract/Free FullText] Hixson, J. 

Phrase: "271,"

Phrase: "22908-22914"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hixson,"

Phrase: "J."
Processing 00000000.tx.440: E., and Vernier, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Vernier,"

Phrase: "D."
Processing 00000000.tx.441: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.442: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.443: Lipid Res. 

Phrase: "Lipid Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.444: 31, 545-548[Abstract] Duewel, H. 

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "545-548"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Duewel,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.445: S., and Honek, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Honek,"

Phrase: "J."
Processing 00000000.tx.446: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.447: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.448: Protein Chem. 

Phrase: "Protein Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.449: 17, 337-350[CrossRef][Medline] [OrderarticleviaInfotrieve] Butterfield, D. 

Phrase: "17,"

Phrase: "337-350"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Butterfield,"

Phrase: "D."
Processing 00000000.tx.450: A. 

Phrase: "A."
Processing 00000000.tx.451: (2002) Free Radical Res. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Free Radical Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
Processing 00000000.tx.452: 36, 1307-1313[CrossRef][Medline] [OrderarticleviaInfotrieve] Matsubara, E., Frangione, B., and Ghiso, J. 

Phrase: "36,"

Phrase: "1307-1313"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Matsubara,"

Phrase: "E.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Ghiso,"

Phrase: "J."
Processing 00000000.tx.453: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.454: Biol. 

Phrase: "Biol."
Processing 00000000.tx.455: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.456: 270, 7563-7567[Abstract/Free FullText] Mori, H., Takio, K., Ogawara, M., and Selkoe, D. 

Phrase: "270,"

Phrase: "7563-7567"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ogawara,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.457: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.458: Biol. 

Phrase: "Biol."
Processing 00000000.tx.459: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.460: 267, 17082-17086[Abstract/Free FullText] Saido, T., Yamao-Harigaya, W., Iwatsubo, T., and Kawashima, S. 

Phrase: "267,"

Phrase: "17082-17086"

Phrase: "[Abstract/Free FullText"

Phrase: "] Saido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamao-Harigaya,"

Phrase: "W.,"

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kawashima,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.461: (1996) Neurosci. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.462: Lett. 

Phrase: "Lett."
Processing 00000000.tx.463: 13, 173-176[CrossRef] Tekirian, T., Saido, T., Markesbery, W., Russell, M., Wekstein, D., Patel, E., and Geddes, J. 

Phrase: "13,"

Phrase: "173-176"

Phrase: "[CrossRef"

Phrase: "] Tekirian,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Saido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Markesbery,"

Phrase: "W.,"

Phrase: "Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "M."

Phrase: ","

Phrase: "Wekstein,"

Phrase: "D."

Phrase: ","

Phrase: "Patel,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Geddes,"

Phrase: "J."
Processing 00000000.tx.464: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.465: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.466: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.467: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.468: 57, 76-94[Medline] [OrderarticleviaInfotrieve] Sykes, P. 

Phrase: "57,"

Phrase: "76-94"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sykes,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.469: A., Watson, S. 

Phrase: "A.,"

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.470: J., Temple, J. 

Phrase: "J.,"

Phrase: "Temple,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230007:temple [Body Location or Region]
  1000   C0935456:Temple [Body Location or Region]

Phrase: "J."
Processing 00000000.tx.471: S., and Bateman, R. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Bateman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.472: C. 

Phrase: "C."
Processing 00000000.tx.473: J. 

Phrase: "J."
Processing 00000000.tx.474: (1999) FEBS Lett. 

Phrase: "(1999"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.475: 455, 159-161[CrossRef][Medline] [OrderarticleviaInfotrieve] Busby, W. 

Phrase: "455,"

Phrase: "159-161"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Busby,"

Phrase: "W."
Processing 00000000.tx.476: H., Quackenbush, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Quackenbush,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.477: E., Humm, J., Youngblood, W. 

Phrase: "E.,"

Phrase: "Humm,"

Phrase: "J.,"

Phrase: "Youngblood,"

Phrase: "W."
Processing 00000000.tx.478: W., and Kizer, J. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Kizer,"

Phrase: "J."
Processing 00000000.tx.479: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.480: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.481: Biol. 

Phrase: "Biol."
Processing 00000000.tx.482: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.483: 262, 8532-8536[Abstract/Free FullText] Fischer, W. 

Phrase: "262,"

Phrase: "8532-8536"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fischer,"

Phrase: "W."
Processing 00000000.tx.484: H., and Spiess, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Spiess,"

Phrase: "J."
Processing 00000000.tx.485: (1987) Proc. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.486: Natl. 

Phrase: "Natl."
Processing 00000000.tx.487: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.488: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.489: U. 

Phrase: "U."
Processing 00000000.tx.490: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.491: A. 

Phrase: "A."
Processing 00000000.tx.492: 84, 3628-3632[Abstract/Free FullText] Bateman, A., Solomon, S., and Bennett, H. 

Phrase: "84,"

Phrase: "3628-3632"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bateman,"

Phrase: "A.,"

Phrase: "Solomon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551833:Solomon [Population Group]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Bennett,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.493: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.494: J. 

Phrase: "J."
Processing 00000000.tx.495: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.496: Biol. 

Phrase: "Biol."
Processing 00000000.tx.497: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.498: 265, 22130-22136[Abstract/Free FullText] Yamashiro, D., and Li, C. 

Phrase: "265,"

Phrase: "22130-22136"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yamashiro,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C."
Processing 00000000.tx.499: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.500: (1976) Biochim. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.501: Byophys. 

Phrase: "Byophys."
Processing 00000000.tx.502: Acta 451, 124-132[Medline] [OrderarticleviaInfotrieve] Saido, T., Iwatsubo, T., Mann, D. 

Phrase: "Acta 451,"

Phrase: "124-132"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Saido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mann,"

Phrase: "D."
Processing 00000000.tx.503: M., Shimada, H., Ihara, Y., and Kawashima, S. 

Phrase: "M."

Phrase: ","

Phrase: "Shimada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ihara,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Kawashima,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.504: (1995) Neuron 14, 457-466[CrossRef][Medline] [OrderarticleviaInfotrieve] Garden, R. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuron 14,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "457-466"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Garden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868963:garden [Daily or Recreational Activity]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.505: W., Moroz, T. 

Phrase: "W., Moroz,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.506: P., Gleeson, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gleeson,"

Phrase: "J."
Processing 00000000.tx.507: M., Floyd, P. 

Phrase: "M."

Phrase: ","

Phrase: "Floyd,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.508: D., Li, L., Rubakhin, S. 

Phrase: "D."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Rubakhin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.509: S., and Sweedler, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Sweedler,"

Phrase: "J."
Processing 00000000.tx.510: V. 

Phrase: "V."
Processing 00000000.tx.511: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.512: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.513: 72, 676-681[CrossRef][Medline] [OrderarticleviaInfotrieve] Gowing, E., Roher, A. 

Phrase: "72,"

Phrase: "676-681"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gowing,"

Phrase: "E.,"

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.514: E., Woods, A. 

Phrase: "E.,"

Phrase: "Woods,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0043217:Woods [Substance]
  1000   C0442548:Woods [Geographic Area]
   928 E C0144237:Sylvan [Organic Chemical]

Phrase: "A."
Processing 00000000.tx.515: S., Cotter, R. 

Phrase: "S."

Phrase: ","

Phrase: "Cotter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.516: J., Chaney, M., Little, S. 

Phrase: "J.,"

Phrase: "Chaney,"

Phrase: "M."

Phrase: ","

Phrase: "Little,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.517: P., and Ball, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706910:Ball [Manufactured Object]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.518: J. 

Phrase: "J."
Processing 00000000.tx.519: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.520: Biol. 

Phrase: "Biol."
Processing 00000000.tx.521: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.522: 269, 10987-10990[Abstract/Free FullText] Lalowski, M., Golabek, A., Lemere, C. 

Phrase: "269,"

Phrase: "10987-10990"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lalowski,"

Phrase: "M."

Phrase: ","

Phrase: "Golabek,"

Phrase: "A.,"

Phrase: "Lemere,"

Phrase: "C."
Processing 00000000.tx.523: A., Selkoe, D. 

Phrase: "A.,"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.524: J., Wisniewski, H. 

Phrase: "J.,"

Phrase: "Wisniewski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.525: M., Beavis, R. 

Phrase: "M."

Phrase: ","

Phrase: "Beavis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.526: C., Frangione, B., and Wisniewski, T. 

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Wisniewski,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.527: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.528: Biol. 

Phrase: "Biol."
Processing 00000000.tx.529: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.530: 271, 33623-33631[Abstract/Free FullText] Wisniewski, T., Lalowski, M., Bobik, M., Russell, M., Strosznajder, J., and Frangione, B. 

Phrase: "271,"

Phrase: "33623-33631"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lalowski,"

Phrase: "M."

Phrase: ","

Phrase: "Bobik,"

Phrase: "M."

Phrase: ","

Phrase: "Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "M."

Phrase: ","

Phrase: "Strosznajder,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.531: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.532: J. 

Phrase: "J."
Processing 00000000.tx.533: 313, 575-580[Medline] [OrderarticleviaInfotrieve] Iwatsubo, T., Saido, T., Mann, D. 

Phrase: "313,"

Phrase: "575-580"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Saido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mann,"

Phrase: "D."
Processing 00000000.tx.534: M., Lee, V., and Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "V.,"

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.535: Q. 

Phrase: "Q."
Processing 00000000.tx.536: (1996) Am. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.537: J. 

Phrase: "J."
Processing 00000000.tx.538: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.539: 149, 1823-1830[Abstract] Castano, E. 

Phrase: "149,"

Phrase: "1823-1830"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Castano,"

Phrase: "E."
Processing 00000000.tx.540: M., Prelli, F., Soto, C., Beavis, R., Matsubara, E., Shoji, M., and Frangione, B. 

Phrase: "M."

Phrase: ","

Phrase: "Prelli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Soto,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Beavis,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Matsubara,"

Phrase: "E.,"

Phrase: "Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.541: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.542: Biol. 

Phrase: "Biol."
Processing 00000000.tx.543: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.544: 271, 32185-32191[Abstract/Free FullText] Pike, C. 

Phrase: "271,"

Phrase: "32185-32191"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.545: J., Overman, M. 

Phrase: "J.,"

Phrase: "Overman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.546: J., and Cotman, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.547: W. 

Phrase: "W."
Processing 00000000.tx.548: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.549: Biol. 

Phrase: "Biol."
Processing 00000000.tx.550: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.551: 270, 23895-23898[Abstract/Free FullText] Hiraiwa, M. 

Phrase: "270,"

Phrase: "23895-23898"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hiraiwa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.552: (1999) Cell. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.553: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.554: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.555: 56, 894-907[CrossRef][Medline] [OrderarticleviaInfotrieve] Wallis, T. 

Phrase: "56,"

Phrase: "894-907"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wallis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.556: P., Pitt, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Pitt,"

Phrase: "J."
Processing 00000000.tx.557: J., and Gorman, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Gorman,"

Phrase: "J."
Processing 00000000.tx.558: J. 

Phrase: "J."
Processing 00000000.tx.559: (2001) Protein Sci. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.560: 10, 2251-2271[Abstract/Free FullText] van der Burg, H. 

Phrase: "10,"

Phrase: "2251-2271"

Phrase: "[Abstract/Free FullText"

Phrase: "] van der Burg,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.561: A., Westerink, N., Francoijs, K. 

Phrase: "A.,"

Phrase: "Westerink,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Francoijs,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.562: J., Roth, R., Woestenenk, E., Boeren, S., de Wit, P. 

Phrase: "J.,"

Phrase: "Roth,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Woestenenk,"

Phrase: "E.,"

Phrase: "Boeren,"

Phrase: "S."

Phrase: ","

Phrase: "de Wit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043197:Wit [Idea or Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.563: J. 

Phrase: "J."
Processing 00000000.tx.564: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.565: M., Joosten, M. 

Phrase: "M."

Phrase: ","

Phrase: "Joosten,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.566: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.567: A. 

Phrase: "A."
Processing 00000000.tx.568: J., and Vervoort, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Vervoort,"

Phrase: "J."
Processing 00000000.tx.569: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.570: Biol. 

Phrase: "Biol."
Processing 00000000.tx.571: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.572: 278, 27340-27346[Abstract/Free FullText] Novokhatny, V. 

Phrase: "278,"

Phrase: "27340-27346"

Phrase: "[Abstract/Free FullText"

Phrase: "] Novokhatny,"

Phrase: "V."
Processing 00000000.tx.573: V., and Ingham, K. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Ingham,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.574: C. 

Phrase: "C."
Processing 00000000.tx.575: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.576: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.577: Biol. 

Phrase: "Biol."
Processing 00000000.tx.578: 238, 833-844[CrossRef][Medline] [OrderarticleviaInfotrieve] Howell, S., Nalbantoglu, J., and Crine, P. 

Phrase: "238,"

Phrase: "833-844"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Howell,"

Phrase: "S."

Phrase: ","

Phrase: "Nalbantoglu,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Crine,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.579: (1995) Peptides 16, 647-652[CrossRef][Medline] [OrderarticleviaInfotrieve] Morelli, L., Llovera, R., Gonzalez, S. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Peptides 16,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "647-652"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Morelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Llovera,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gonzalez,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.580: A., Affranchino, J. 

Phrase: "A.,"

Phrase: "Affranchino,"

Phrase: "J."
Processing 00000000.tx.581: L., Prelli, F., Frangione, B., Ghiso, J., and Castano, E. 

Phrase: "L., Prelli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Castano,"

Phrase: "E."
Processing 00000000.tx.582: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.583: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.584: Biol. 

Phrase: "Biol."
Processing 00000000.tx.585: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.586: 278, 23221-23226[Abstract/Free FullText] Junaid, M. 

Phrase: "278,"

Phrase: "23221-23226"

Phrase: "[Abstract/Free FullText"

Phrase: "] Junaid,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.587: A., Wu, G., and Pullarkat, R. 

Phrase: "A.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Pullarkat,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.588: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.589: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.590: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.591: 74, 287-294[CrossRef][Medline] [OrderarticleviaInfotrieve] Liao, L., Cheng, D., Wang, J., Duong, D. 

Phrase: "74,"

Phrase: "287-294"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Liao,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cheng,"

Phrase: "D."

Phrase: ","

Phrase: "Wang,"

Phrase: "J.,"

Phrase: "Duong,"

Phrase: "D."
Processing 00000000.tx.592: M., Losik, T. 

Phrase: "M."

Phrase: ","

Phrase: "Losik,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.593: G., Gearing, M., Rees, H. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gearing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706469:Gear [Qualitative Concept]
   966   C1706470:Gear [Manufactured Object]

Phrase: "M."

Phrase: ","

Phrase: "Rees,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555622:Ree [Language]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.594: D., Lah, J. 

Phrase: "D."

Phrase: ","

Phrase: "Lah,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0238705:LAH [Anatomical Abnormality,Disease or Syndrome]
  1000   C1427484:LAH [Gene or Genome]
  1000   C1842839:LAH [Disease or Syndrome]

Phrase: "J."
Processing 00000000.tx.595: J., Levey, A. 

Phrase: "J.,"

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.596: I., and Peng, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Peng,"

Phrase: "J."
Processing 00000000.tx.597: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.598: Biol. 

Phrase: "Biol."
Processing 00000000.tx.599: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.600: 279, 37061-37068[Abstract/Free FullText] Cohen, A. 

Phrase: "279,"

Phrase: "37061-37068"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cohen,"

Phrase: "A."
Processing 00000000.tx.601: S., and Calkins, E. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Calkins,"

Phrase: "E."
Processing 00000000.tx.602: (1964) J. 

Phrase: "(1964"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.603: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.604: 21, 481-486[Free FullText] Glenner, G. 

Phrase: "21,"

Phrase: "481-486"

Phrase: "[Free FullText"

Phrase: "] Glenner,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.605: G., and Wong, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wong,"

Phrase: "C."
Processing 00000000.tx.606: W. 

Phrase: "W."
Processing 00000000.tx.607: (1984) Biochem. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.608: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.609: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.610: Commun. 

Phrase: "Commun."
Processing 00000000.tx.611: 120, 885-890[CrossRef][Medline] [OrderarticleviaInfotrieve] Glenner, G. 

Phrase: "120,"

Phrase: "885-890"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Glenner,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.612: G., and Wong, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wong,"

Phrase: "C."
Processing 00000000.tx.613: W. 

Phrase: "W."
Processing 00000000.tx.614: (1984) Biochem. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.615: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.616: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.617: Commun. 

Phrase: "Commun."
Processing 00000000.tx.618: 122, 1131-1135[CrossRef][Medline] [OrderarticleviaInfotrieve] Prelli, F., Castano, E. 

Phrase: "122,"

Phrase: "1131-1135"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Prelli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Castano,"

Phrase: "E."
Processing 00000000.tx.619: M., Glenner, G. 

Phrase: "M."

Phrase: ","

Phrase: "Glenner,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.620: G., and Frangione, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.621: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.622: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.623: 51, 648-651[Medline] [OrderarticleviaInfotrieve] Miller, D. 

Phrase: "51,"

Phrase: "648-651"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "D."
Processing 00000000.tx.624: L., Papayannopoulos, I. 

Phrase: "L., Papayannopoulos,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.625: A., Styles, J., Bobin, S. 

Phrase: "A.,"

Phrase: "Styles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0489654:styles [Idea or Concept]

Phrase: "J.,"

Phrase: "Bobin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.626: A., Lin, Y. 

Phrase: "A.,"

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "Y."
Processing 00000000.tx.627: Y., Biemann, K., and Iqbal, K. 

Phrase: "Y.,"

Phrase: "Biemann,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Iqbal,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.628: (1993) Arch. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.629: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.630: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.631: 301, 41-52[CrossRef][Medline] [OrderarticleviaInfotrieve] Ghiso, J., and Frangione, B. 

Phrase: "301,"

Phrase: "41-52"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ghiso,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.632: (2002) Adv. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.633: Drug Delivery Rev. 

Phrase: "Drug Delivery Rev."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347961:Rev. [Professional or Occupational Group]
   734   C0085104:Drug Delivery [Medical Device]
Processing 00000000.tx.634: 54, 1539-1551[CrossRef][Medline] [OrderarticleviaInfotrieve] Van Dorpe, J., Smeijers, L., Dewachter, I., Nuyens, D., Spittaels, K., Van der Haute, C., Mercken, M., Moechars, D., Laenen, I., Kuiperi, C., Bruynseels, K., Tesseur, I., Loos, R., Vanderstichele, H., Checler, F., Sciot, R., and Van Leuven, F. 

Phrase: "54,"

Phrase: "1539-1551"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Van Dorpe,"

Phrase: "J.,"

Phrase: "Smeijers,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Dewachter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Nuyens,"

Phrase: "D."

Phrase: ","

Phrase: "Spittaels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Van der Haute, C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0007776:Cortex [Body Part, Organ, or Organ Component]
   812   C1176472:Cortex [Body Part, Organ, or Organ Component]
   812   C2700441:Cortex [Plant]

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Moechars,"

Phrase: "D."

Phrase: ","

Phrase: "Laenen,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kuiperi,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Bruynseels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tesseur,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Loos,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sciot,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.635: (2000) Am. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.636: J. 

Phrase: "J."
Processing 00000000.tx.637: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.638: 157, 1283-1298[Abstract/Free FullText] Kuo, Y.-M., Kokjohn, T. 

Phrase: "157,"

Phrase: "1283-1298"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuo,"

Phrase: "Y.-"

Phrase: "M."

Phrase: ","

Phrase: "Kokjohn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.639: A., Beach, T., Sue, L., Brune, D., Lopez, J., Kalback, W., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., and Roher, A. 

Phrase: "A.,"

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sue"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Brune,"

Phrase: "D."

Phrase: ","

Phrase: "Lopez,"

Phrase: "J.,"

Phrase: "Kalback,"

Phrase: "W.,"

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Sturchler-Pierrat,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Staufenbiel,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.640: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.641: Biol. 

Phrase: "Biol."
Processing 00000000.tx.642: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.643: 276, 12991-12998[Abstract/Free FullText] Fryer, J. 

Phrase: "276,"

Phrase: "12991-12998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fryer,"

Phrase: "J."
Processing 00000000.tx.644: D., Taylor, W., DeMattos, R. 

Phrase: "D."

Phrase: ","

Phrase: "Taylor,"

Phrase: "W.,"

Phrase: "DeMattos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.645: B., Bales, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.646: R., Paul, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.647: M., Parsadanian, M., and Holtzman, D. 

Phrase: "M."

Phrase: ","

Phrase: "Parsadanian,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.648: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.649: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.650: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.651: 23, 7889-7896[Abstract/Free FullText] Herzig, M. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "7889-7896"

Phrase: "[Abstract/Free FullText"

Phrase: "] Herzig,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.652: C., Winkler, D. 

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Winkler,"

Phrase: "D."
Processing 00000000.tx.653: T., Burgermeister, P., Pfeifer, M., Kohler, E., Schmidt, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Burgermeister,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Pfeifer,"

Phrase: "M."

Phrase: ","

Phrase: "Kohler,"

Phrase: "E.,"

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.654: D., Danner, S., Abramowski, D., Strchler-Pierrat, C., Brki, K., van Duinen, S. 

Phrase: "D."

Phrase: ","

Phrase: "Danner,"

Phrase: "S."

Phrase: ","

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Strchler-Pierrat,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Brki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "van Duinen,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.655: G., Maat-Schieman, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Maat-Schieman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.656: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.657: C., Staufenbiel, M., Mathews, P. 

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Staufenbiel,"

Phrase: "M."

Phrase: ","

Phrase: "Mathews,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.658: M., and Jucker, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Jucker,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.659: (2004) Nat. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.660: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.661: 7, 954-960[CrossRef][Medline] [OrderarticleviaInfotrieve] McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. 

Phrase: "7,"

Phrase: "954-960"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McGowan,"

Phrase: "E.,"

Phrase: "Pickford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kim,"

Phrase: "J.,"

Phrase: "Onstead,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eriksen,"

Phrase: "J.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "Skipper,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Murphy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.662: P., Beard, J., Das, P., Jansen, K., DeLucia, M., Lin, W.-L., Dolios, G., Wang, R., Eckman, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Beard,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0221982:Beard [Body Part, Organ, or Organ Component]
  1000   C1266881:Beard [Body Part, Organ, or Organ Component]
  1000   C1280542:Beard [Body Part, Organ, or Organ Component]

Phrase: "J.,"

Phrase: "Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
  1000   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jansen,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "DeLucia,"

Phrase: "M."

Phrase: ","

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "W.-L., Dolios,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.663: B., Dickson, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.664: W., Hutton, M., Hardy, J., and Golde, T. 

Phrase: "W., Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.665: (2005) Neuron 47, 191-199[CrossRef] Klein, W. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Neuron 47,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "191-199"

Phrase: "[CrossRef"

Phrase: "] Klein,"

Phrase: "W."
Processing 00000000.tx.666: L., Krafft, G. 

Phrase: "L., Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.667: A., and Finch, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C."
Processing 00000000.tx.668: (2001) Trends Neurosci. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.669: 24, 219-224[CrossRef][Medline] [OrderarticleviaInfotrieve] Lansbury, P. 

Phrase: "24,"

Phrase: "219-224"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.670: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.671: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.672: Natl. 

Phrase: "Natl."
Processing 00000000.tx.673: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.674: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.675: U. 

Phrase: "U."
Processing 00000000.tx.676: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.677: A. 

Phrase: "A."
Processing 00000000.tx.678: 96, 3342-3344[Free FullText] Small, D. 

Phrase: "96,"

Phrase: "3342-3344"

Phrase: "[Free FullText"

Phrase: "] Small, D."
Processing 00000000.tx.679: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.680: (1998) Amyloid Int. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Amyloid Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]
Processing 00000000.tx.681: J. 

Phrase: "J."
Processing 00000000.tx.682: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.683: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.684: Invest. 

Phrase: "Invest."
Processing 00000000.tx.685: 5, 301-304 Haass, C., and Steiner, H. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "301-304 Haass,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "Steiner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.686: (2001) Nat. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.687: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.688: 4, 859-860[CrossRef][Medline] [OrderarticleviaInfotrieve] Grabowski, T. 

Phrase: "4,"

Phrase: "859-860"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Grabowski,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.689: J., Cho, H. 

Phrase: "J.,"

Phrase: "Cho,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.690: S., Vonsattel, J. 

Phrase: "S."

Phrase: ","

Phrase: "Vonsattel,"

Phrase: "J."
Processing 00000000.tx.691: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.692: G., Rebeck, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.693: W., and Greenberg, S. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.694: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.695: (2001) Ann. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.696: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.697: 49, 697-705[CrossRef][Medline] [OrderarticleviaInfotrieve] This Article Abstract Full Text (PDF) All Versions of this Article: 280/44/36883 most recent M504038200v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Permissions Google Scholar Articles by Tomidokoro, Y. 

Phrase: "49,"

Phrase: "697-705"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "280/44/36883 most recent M504038200v1 Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C0441061:Shopping cart [Manufactured Object]
   788   C0179636:Cart [Manufactured Object]
   788   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Tomidokoro,"

Phrase: "Y."
Processing 00000000.tx.698: Articles by Ghiso, J. 

Phrase: "Articles by Ghiso,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.699: PubMed PubMed Citation Articles by Tomidokoro, Y. 

Phrase: "PubMed PubMed Citation Articles by Tomidokoro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "Y."
Processing 00000000.tx.700: Articles by Ghiso, J. 

Phrase: "Articles by Ghiso,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.701: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular and Cellular Proteomics Journal of Lipid Research Biochemistry and Molecular Biology Education Copyright  2005 by the American Society for Biochemistry and Molecular Biology.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Proteomics Journal of Lipid Research Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Molecular Biology Education Copyright  2005 by the American Society"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   742   C0005532:Biology [Biomedical Occupation or Discipline]
   742   C0009993:Copyright [Intellectual Product]
   742   C0013621:Education [Educational Activity]
   742   C0013622:education [Classification]
   742   C0013658:Education, NOS [Finding]
   742   C0037455:society [Organization]
   742   C0039401:Education [Educational Activity]
   742   C0596070:American [Population Group]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

